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Nucleotide excision repair (NER) is a DNA repair pathway that processes helix distorting
lesions in DNA. In humans, lesions such as UV-induced photoproducts are recognized by the
UV-damaged DNA binding protein (UV-DDB). How human DNA repair proteins survey
the genome for UV-induced photoproducts remains a poorly understood aspect of the ini-
tial damage recognition step in nucleotide excision repair (NER). Specifically, the transport
mechanisms employed by UV-DDB, as well as, the stoichiometry of UV-DDB on physio-
logically relevant DNA substrates containing DNA damage remain unclear. To understand
damage recognition by UV-DDB, we performed single molecule experiments, which revealed
that the human UV-damaged DNA binding protein (UV-DDB) samples damage in DNA
primarily via a three dimensional search mechanism. We found that UV-DDB displays a
remarkable heterogeneity in the kinetics of damage recognition. Our results indicate that
UV-DDB examines sites on DNA in discrete steps prior to forming long-lived, non-motile
(DDB1-DDB2)2 dimers at sites of damage. To understand structure-function relationships
governing DNA damage recognition by UV-DDB, we tested the xeroderma pigmentosum
group E (XP-E) causing K244E mutant of DDB2 found in patient XP82TO. We found that
K244E DDB2 supported UV-DDB dimerization but was found to slide on DNA and failed
to stably engage lesions. These findings provide molecular insight into the loss of damage
discrimination observed in this XP-E patient. Here we propose a framework for a conforma-
tional proofreading mechanism for specific damage recognition by UV-DDB.
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1.0 INTRODUCTION
1.1 MAMMALIAN NUCLEOTIDE EXCISION REPAIR AND
XERODERMA PIGMENTOSUM
Exposure of DNA to genotoxins results in the alteration of the integrity of the double helix
of DNA (termed as ‘damage’) (Figure 1.1). Damage in DNA may correspond to base dam-
age (including spontaneous loss of bases, oxidation of bases, formation of chemical adducts,
intra- and inter- strand cross-links) or damage to the phosphodiester backbone of the DNA
(including single or double strand breaks) [1]. DNA damage may be reversed, repaired or
tolerated. Uncorrected damage in DNA can lead to a loss or alteration of the genetic infor-
mation. Maintaining an undamaged copy of the genetic information is critical to survival and
propagation of life, and various DNA repair pathways have evolved to process the different
classes of damage [1]. Not surprisingly, these mechanisms are broadly conserved across all
life forms.
DNA damage which results in the formation of adducts or intra-strand crosslinks due
to chemical modification (henceforth referred to as ‘lesions’) is repaired by the Nucleotide
Excision Repair pathway (NER). This pathway has specifically evolved to repair bulky, helix
distorting lesions in the genome. In this repair pathway, the damage is recognized, verified
and excised followed by restoration of the DNA by the coordinated and highly regulated
activity of over 30 different polypeptides (repair factors) [3]. Deficiencies in the molecular
functions of these repair factors lead to the imperfect processing of DNA lesions resulting
in unrepaired lesions. Patients with mutations in the genes corresponding to some of these
repair factors exhibit forms of the autosomal recessive disorder termed xeroderma pigemen-
tosum (XP), Cockayne syndrome (CS), combined XP/CS and Trichothiodystrophy (TTD)
1
Figure 1.1: DNA damage and repair pathways
Adapted from [2]
[2]. These patients can exhibit photosensitivity, susceptibility to skin-cancers, neurological
abnormalities and premature aging among other symptoms [4, 2].
Bulky DNA damage may be processed in three different ways. These are: global genomic
repair (GG-NER), transcription coupled repair (TC-NER) and translesion synthesis [5, 6,
7]. The presence of lesions in the genome leads to the stalling of the replication fork in
replicating cells. This is because replicative polymerases such as Polδ and Pol are high
fidelity polymerases [8]. Upon encountering unfamiliar bases, these polymerases stall and
are thought to be ‘switched’ out by the lower fidelity, low processivity polymerases which are
capable of incorporating the correct bases against certain types of damaged bases [8, 7]. This
process is called translesion synthesis. In this process, the lesion is not repaired, it is merely
tolerated and the genome is replicated relatively accurately, giving the repair machinery
another chance to detect it.
An alternate strategy to process damage is to detect it and to repair it. In this case, there
are two ways by which damage may be recognized (see figure 1.2). In actively transcribed
DNA, RNAP which reads the DNA to generate template RNA stalls at sites of damage.
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These stalled RNA polymerases (RNAP) at sites of lesions in the template strand undergoing
transcription serve to trigger the TC-NER pathway of NER [6]. These lesions are then
handed over to the damage verification factor in NER, followed by lesion processing.
On the other hand, damage in genomic DNA is also recognized and repaired indepen-
dently of the transcriptional state of the genome. This pathway of NER is known as Global
Genomic Repair (GG-NER). In this pathway, DNA damage surveillance factors recognize
damage in genomic DNA and then hand over the lesion to downstream damage verification
and processing factors. In mammalian cells, these two pathways converge at the stage of
damage verification and these reactions are orchestrated by over 30 different gene products
(figure 1.2) [3].
1.2 SUBSTRATES OF THE NER PATHWAY
The NER machinery is capable of processing a wide variety of lesions. Some of these have
been characterized and include: UV-induced photoproducts, polycyclic aromatic hydrocar-
bons, aromatic amines, cholesterol adducts and psoralen mono-adducts. For a comprehensive
list, refer to the review by Gillet and Scharer [5].
1.3 DNA TRANSACTIONS IN GLOBAL GENOMIC REPAIR
In this work, we will discuss damage recognition during the GG-NER pathway of NER. The
basic DNA transactions involved in NER broadly consist of the following steps: damage
surveillance and recognition; damage verification; helix opening and stabilizing of the repair
intermediates; dual incision of the DNA in the context of the lesion; repair synthesis and DNA
ligation [9]. These DNA transactions are coordinated by a large number of repair factors
which assemble and disassemble sequentially at sites of damage [10, 11, 12, 13, 14]. It follows
thus, that the composition of the NER machinery is dynamic and its biological function is
highly regulated both by the presence of available binding motifs/partners as well as post-
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Figure 1.2: Global genomic nucleotide excision repair
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translational modifications. With this concept of hand-offs in mind, here, we will outline the
roles of the various gene products that co-ordinate the various DNA transactions discussed
above, with an emphasis on known interactions and known roles in DNA processing.
Damage in DNA is recognized by two damage surveillance factors - the UV-DDB complex
and the XPC complex (Figure 1.2) [15]. The UV-DDB complex consists of the heterodimer
of the DDB1 (p127) and DDB2 (p48) peptides, which are tightly associated together [16].
Early studies failed to detect a significant role of UV-DDB in promoting NER in vitro,
since the complete repair reaction could be recapitulated in the absence of UV-DDB using
recombinant repair factors on naked damaged DNA substrates [3]. Hence, UV-DDB was
considered to be an accessory factor in the recognition of photoproducts in vitro. However,
in vitro studies provided evidence that UV-DDB efficiently recognizes certain types of damage
such as cyclobutane pyrimidine dimers (CPD) [17, 18], compared to the global damage sensor
XPC-HR23B-Centrin2 (‘XPC’) [19, 20]. This in vitro finding was recapitulated in vivo, where
UV-DDB was found to greatly stimulate the repair of these lesions in cells [21, 22]. Further,
it was found that the repair of lesions in nucleosomal DNA is greatly inhibited in the absence
of UV-DDB and that this repair factor is not dispensable for the recognition of lesions in
the context of chromatin [22, 23]. In vivo, DDB2 is found to be constitutively associated
with the E3 ligase formed by DDB1, Cullin4A/B proteins and the E2 ligase RBX1/Roc1
(CRL4DDB2) [24, 25]. DDB2 is considered to be a DDB-Cullin4 associated factor (DCAF)
[24] specializing in damage recognition [16] and can be thought of as an adapter protein for
targeting E3 ligase activity to sites of DNA repair (Figure 4.1) [25, 26, 27, 28, 29]. A survey
of cell lines derived from XP-E patients has revealed that patients suffering from the XP-E
phenotype exhibit defects in the DDB2 gene corresponding to mutations in the DNA binding
interface, or result in a misfolded protein or premature stop codons [30].
The ubiquitination activity of CRL4DDB2 is regulated by the Cop9 signalosome (CSN)
[29, 25, 31]. Upon DNA damage binding, the CSN complex dissociates, enabling the NEDDy-
lation of Cullin4, thus activating the E3 ligase [31, 25]. Activated CRL4DDB2 ubiquitinates
histones (H2A, H2B, H3 and H4) in the vicinity of the lesion, and this activity is required for
chromatin relaxation [28, 27, 32]. This chromatin relaxation regulates access to the down-
stream repair factors such as the XPC complex [33]. In addition, XPC has been found to be a
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substrate for ubiquitination of CRL4DDB2 [29]. This post-translational modification of XPC
leads to an enhanced affinity for the lesion [29]. As final substrates, lysines in the N-terminus
of DDB2 are auto-ubiquitinated resulting in a degradation signal for DDB2 completing the
hand-off of the lesion from UV-DDB to XPC [29, 28, 26, 32, 25].
The XPC protein exists as a heterotrimer of XPC-hR23A/B-Centrin2 (XPC complex)
[34, 35, 36]. In this complex, hR23A and hR23B play a functionally redundant role by
enhancing XPC stability and protecting it against proteasomal degradation [37, 38, 34]. A
recent report suggests that hR23A/B dissociates upon stable damage recognition by XPC
in vivo [39]. Centrin2 has been shown to enhance the DNA binding activity of XPC to
6-4 PP in vitro and the binding of centrin2 leads to an enhanced rate of NER in vitro as
well as in vivo [36]. The damage recognition activity of XPC is indispensable for NER, and
patients suffering from molecular defects in XPC exhibit the xeroderma pigmentosum group
C phenotype [40]. It is now clear that UV-DDB is the initiator of global genomic repair
in mammalian cells, whereas, the XPC complex recognizes a wider set of damaged DNA
substrates and functions as a global damage sensor [41]. Thus, between UV-DDB and XPC,
these two damage recognition factors recognize a diverse set of structurally distinct bulky
DNA adducts in DNA.
Damage recognized by upstream factors such as UV-DDB and XPC is verified by the
basal transcription factor IIH (TFIIH) (Figure 1.2) - a ten subunit protein complex consisting
of XPB, XPD, p62, p52, p44, p34 and p8/TTDA, which form the core complex, and the
cdk-activating kinase (CAK) sub-complex, which consists of cdk7, MAT1 and cyclin H [42].
Mutations in TFIIH have been found in XPB, XPD and p8 and these have been linked to XP,
XP/CS and TTD [43]. Disease causing mutations in the other subunits of TFIIH have not
been discovered so far. This may be due to an extremely disruptive manifestation of these
mutations leading to inviability because of the multiple known roles of TFIIH in repair as
well as transcription. It is quite conceivable that pathogenic mutations in the other subunits
which affect the molecular functions of TFIIH may be discovered in the future. TFIIH is the
next factor to arrive at the site of damage and this recruitment is thought to occur through
specific interactions of XPB and/or p62 subunits with XPC bound to a lesion [44, 45]. This
interaction occurs via the C-terminus of XPC which is intrinsically disordered in the apo
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state [45, 46]. In addition to this previously described binding site of XPC, a new set of
residues 76-115 have been identified for the Rad4/XPC protein which bind the PH domain
of the Tfb1/p62 subunit of TFIIH [47]. This newly discovered interaction has implications
in regulating the interactions with XPG and will be discussed later.
XPB is a 3’-5’ helicase whose activity is modulated by the p52 subunit of TFIIH via a
physical interaction between the two [48, 49, 50]. Interestingly, it has been demonstrated
that its helicase activity is dispensible for NER, whereas its ATPase activity is not [51]. The
ATPase activity of XPB is thought to induce a conformational change which promotes the
loading of TFIIH at sites of damage [52]. The precise role of XPB in DNA melting during
NER is not known, however, it is speculated that XPB acts as a wedge to keep the two DNA
strands from re-annealing [51]. Defects in the ATPase activity of XPB helicase lead to the
xeroderma pigmentosum group B phenotype [53].
TFIIH contains within it, another helicase, known as the XPD helicase [52]. XPD is
a FeS containing 5’-3’ helicase and is considered to be the active helicase in NER [54, 55].
Its helicase (and associated ATPase) activity is required to open up the DNA around a
damaged site by about 25 nt [56, 51]. Emerging evidence points to its importance as a
damage verification factor in NER and recent biochemical studies have revealed that XPD
can discriminate the damaged strand from the undamaged strand and further, mutational
studies have revealed the presence of residues which lack this ability [57]. Defects in XPD
lead to the xeroderma pigmentosum group D phenotype, TTD and also result in combined
XPD\Cockayne Syndrome [58]. XPD has been demonstrated to physically interact with
CAK via MAT1 [59]. The helicase activity of XPD is highly regulated by protein-protein
interactions with negative regulation by the CAK complex and positive regulation by its
interactions with p44 [60, 61]. Mutations found in XP-D patients have been mapped to the
p44 interacting domain of XPD and the ATPase domain. In vitro, these mutants were found
to exhibit impeded DNA opening in the absence of ATPase (and hence helicase) activity and
limited DNA opening for mutations in the p44 interacting domain [51].
Opening up of the helix by the XPD helicase in TFIIH is thought to generate repair
intermediates which are synergistically stabilized by the XPA and RPA proteins (Figure 1.2)
[59]. In this intermediate, XPA is thought to bind the kinked DNA [62]. The RPA proteins
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are single strand DNA binding proteins and are thought to stabilize the single strands gen-
erated by the unwinding action of TFIIH. Importantly, RPA recruitment is contingent to
XPA recruitment to TFIIH [59]. The XPA protein has been demonstrated to bind residues
in the N-terminus of XPC (156-325) [63]. The recruitment of XPA to TFIIH in turn, is
dependent on successful helix unwinding by XPD, via interactions in its C-terminus and
results in the dissociation of CAK from TFIIH [59, 64]. This dissociation of CAK acts as
a switch that determines the participation of TFIIH in repair or transcription [59]. Suc-
cessful damage recognition and verification leads to the formation of a pre-incision complex
containing XPC, TFIIH (minus CAK), XPA and RPA (Figure 1.2).
Clearly, XPA is a central player mediating the various interactions in mammalian NER.
Opening up of the lesion allows for recruitment of XPA which in turn recruits the endonucle-
ases XPF-ERCC1 and XPG. In addition to interactions with XPC, RPA and TFIIH, XPA
interacts with the structure specific, metal dependent nuclease (Mg2+) XPF-ERCC1 which
performs the 5’ cut [65]. XPF is an obligate heterodimer with the ERCC1 protein and recog-
nizes and incises various DNA structures including bubbles, flaps and loops [65, 66, 67, 68].
XPF-ERCC1 is known to interact with RPA and this interaction is thought to be responsible
for the correct cellular localization of XPF in vivo [69, 70, 71]. Further, ERCC1 has been
demonstrated to interact with XPA [72, 73, 74]. XPF-ERCC1 is thought to be recruited
in an XPB dependent manner and binds the single strands in the open complex which are
generated by unwinding [75, 76, 77].
The metal (Mg2+) dependent, structure specific endonuclease XPG performs the 3’ cut
and has been demonstrated to incise 10-30 nt bubbles, splayed arms and release a mononu-
cleotide from ssDNA in vitro [78, 75]. XPG interacts with RPA as well as with the XPB,
XPD, p44, p62 in TFIIH [79, 80, 81]. Importantly, there is evidence that both Rad4/XPC
and Rad2/XPG compete for binding to the Tfb1/p62 subunit of TFIIH in NER by occu-
pying the same site on Tfb1 [47]. This finding provides evidence for the competition of
XPC-HR23B and XPG for a common binding site on the PH domain of Tfb1, validating
previous evidence which indicates that XPG competes off XPC-HR23B [82]. This suggests
that recruitment of XPG to the open complex generated by TFIIH displaces XPC (Figure
1.2).
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The incision by XPF-ERCC1 occurs after the DNA has been unwound by XPD [75]. In
this function, XPG plays a structural role in promoting the 5’ incision since, catalytically
dead XPG is sufficient to induce incision by XPF-ERCC1, suggesting that the 5’ incision
occurs first [83, 84, 85]. On the other hand, recent research reveals that active XPF-ERCC1
is required for incision by XPG [84, 85]. Further, partial repair synthesis has been detected
in the presence of catalytically dead XPG suggesting that repair synthesis triggers a con-
formational change in XPG which in turn induces its catalytic activity [85]. Since, incision
by XPF-ERCC1 occurs in an XPB dependent manner [86], and XPG is recruited via inter-
actions with TFIIH, it is likely that TFIIH dissociates after the 5’ incision is performed by
XPF-ERCC1 (Figure 1.2). It is known however, that recruitment of a minimal replication
system consisting of RFC, PCNA and Polδ is dependent on the presence of catalytically
active XPF-ERCC1 [85]. Polymerization by Polδ is believed to displace RPA and XPG
from the site [86]. Finally, ligation is performed by ligase I and by ligaseIII-XRCC1 [86, 87]
(Figure 1.2).
1.4 DAMAGE RECOGNITION AND VERIFICATION IN NER
The basic DNA transactions involved in NER broadly consist of the following steps: damage
surveillance and recognition; damage verification; helix opening and stabilizing of the repair
intermediates; dual incision of the DNA in the context of the lesion; repair synthesis and DNA
ligation. At each step along this complex transformation and restoration of DNA, protein
partners are recruited to the site of repair to perform these DNA transactions. Each of these
transactions proceeds via combinations of highly regulated protein-protein and protein-DNA
interactions that act upon specific substrate repair intermediates to transform them into a
new set of product repair intermediates that can be recognized by subsequent players in the
pathway. Here we examine some of the features of damage recognition and verification.
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1.4.1 DNA damage influences the local dynamics and thermodynamics of DNA
Chemical modification of the base pairs in DNA via the formation of bulky adducts results
in the loss of base pairing information. These lesions lead to the formation of poorly paired
or unpaired bases (‘orphaned bases’) in DNA. Modified bases in DNA may be extra- or
intra-helical in nature arising from a reconfiguration of the local structure and dynamics of
the DNA in the context of the lesion. For example, bulky polycyclic aromatic hydrocarbon
(PAH) lesions intercalate in the DNA helix displacing the orphaned base and subsequently
altering its dynamics and thermodynamics [88]. Further, the dynamics of the lesion are also
affected by the specific sequence of the context in which the lesion is formed [89]. Indeed,
the energy minimized rearrangement of the lesion in the context of the DNA influences
both the local dynamics as well as the local thermodynamics of the DNA. This is achieved
by maximizing favorable interactions (hydrogen bonding, van der Waals forces, aromatic
stacking) of the lesion with the neighboring bases at the cost of unfavorable interactions
(disruption of both hydrogen bonding and aromatic stacking of the orphaned bases via base
eviction or distortion of the double helix). Experimental evidence has revealed that the repair
of structurally diverse lesions proceeds at different rates and this is due to the differential
detectability of the lesions by NER - a phenomenon which is crucially dependent on the
structure and dynamics of the lesion in the context of the undamaged DNA [88, 90, 91].
1.4.2 Base-flipping is a universal mechanism in damage recognition
The impairment of Watson-Crick pairing may result in a greater ability of the orphaned base
or the lesion to be flipped out. The base flipping transition involves two regimes, a regime
in which the penalty of disrupting the Watson-Crick pairing rises quadratically around the
mean position of the base in the intrahelical conformation until about a displacement by 25◦
on either side, and a second regime in which the energy rises linearly [92]. The energetic
costs of flipping undamaged adenine (A), thymine (T), guanine (G) and cytosine (C) are
estimated to lie in the range of 15-20 kcal mol−1 [93, 94]. Alteration of base chemistry results
in perturbations in its base flipping energy. In contrast, the energetic cost of flipping a cis,
syn-cyclobutane pyrimidine dimer (CPD) is estimated to be 6.25 kcal mol−1 [94]. Further,
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this estimated value was found to be sensitive to the sequence context with a lower ∆Gflip for
the CPD in the context of A or T sequences by about 0.5-2 kcal mol−1 [95]. Similarly, the en-
ergetic cost of flipping another NER substrate 14R (+)-trans-anti-dibenzo[a,l]pyrine-N2-dG
(14R-dG*) was found to be 10.4 kcal mol−1, about 7.7 kcal mol−1 lower than the correspond-
ing undamaged DNA [96]. It is important to note that even with these lower penalties of
base flipping, neither the damaged nor the orphaned bases are predominantly extrahelical
in nature. These values merely indicate that damaged bases have a greater propensity to
make extrahelical excursions compared to undamaged bases, in a lesion dependent manner.
The destabilization of the damaged and orphaned bases arising from the lower energetic
penalty of base flipping of damaged bases may be exploited by damage recognition enzymes
to recognize damage with high specificity. Given the significantly lower energetic barrier to
flipping damaged bases, a first test for damage might involve the probing of the Watson-
Crick base pairing (or lack thereof) between the bases being tested in the search for damage.
Structural features on the protein which act as the probe and evict the damaged bases could
interact with undamaged bases in the context of the DNA, resulting in the lowering of the
barrier for base-flipping so that it would be accessible to thermal fluctuations in the presence
of the repair factor. Damage recognition might involve probing the DNA for deformability
via the energetically unfavorable transition of base flipping and this may represent a test
for the presence of damage. Such a mechanism would confer damage specificity, enabling
the recognition of rare damaged bases in a vast majority of undamaged bases upon rapid
sampling. Indeed examination of the DNA bound states of various photoproduct recognizing
repair factors reveals that base flipping is a common theme for the recognition of UV-induced
photoproducts and likely other bulky lesions (see table 1.1).
1.4.3 Damage recognition factors utilize structural features to sense alterations
in DNA dynamics
If damage recognition occurs spontaneously, the energetic cost of displacing the lesion must
be compensated by enthalpic interactions which release energy upon binding or increase the
entropy of the system upon binding. How might these constraints be met?
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(a) T4 bacteriophage EndoV (b) S. acidocaldarus UVDE
Figure 1.3: UV-endonucleases
Two possible solutions involve providing enthalpic stabilization by providing interactions
to the displaced lesion or to the orphaned bases. Thus, successful damage recognition would
be bipartite: in the first step, the lesion is displaced to an extrahelical conformation and
in the second step, the orphaned base or the lesion is stabilized via interactions with the
protein.
An examination of crystal structures of damage recognition enzymes reveals that these
ideas outlined above are general features of photoproduct recognition and variations on the
combinations of these are present in nature. Table 1.1 represents a non-exhaustive, but
illustrative survey of different classes of DNA repair proteins that recognize UV induced
photoproducts as part of their biological functions.
(a) A. nidulans CPD
Photolyase
(b) M. mazei CPD
Photolyase
(c) D. melanogaster 6-4
Photolyase
Figure 1.4: Photolyases
Table 1.1: Survey of structural features in proteins recognizing UV-induced damage
Repair
factor
Activity Organism Lesion Probe Lesion Pocket
Orphaned
base pocket
PDB Ref
T4 endoV endonuclease
T4
bacteriophage
Thymine
dimer
R22, Q23, R26 K121, R117
Y21,D87, T89,
Q91
1VAS [97]
UVDE endonuclease
Sulfolobus
acidocaldarius
6-4 PP Q103, Y104
K271, S7,
K269, S60,
R57, E266,
H243,
L65, S67, H68,
E121
4GLE [98]
CPD
photolyase
lyase
Anacystis
nidulans
split TT dimer P402
M353, N349,
W392, E283,
R232, W286
Y468, L403,
K472
1TEZ [99]
CPD
photolyase
lyase
Methanosarcina
mazei
CPD R429, W431
M379, W305,
W421, E301,
D428, R441
None 2XRZ [100]
6-4
photolyase
lyase
Drosophila
melanogaster
6-4 PP Q418, R421
Q299, W302,
W409, P247,
V294
None 3CVU [101]
Rad4
damage
recognition
Saccharomyces
cerevisiae
CPD
E600, R601,
G602, S603,
T604
none
Q495, M498,
R494,F556,
V594, F597,
F599
2QSG [41]
UV-DDB
damage
recognition
Homo sapiens
DDB1, Danio
rario DDB2
CPD
F371, Q372,
H373
W239, I213,
G192, R214
None 4A08 [25]
1.4.4 Combinations of structural features determine biological function
The substrate affinity, specificity and repertoire for DNA damage recognition enzymes arise
from the steric constraints imposed by the lesion recognition pocket. Indeed, from the
examples provided here (see table 1.1), it is evident that the lesion binding pocket has
evolved specifically to recognize certain substrates and these direct the substrate specificity
of the enzyme. Highly functionally specialized enzymes such as CPD or 6-4 photolyases
demonstrate a high specificity for one substrate over another that arises from sterically
selective interactions in the lesion binding pockets [98, 99, 100, 101]. Broader substrate
specificity is obtained by more permissive lesion binding pockets. For example, the UV-
DDB protein exhibits a lesion binding pocket that accommodates 6-4PP and CPD lesions,
suggesting that this repair factor has evolved for the specific recognition of these lesions
[25, 102, 16]. Other damage recognition factors possess even broader substrate specificity.
The global damage recognition factor, Rad4 (orthologue of the human XPC protein) exhibits
a binding pocket for the orphaned base while exhibiting no apparent binding pocket for the
lesion [41]. This lack of a binding pocket for the lesion explains the broad substrate repertoire
of Rad4 and the related XPC protein [103, 104, 29], while conferring the properties of a sensor
of altered DNA dynamics arising from DNA damage.
1.4.5 Successful damage recognition generates a repair intermediate with a con-
served topology and reduced conformational entropy
The NER pathway repairs structurally and dynamically heterogeneous lesions in DNA. DNA
damage surveillance factors must recognize a wide variety of initial configurations of the DNA
and manipulate them to generate a product repair intermediate that has little dependence
on the exact chemical nature of the lesion. In this process, the repair machinery must
modulate and accomodate both the structure as well as dynamics of the DNA containing
the lesion to create this product repair intermediate. This product repair intermediate must
be recognizable by downstream repair machinery so that manipulations may be performed on
the damaged DNA with a minimal requirement for damage re-recognition or re-verification.
As discussed above, the substrate repertoire is determined by the specific configurations of the
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(a) S. cerevisiae Rad4-Rad23 (b) hsDDB1-drDDB2
Figure 1.5: NER damage recognition factors
lesion binding pocket. From the examples presented in table 1.1 and figures 1.3, 1.4 and 1.5,
a remarkable convergence of the topology of the repair intermediate generated upon repair
factor binding emerges - one in which the helix is probed by the factor, and the lesion or the
orphaned bases or both are stabilized on the binding surface. In this process of binding, the
repair factor converts highly dynamic damaged DNA to a highly stable DNA intermediate,
reducing its conformational entropy in this process. This reduction in conformational entropy
may be a pre-requisite for successful damage processing by downstream factors.
1.4.6 Intermediates generated by damage recognition may not be substrates
for the pathway
It is important to note that this process of recognition discriminates and selects for DNA
damage that may be stabilized in this manner. The set of substrates repaired by the NER
machinery may be smaller than the set of substrates recognized by the repair factors and
smaller yet than the set of bulky lesions formed in DNA. For example, DDB2 has been
demonstrated to bind a variety of DNA structures including 6-4 photoproducts, abasic sites
and two base mismatches with extremely high affinity and CPD lesions and cisplatin adducts
with relatively lower affinity [105, 18], however, the repair of abasic sites and mismatches
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is not known to proceed via NER. In this first step, the recognition factors falsely identify
other lesions that can be stabilized in the configuration of the intermediate recognized by
subsequent NER machinery. On the other hand, there may exist a class of bulky lesions
which might appear to be canonical NER substrates at first glance, but escape detection
since these lesions may fail to participate in the recognition reaction or yield an unstable
repair intermediate resulting from the binding of the repair factor. The efficiency of repair
of lesions is highly determined by the lesion context, chemistry and stereochemistry as well
as downstream events as observed [106].
1.4.7 Repair intermediates are further processed to verify damage
Given that the recognition factors generate repair intermediates that can be stabilized by
intrahelical probing and lesion or orphaned base stabilization, the end products of this re-
action are not guaranteed substrates for downstream processing in NER. This necessitates
the requirement for a damage verification enzyme. The NER machinery must then trans-
form the repair intermediate containing a candidate NER substrate to a repair intermediate
containing a verified NER substrate. In the next step following damage recognition, the
machinery must distinguish the damaged strand from the undamaged strand and identify
the specific position of the lesion. Further, the repair machinery must interact with the
lesion in a non-specific manner, so as to be able to process a diverse substrate repertoire. In
the absence of structural evidence for the intermediates, identification of general structural
principles is difficult; however, hints for the mechanism of action are available from genetic,
molecular biology, biochemical and single molecule biophysical studies.
Following damage recognition by the XPC complex, damage verification is performed
by TFIIH. TFIIH is recruited to the sites of damage via specific interactions with the XPB
subunit. This finding suggests that loading of TFIIH at sites of damage occurs in a defined
manner which might explain the ability of the complex to distinguish the non-damaged from
the damaged strand. Binding of TFIIH also promotes the binding of XPA to the sites of
damage. XPA is known to bind highly distorted DNA structures and perhaps the synergistic
binding of XPA and RPA to the open complex generated by unwinding of the double helix
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by XPD might serve to form a damage verification intermediate. Since NER is known
to progress via the sequential assembly of repair factors, this intermediate may function
to ensure that all the protein partners are in conformations that enable the complex to
progress along the correct reaction trajectory. Available data from single molecule studies
of the helicase activity of XPD indicate that XPD is a poorly processive helicase with a step
size of 1 bp, with frequent backtracking due to re-annealing [54]. This finding is consistent
with its biological role where it unwinds short tracks of dsDNA in the context of lesions.
However, these data must be interpreted cautiously since the biological function of XPD is
manifested in the context of the other subunits of TFIIH, which are known to modulate its
processivity. Biochemical evidence is available demonstrating that the XPD helicase stalls
upon encountering CPD lesions in its ATP dependent translocation [107]. Further, mutants
of XPD have also been identified which fail to stall at sites of CPD lesions, suggesting the
presence of structural features on XPD which recognize damage in DNA [57]. The emerging
model suggests that damage verification in NER, occurs in an ATP dependent manner by a
helicase which is the ultimate gatekeeper of competency of the damage for NER. The roles
of the other subunits of TFIIH and the interplay between them during damage verification
by XPD remain largely un-elucidated.
1.5 PROOFREADING MECHANISMS FOR LESION RECOGNITION
AND VERIFICATION
Damage recognition factors are faced with the task of rapid and accurate recognition of
damage. In this process, recognition factors bind DNA and upon successful recognition, the
complex transits to a stable intermediate in a process that requires the crossing of energy
barriers. While some of these barriers may be overcome by the enthalpy of binding, in
some steps, the energy of ATP hydrolysis may be required to successfully navigate the free
energy landscape along the reaction coordinate. However, examination of the various DNA
repair pathways reveals a general theme (not without exceptions) that damage recognition
can occur in the absence of external energetic inputs, whereas damage verification relies on
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additional energy for accurate processing. Keeping with these differences, two mechanisms of
proof-reading have been described, including kinetic proofreading [108] and conformational
proofreading [109] for molecular recognition with high specificity. How is specificity achieved
in molecular recognition in these two distinct mechanisms?
1.5.1 Kinetic proofreading
Kinetic proofreading was originally proposed to explain the low error rates of polymerases
in replication. Systems employing kinetic proofreading are proposed to have three distinct
features:
1. They exhibit a low specificity for substrates
2. An essentially irreversible reaction involving the conversion of a high energy cofactor to
a low energy product is used to generate a high energy intermediate. Importantly, in the
absence of this external energetic input, the high energy intermediate is rarely formed.
3. A branched enzymatic pathway converts the high energy intermediate with the correct
substrate to the correct product along one pathway, and rejects the intermediate to
generate the original enzyme configuration and a rejected, modified substrate.
Such a proofreading mechanism has been proposed to explain the ability of the NER
pathway to utilize ATP hydrolysis to process a broad set of substrates which are recognized
with low specificity by the damage recognition factors [110].
1.5.2 Conformational proofreading
An alternate mechanism for discrimination of substrates with high specificity in the absence
of energy utilization has been proposed, termed as conformational proofreading [109]. In
this mechanism, instead of a high energy intermediate, a structural mismatch is proposed
to exist between the bound state and the unbound state for the enzyme. In this case, only
the correct substrate is able to induce a conformational transition between the unbound
state and a highly stabilized bound state. Binding of the incorrect substrate does not invoke
the structural transition to the same stabilized state; enhancing the substrate specificity
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of the recognition factor. Conformational proofreading has been proposed to explain the
specific recognition of cognate sequences by transcription factors and has been experimentally
validated for homologous recombination where the dsDNA is proposed to be the recognizer
[109, 111].
Conformational proofreading is an attractive alternate explanation for molecular recog-
nition in the absence of energy inputs in the initial step of damage recognition. However, to
date, conformational proofreading has not been proposed as a mechanism for damage recog-
nition with high specificity in the binding of damage recognition factors to DNA damage in
the initial stages of NER.
Here, we hypothesize that conformational proofreading is the predominant mechanism
for recognition of damage in NER. Further, we propose that a complex interplay of confor-
mational as well as kinetic proofreading is required to process NER competent substrates.
While apparently operative in molecular recognition in homologous recombination, whether
conformational proofreading is a universal mechanism in damage discrimination in other
DNA repair pathways remains to be seen.
1.6 THE SUBSTRATE SEARCH PROBLEM
DNA binding proteins that bind specific targets (sequences or structures) in DNA must
discriminate their cognate substrates in a noisy environment constituted of a large number
of mis-substrates that resemble the cognate substrate. The search problem for DNA binding
proteins locating their targets is conceptually very simply stated as follows: what transport
mechanisms do DNA binding proteins utilize to identify their targets in DNA?
Various transport mechanisms have been proposed involving combinations of three di-
mensional diffusion and/or ‘jumping’ (see figure 1.6 a) based iterative cycles of binding and
dissociation and one-dimensional sliding mechanisms [112]. Within the one dimensional slid-
ing mechanism, there are several possible modes of facilitated diffusion including, hopping
(figure 1.6 b), directed motion (figure 1.6 c), simple linear diffusion or linear diffusion coupled
to rotational diffusion (figure 1.6 d), and inter-segmental transfer (figure 1.6 e). Not all of
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Figure 1.6: Transport mechanisms involved in target site location
these modes of motion may be accessible to all DNA binding proteins and this accessibility
of search modes is influenced by protein structure. For instance, only proteins with ATPase
domains may be able to participate in an energy driven directed motion, and only those
proteins containing multiple DNA binding domains may perform inter-segmental transfer.
Irrespective of the transport mechanism, proofreading is an indispensible aspect of the search
mechanism. Efficient search relies on cycles of transport and proofreading.
1.7 OBJECTIVES OF THIS WORK
In recent years, the core set of NER factors which orchestrate repair has been identified and
many features of repair have been reconstituted in vitro. Even with this understanding of
interacting partners and a broad understanding of the roles of these factors, our understand-
ing of NER remains incomplete. Much of the progress has arisen from investigation of this
pathway using genetic, molecular biology, biochemical and cell biology approaches. How-
ever, our understanding of the heterogeneity of the dynamics, sequence and determinants
(presence of protein partners, conformational changes and post-translational modification)
of these protein-protein and protein-DNA interactions using targeted structure-function ap-
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proaches at the single molecule level has been limited owing to tremendous challenges in
purification of functionally active recombinant NER proteins.
The elucidation of crystal structures and the amenability to recombinant expression
and purification of the UV-DDB heterodimer have enhanced our understanding of the initial
stages of damage recognition in NER. In vivo, as well as, in vitro studies have greatly clarified
the role of UV-DDB in initiating global genomic nucleotide excision repair. However, even
as our understanding of the network of interactions of UV-DDB and its protein partners
increases, fundamental questions regarding damage surveillance and substrate recognition
remain. How does UV-DDB search for damage on DNA? How does it proofread DNA
for damage? What are the structure-function relationships that govern this proofreading?
What is the oligomeric state of UV-DDB in damage recognition? What is the basis for the
specificity of UV-DDB for UV-damage in DNA?
In this work, we wanted to examine the interactions of UV-DDB with undamaged and
damaged DNA substrates using single molecule techniques in order to understand some of
these fundamental questions pertaining to the structural and dynamical bases of damage
recognition. To that end, the objectives of this work were three fold:
1. Implement assays and algorithms to observe and analyze single particle tracking data to
understand the diffusive and binding behaviors of single labeled molecules
2. To develop biological reagents and identify strategies to observe site specific interactions
of quantum dot conjugated proteins at sites of repair substrates
3. To implement these methods to study the real-time interactions of the damage recogni-
tion enzyme UV-DDB in order to elucidate the kinetics of the initial steps of damage
recognition
In the following chapters, we will treat these objectives sequentially. Chapter 2 will describe
experimental methods used in the study. Chapter 3 will discuss the relevant theory and
methods for analysis of data arising from single particle tracking experiments. Chapter 4
will describe the study of UV-DDB binding to various damaged DNA substrates. In Chapter
5 we will summarize the results of this study and discuss avenues for further investigation.
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2.0 MATERIALS AND METHODS
2.1 CHARACTERIZATION OF DNA BINDING ACTIVITY
2.1.1 Electrophoretic mobility assays
2.1.1.1 Binding conditions
UV-DDB binding was performed by incubating the indicated amounts of UV-DDB with
indicated DNA substrate for 20 min at RT. Samples were diluted in loading buffer containing
glycerol prior to separation using native gels.
2.1.1.2 Agarose gel electrophoresis
Binding reactions were separated over a 1 % agarose gel for 50 min at 100 V on ice. Gels
were dried for 1 h at 65 ◦C.
Abasic site substrates
36 mer DNA substrates for EMSA containing a defined lesion were created by hybridizing
the top strand (AP36: 5’- Phos CCG AGT CAT TCC TGC AGC G/idSp/G TCC ATG
GGA GTC AAA - 3’ or UD36: 5’ - Phos CCG AGT CAT TCC TGC AGC GAG TCC
ATG GGA GTC AAA - 3’) with its 32P radiolabeled reverse complement. Hybridization
was performed in 1X hybridization buffer at 1µM concentration of each strand.
2.1.2 Pulldown experiment
2.1.2.1 Preparation of DNA substrates
DNA substrates for pulldown experiment were designed with modifications on both ends.
517 bp DNA was created by amplifying pUC18 using the Dig1890A (5’ - /5DigN/ GGT CTG
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ACG CTC AGT GGA ACG - 3’) and Bio1373s (5’ - GGA ACC GGA GCT GAA TGA AG
- 3’) primers to create DNA substrate which can be blocked on either end with streptavidin
or anti-digoxigenin antibody. PCR was performed using Pfu ultra with 10 ng of pUC18.
Cycle conditions for PCR were: 94 ◦C for 5 min (hot start, add pol after 2 min), 94 ◦C for
30 s, 57 ◦C for 1 min, 72 ◦C for 1 min (30 cycles) and 72 ◦C for 7 min. PCR product was
separated on a 1 % agarose gel to identify homogeneity of amplification. PCR reaction was
then purified using Qiaquick PCR purification kit (Qiagen, cat. # 28104). Purified DNA
was eluted in tris-Cl pH 8.0 and concentrations of DNA were measured using a Nanodrop.
Typical yields for purification were found to be between 50 - 60 %.
2.1.2.2 UV-irradiation of 517 bp DNA
UV-damaged DNA was obtained by exposing the purified DNA to a dose of 20 Jm−2 at 50
ngµL−1. DNA damage in 517 bp DNA was quantified using QPCR and was found to occur
at a frequency of 1.2 polymerase blocking lesions per 517 bp fragment from two experiments
(15 and 16 cycles).
2.1.2.3 Conjugation to beads
Bio-517-dig DNA (either mock or UV- irradiated) was then incubated with streptavidin
coated magnetic beads in the presence (4X excess over DNA) or absence of anti-digoxigenin
antibody (Roche, cat. # 11 333 062 910) to get undamaged or UV-damaged DNA bound to
beads with either one free end or no free ends. Blocking was performed for 3 overnights at
4◦C. WT UV-DDB or K244E was incubated with DNA bound on beads in 1X binding buffer
for 30 min at RT in a reaction volume of 20 µL. In these experiments, the final concentration
of the UV-DDB (WT or K244E mutant) was either 5 nM or 10 nM (as indicated) and that
of DNA on beads was 12.5 nM in a total reaction volume of 20 µL. After binding, the beads
were washed with 3 volumes and resuspended in 21 µL of 1X binding buffer and 7 µL of
4X LDS buffer. Samples were boiled for 10 min at 95◦C and separated on a 4-12 % SDS
gradient gel. Gel was subsequently transferred and Western blotting was performed on the
various fractions which were probed with α-DDB1 and α-DDB2 antibody.
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2.2 ATOMIC FORCE MICROSCOPY
2.2.1 Sample preparation
2.2.1.1 Proteins
Protein only samples were deposited on a freshly cleaved mica surface at concentrations in
the range from 20-40 nM in 1X AFM deposition buffer (25 mM NaOAc, 10 mM Mg(OAc)2
and 25 mM Hepes pH 7.5).
2.2.1.2 DNA
DNA substrates in the range of 450-600 bp were deposited under conditions of 0.5-2 nM in
AFM deposition buffer on freshly cleaved mica surfaces.
2.2.1.3 Protein-DNA samples
50 nM WT or K244E UV-DDB was incubated with 25 nM DNA substrate for 10 minutes
at 37◦C in 1X binding buffer - glycerol -DTT. Samples were diluted 1:5 or 1:10 fold prior to
deposition.
2.2.1.4 Deposition
Diluted samples were deposited on freshly cleaved mica (SPI Supply, West Chester, PA)
followed by washing with MilliQ water and drying under a stream of nitrogen gas.
2.2.2 Data acquisition
AFM images were collected using a MultiModeV microscope (Bruker, Santa Barbara, CA)
using an E scanner in tapping mode in air. Pointprobe plus non-contact/tapping mode
silicon probes (PPP-NCL, Agilent) with spring constants of approximately 50 Nm−1 and
resonance frequencies in the range from 150 - 200 kHz were used. Images were captured at
a scan size of 1 µM × 1 µM with a resolution of 512 × 512 pix2 at a scan rate of 4 Hz and
a target amplitude of 300 mV.
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2.2.3 Volume analysis
AFM volumes of proteins deposited on the surface were calculated as V = S × (H − B)
where, S is the cross sectional area of the protein at a height H over the mean background
B. Images were analyzed in Image SXM in order to obtain the values of S, H and B.
Histograms of AFM volumes for a large number of particles were plotted and peaks were fit
to Gaussians to identify the mean AFM volume. Mean AFM volumes and standard error of
the mean were obtained from three depositions.
2.2.4 Calibration curve
A plot of the mean AFM volumes (nm3) of the following proteins and their molecular weight
in kDa {Pot1 (65 kDa), PcrA monomer (86.4 kDa), UvrA monomer (105 kDa), Taq MutS
dimer (181 kDa), UvrA dimer (210 kDa) and Taq MutS tetramer (362 kDa)} was plotted
and a linear relationship was found to best describe the data (see appendix B and Figure
2.1). The fit to the data is: V (nm3) = 1.471MW (kDa)− 7.294(Rsq = 0.9886).
Figure 2.1: AFM calibration curve
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2.3 DNA TIGHTROPE ASSAY
2.3.1 DNA substrates for tightrope assay
2.3.1.1 Undamaged DNA
λ-DNA (New England Biolabs, Catalog # N3013L N6-methyladenine-free) at 500 µgmL−1
was diluted 10 fold in TE buffer (DNase, RNase and Protease Free, 10 mM Tris pH 8.0 ± 0.1,
EDTA 1 mM, Fisher Scientific Catalog # BP2473-500) and its concentration was verified
after dilution by measurement using a Nanodrop. Efficient stringups were obtained when 1
µg of λ-DNA (corresponding to 20 µL of 50 ngµL−1 DNA) was used.
2.3.1.2 UV-damaged DNA
In order to study binding of UV-DDB to long DNA substrates in the DNA tight rope
assay two strategies were employed. In the first strategy, undamaged λ-DNA tightropes
were elongated between beads in the flowcell and this was followed by exposure to UV-C
irradiation. This was followed by examination of binding of CPD antibody conjugated to IgG
coated QD. However, after several unsuccessful attempts to detect binding of CPD antibody,
an alternate approach was employed to create UV-damaged DNA tightropes.
In this approach, a UV-C lamp was used to generate randomly UV-damaged λ-DNA.
UV-induced damage in DNA was quantified by qPCR essentially as previously described
[113], using the GeneAmp XL PCR Kit (Applied Biosystems cat. # N8080193). A 12.5kb
fragment of λ-DNA was amplified between nucleotides 26,890 and 39,488 (Forward primer:
5 CCA ACC ATC TGC TCG TAG GAA TGC 3; reverse primer: 5AGT TGG GTC CAC
TTA TCG CGG AGT 3). Cycle conditions for amplification of 15 ng of λ-DNA template
were: 1:30 s for 75◦C, followed by addition of polymerase, 94◦C for 1:00 min, 94◦C for
15s, 64◦C for 12 min (11 cycles), final extension: 72◦C 10 min. Amplification of damaged
DNA was measured relative to mock irradiated λ-DNA that was treated similarly. Final
product was visualized by gel electrophoresis with ethidium bromide staining. PCR product
concentrations were measured using PicoGreen fluorescent DNA binding dye (Molecular
Probes, Quant-iT PicoGreen dsDNA assay kit, cat. # P7581). 3µL of PCR product were
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diluted in a 1:20 dilution of PicoGreen in TE and relative fluorescence units were calculated
for each sample. Further, these samples were converted to an absolute DNA concentration by
using a standard curve created from measuring the relative fluorescence units for different
concentrations of λ-HindIII standards. 50% controls were performed with undamaged λ-
DNA. A dose response curve relating the number of UV lesions in the λ-DNA fragment as
a function of UV-dose was obtained as: Lesions/λ-DNA = 1.0958 UV-dose(Jm−2) 0.0136;
Rsq = 0.9997, n = 2 with each experiment performed in duplicate.
2.3.1.3 Defined lesion substrates for tightrope assay
Oligonucleotides with custom chemical modification were introduced into the pSCW01 plas-
mid essentially as described before [114]. pSCW01 was amplified in DH5α and purified using
the Qiafilter Maxiprep kit. Typically, 400 µg of pSCW01 were incubated with 60 µL−1 of
Nt.BstNbI (New England Biolabs, 10 UµL−1) for 4h at 55◦C in the presence of 100X com-
plementary displacer oligonucleotides to nick the plasmid at the four adjacent nickase sites.
Following this the reaction was inactivated by heating at 85◦C for 10 minutes followed by
annealing to displace the nicked oligonucleotides. An equal volume of the reaction mixture
was then added to a 2X solution containing 26% PEG-8000 in 20 mM MgCl2 followed by cen-
trifugation for 1 h at 4◦C. Precipitated DNA pellet was then washed with ethanol followed
by resuspension of the gapped plasmid. Purified gapped plasmid DNA was then incubated
with the desired oligo in 3X excess followed by annealing in NEB4 buffer. After annealing,
the reaction was supplanted with 8 mM ATP and ligation was performed by the addition of
5 µL of T4 DNA ligase (New England Biolabs, M0202, 2000 U µL−1) to a 400 µL reaction
containing 400 ng µL−1 of purified gapped plasmid DNA for 18 h at 16◦C. The reaction
was then heated to 65◦C for 20 mins to inactivate the T4 DNA ligase and supplemented
with XhoI (New England Biolabs) to digest the plasmid DNA containing custom oligonu-
cleotide. Restriction was performed for 2 h at 37◦C followed by inactivation at 85◦C for 20
minutes. Linearized plasmid DNA containing custom chemical modification (monomer) was
then stored at -20◦C until further use. To obtain long DNA substrates for the DNA tight rope
assay, 1µg of DNA monomers was ligated for 15 mins at RT in Quickligase buffer with 2 µL
of T4 DNA ligase (2000 U µL−1). Using this strategy we were able to make DNA substrates
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with a tetrahydrofuran moeity (abasic site analog) by inserting the following oligonucleotide:
/5Phos/ CCG AGT CAT TCC TGC AGC G/idSp/G TCC ATG GGA GTC AAA
/3BiodT/
2.3.2 Conjugation strategies for QD conjugation to UV-DDB
2.3.2.1 Using the BT-NTA compound
SA QD were incubated with the biotinylated nitrilotriaceticacid (BT-NTA, Jacob Piehler)
compound in 1X binding buffer (20 mM Hepes 7.5, 150 mM NaCl, 2 mM BME, 5% glycerol
and 1 mM MgCl2) in a molar ratio of 1:2 for 30 min at RT to obtain the BT-NTA-QD
conjugate. FLAGHisDDB1-DDB2 was incubated with the BT-NTA-QD conjugate to obtain a
final ratio of 1:2:1 corresponding to UV-DDB:BT-NTA:QD for an additional 30 min at RT.
2.3.2.2 Using the penta-His biotin conjugate
The strategy for conjugating the penta-His-biotin conjugate (His-Ab, Qiagen, cat # 34440)
was adapted from a previously published strategy. His-Ab was incubated with SA QD in the
molar ratio of 5:1 for at least 30 min at RT. 2 µL of the His-Ab were incubated with 2 µL of
SA QD for an additional 30 min at RT to obtain a final molar ratio of 1:5:1 corresponding
to UV-DDB:His-Ab:QD.
2.3.3 Flow cells for DNA tightrope assay
Flow cells were constructed essentially as described before [115], but with changes described
here. Cleaned glass slides (Thermo scientific, precleaned 25×75×1mm microscope slides, cat.
# 4951-001) were drilled with two holes, 15 mm apart using 1.25 mm Cylinder Diamond
drill bit (Dads rock shop). Inlets and outlets were created by passing PFA tubing (Idex,
Tub PFA Nat 1/16×0.03 ×5ft, cat # 1502) which was glued in place using epoxy (BONDiT
B-45TH) followed by curing for 36-48 h. Prior to gluing, the ends of the tubing were sanded
using a sanding sponge (3M PRO GRADE, Sanding sponge) to create a greater surface area
to enable efficient adhesion. Following tubing affixation, the excess tubing was cut off using
a scalpel. The flowcell was assembled by using a double sided sticky gasket (created from
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3M double sided sticky tape, cat #. B1079). The gasket consists of a rectangular ring of
outer dimension: 0.775”×1.195” with an inner hole of dimension: 0.395”×0.77”). The flow
chamber is assembled by adhering a treated cover slip (Corning, cat. # 2940-244, 24×40
mm). The inlet and outlet from the flow cells are connected to the syringe and reservoir with a
union assembly (Idex, cat. # P-702) and flangeless ferrules (Idex, cat. # P-200X). Coverslips
were treated with N-(2-Aminoethyl)-3-aminopropyltrimethoxysilane (APTES; UCT, cat. #
A0700-KG) followed by pegylation (Laysan Bio, Inc. cat. # MPEG-SVA-5000-1 gram).
2.3.3.1 Setting up the DNA tightropes
Flow cells constructed as described above were first passivated by incubating with a blocking
buffer (50 mM Hepes 7.5, 50 mM NaCl, 1 mg mL−1 BSA(Roche cat. # 10 711 454 001).
Blocking is performed for at least 10 minutes. Next, 5 µm poly-L-lysine (Wako Chemicals
USA, Inc cat. # 163-19091) coated silica beads (Polysciences Inc., Uniform Silica Micro-
spheres, cat. # 24332-15) are deposited in the flow cell on the inner surface of the cover slip.
The flow chamber is then washed with water to get rid of excess poly-L-lysine followed by
elongation of the DNA substrates in 1X imaging buffer (50 mM Hepes 7.5, 150 mM NaCl,
100 mM DTT, 10 mg mL−1 BSA) between these beads by a continuous to-and-fro flow for
30 min.
2.3.3.2 Visualizing the DNA
The DNA may be visualized by staining with YOYO-1 dye (Molecular Probes, YOYO-1,
cat. # Y-3601). DNA tightropes were visualized by incubating the flowcell with up to 1 nM
YOYO-1 dye in 1X imaging buffer.
2.3.4 Oblique angle fluorescence microscopy
Oblique angle fluorescence imaging: Oblique angle fluorescence imaging was performed using
a Nikon Ti eclipse base with a Nikon 100X oil emersion TIRF objective with 1.45 NA. 488 nm
light was used to excite the sample after passing through a 498 nm excitation filter. Emissions
from quantum dots were separated using emission filters: 655 nm (640/20 or 700/75), 705
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nm (700LP or 700/75), 605 nm (600/50), 585 nm (600/50) and 565 nm (535/50) and 520 nm
using a 520/40 (see Figure 2.2). Images were acquired using Nikon Elements Ar 4.11.00 with
a temporal resolution of 100 ms and a laser power of 1-2 mW using an Andor Neo sCMOS
camera (DC-1520-C00-Fl).
2.3.5 Quantum dots for single molecule imaging
Quantum dots for fluorescence imaging are available from Invitrogen with two types of
surface modifications including streptavidin and goat F(ab’)2 anti-mouse IgG Conjugate
(H+L) conjugates. Streptavidin conjugated QDs are available in two formats ‘classic’ (c) or
‘vivid’ (v).
Quantum dots for fluorescence imaging possess several attractive properties. Among
these are high extinction coefficients (and consequent brightnesses), a size based tunable
emission spectrum, strong biocompatibility (inertness, non-toxicity, and solubility) and pho-
toactivity under a wide range of biologically relevant conditions.
However, quantum dots suffer from stochastic excursions to ‘off’ states that are described
by a power-law model [116]. This behavior is controlled by the presence of reducing agents
such as DTT and appears to depend on the size of the QD [117]. Recent versions of commer-
cially available (Invitrogen) Qdot Streptavidin conjugates have exhibited poor photostability,
specifically demonstrating a blue-shift in the emission spectrum and photobleaching. Such
spectral diffusion of QDs has been described previously [118] and was found to occur for
certain QD conjugates in our hands, under certain conditions.
Biocompatible SA QDs offer multiple possibilities to develop orthogonal QD conjugation
strategies, however, QDs suffer from problems of multivalency arising from a limited ability
to estimate the number of accessible binding sites [119]. Achieving a homogenous population
of 1:1 labeled proteins remains a challenge.
The Qdot525 streptavidin conjugate (Invitrogen, Q10141MP, QD525) was used for single
color imaging with a 520/40 nm filter. QD525 was found to exhibit poor brightness and its
use was limited in single color experiments (see Figure 2.2).
The Qdot565 streptavidin conjugate (Invitrogen, Q10131MP, QD565) was used for single
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color imaging with a 530/50 nm filter (see Figure 2.2). QD565 was found to exhibit high
lifetime of ‘on’ states, good brightness. Photostability was not characterized.
The Qdot585 streptavidin conjugate (Invitrogen, ‘vivid’, Q10111MP, QD585) was used
for single color imaging with a 600/50 nm filter (see Figure 2.2). QD585 was found to exhibit
high lifetime of ‘on’ states, good brightness but poor photostability. This QD was found to
photodim under mild imaging conditions and long acquisition times.
The QD605 streptavidin conjugate (Invitrogen, ‘classic’, Q10101MP, QD605) was used
for single color imaging with a 600/50 nm filter (see Figure 2.2). QD605 was found to exhibit
high lifetime of ‘on’ states, excellent brightness and photostability however, it suffered from
slow photobrightening, making it unsuitable for studying lifetimes of highly transient species
on DNA.
The Qdot655 streptavidin conjugate (Invitrogen, ‘classic’, Q10121MP, QD655) was used
for single color imaging with a 700/75 nm filter (see Figure 2.2). QD655 was found to exhibit
high lifetime of ‘on’ states, excellent brightness and photostability. This QD was found to
be good for studying the lifetimes of highly transient interactions.
The QD705 streptavidin conjugate (Invitrogen, ‘classic’, Q10161MP, QD705) was used
for single color imaging with a 700/75 nm or a 700 LP filter (see Figure 2.2). QD705 was
found to exhibit poor lifetime of ‘on’ states, poor photostability in the absence of DTT but
possessed excellent brightness. These properties make it unsuitable for studying lifetimes of
highly transient species on DNA.
2.3.5.1 Choice of QDs for Single color imaging
For single color imaging either the QD655 or QD605 were used depending on the ap-
plication. QD655 was used to study the transient behavior of proteins on DNA whereas,
QD605 was used to mark the positions of introduced lesions in defined DNA substrates.
2.3.5.2 Choice of QDs for Multi-color imaging
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Figure 2.2: Normalized emission spectra for Invitrogen Qdot conjugates with overlay of
emission filters and excitation source
Table 2.1: QD combinations for two color imaging
Sr. no QD1 Filter1 QD2 Filter2 Notes
1 525 nm (c) 520/40 565 nm (c) 530/50 Avoid. Low
SNR for 525
nm.
33
2 525 nm (c) 520/40 585 nm (v) 600/50 Avoid. Low
SNR for 525
nm. Photo-
conversion
and photo-
bleaching of
585 under
low (<1
mM) DTT
and low
brightness
under high
(>10 mM)
DTT.
3 525 nm 520/40 605 nm 600/50 Avoid. Low
SNR for 525
nm. Delayed
photobright-
ening for
605.
4 525 nm 520/40 655 nm (c)
or (v)
640/25 Avoid. Low
SNR for 525
nm.
5 525 nm 520/40 705 nm 700 LP or
700/75
Avoid. Low
SNR for 525
nm.
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6 565 nm 530/50 585 nm (v) 600/50 Usable in the
presence of
1-10 mM
DTT.
7 565 nm 530/50 605 nm (c) 600/50 Usable in the
presence of
1-100 mM
DTT.
8 565 nm 530/50 655 nm (c) 640/25 or
700/75
Usable in the
presence of
1-100 mM
DTT.
9 565 nm 530/50 655 nm (v) 640/25 or
700/75
Usable in the
presence of
1-10 mM
DTT.
10 565 nm 530/50 705 nm (c) 700LP or
700/75
Usable in the
presence of
1-100 mM
DTT.
11 585 nm (v)
or 605 (c)
600/50 655 (c) nm 700/75 Usable in the
presence of
1-100 mM
DTT. Ensure
no spectral
overlap.
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12 585 nm (v)
or 605 nm
(c)
600/50 705 nm (c) 700/75 or
700LP
Usable in the
presence of
1-100 mM
DTT.
13 585 nm (v) 600/50 605 nm (c) 600/50 Do not use.
14 655 nm (c) 640/25 705 nm (c) 700 LP Usable in
1-100 mM
DTT. Ensure
no spectral
overlap or
spectral
diffusion.
15 655 nm (v) 640/25 705 nm (c) 700 LP Usable in
1-10 mM
DTT. Ensure
no spectral
overlap or
spectral
diffusion.
Table 2.2: Combinations of QDs for three-color single molecule imaging.
Sr. no QD1 Filter1 QD2 Filter2 QD3 Filter3 Notes
1 525 nm (c) 520/40 565 nm (c) 530/50 605 nm (c) 600/50
Low SNR for
525 nm.
2 525 nm (c) 520/40 585 nm (c) 600/50 655 nm (c) 640/25
Low SNR for
525 nm.
3 525 nm (c) 520/40 585 nm (c) 600/50 705 nm (c)
700 LP or
700/75
Low SNR for
525 nm. Low
on time for
705 nm.
4 565 nm (c) 530/50 605 nm (c) 600/50 655 nm (c) 640/25
Slow photo-
brightening of
605 nm.
5 565 nm (c) 530/50 605 nm (c) 600/50 705 nm (c)
700 LP or
700/75
Slow photo-
brightening of
605 nm. Low
on time for
705 nm.
6 585 nm (v) 600/50 655 nm (c) 640/25 705 nm (c)
700 LP or
700/75
Low on time
for 705 nm.
Ensure fresh
DTT.
7 605 nm (c) 600/50 655 nm (c) 640/25 705 nm (c)
700 LP or
700/75
Low on time
for 705 nm.
Slow photo-
brightening.
Ensure fresh
DTT.
3.0 SINGLE PARTICLE TRAJECTORIES: ACQUISITION AND
ANALYSES
Single particle tracking (SPT) is the basis of understanding the interactions of single bio-
molecules. Here, we describe the methods employed for acquisition of single particle data
from observed protein-DNA interactions in the DNA tightrope assay described previously
(2.3). In these experiments, real time video microscopy of the interactions of fluorescently
tagged biomolecules (particles) yields a sequence of spatial positions for the interacting
particles at successive times.
3.1 DATA ACQUISITION
3.1.1 Digitization of the spatial signal
If the density of single fluorophores is sufficiently low, then an individual fluorophore may
be identified as a diffraction limited spot (corresponding to the Airy disk) in the image. The
radius of the Airy disk is given by equation 3.1:
r =
0.61λ
NA
(3.1)
Two proximal fluorophores may be resolved in a microscope if they satisfy the Rayleigh
criterion, which defines the resolution as equation 3.2:
Resolutionx,y =
0.61λ
NA
(3.2)
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The Nyquist sampling theorem states that, for optimal resolution of the fluorophore, the
sampling should be performed at half the resolution equation 3.3:
Nyquistsampling =
0.61λ
2NA
(3.3)
In order to resolve single molecules, the data should be spatially sampled at atleast the
Nyquist sampling rate. When the pixel size is larger than the Nyquist sampling rate, the
features of the fluorophore may not be resolved accurately. Pixel sizes which are smaller
than the Nyquist sampling result in oversampling of the data. For 525 nm emission, this
rate corresponds to 110 nm × 110 nm pixels, with progressively higher pixel sizes for higher
emissions. In this work, the pixel sizes were in the range from 46 × 46 nm2pix−1 or 60 × 60
nm2 pix−1.
3.1.2 Determining the positional accuracy
In practice, the resolution criterion described above does not determine the precision with
which the center of the Airy disc may be located. This is because, the PSF of the emitted light
may be approximated as a 2-dimensional Gaussian function with high accuracy. Positional
accuracy then depends on the signal, the quality of the Gaussian fit to the diffraction limited
spot given (at least) optimal Nyquist sampling and the shot noise. The accuracy with which
a single fluorophore in a frame may be localized is termed as the positional accuracy. The
positional accuracy (σi) of a fluorophore in one dimension may be calculated as [120]:
σi =
√
s2 + a
2
12
Nphotons
+
4s3b2
√
pi
aN2photons
(3.4)
where
s is the standard deviation of the peak position
a is the pixel size
b is the standard deviation of the background intensity
Nphotons is the photon count
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To calculate the positional accuracy, first, a line was drawn across the center of the
fluorophore to obtain the intensity profile. The intensity profile was then fit to a Gaussian
fit, to obtain the mean position and its standard deviation (s). The Gaussian fit to the
intensity profile was then used to calculate the number of photons per pixel N as:
N =
(Counts− bias offset)× sensitivity
QuantumEfficiencyatdesiredwavelength
(3.5)
Here, N was considered to be a smooth function. In reality, because of finite pixel size,
both the intensity and N is a step function. The total number of photons Nphotons was
obtained by integrating the area under the curve corrected for the background.
Using this formula and the procedure described here, the positional accuracy was cal-
culated for 605 nm quantum dots conjugated to biotin on DNA damage arrays. For this
purpose, individual QDs were identified from a 200 frame video with an exposure time of
100 ms. For each individual frame in the video, the intensity profile was fit to a Gaussian
function and the corresponding total number of photons was calculated. Then, using a = 46
nm, the standard deviation of the background (b) and the number of photons (Nphotons),
the positional accuracy was calculated using equation 3.4 for each individual frame, and the
average positional accuracy was calculated for the particle in the entire video. The positional
accuracies for 16 such DNA bound QDs were calculated and found to lie in the range from 2
- 11 nm with an average positional accuracy of 6 nm ± 3 nm (mean ± standard deviation).
3.1.3 Determining the localization precision
The positional accuracy does not account for the underlying fluctuations of the DNA tight-
ropes. In order to account for thermal fluctuations and background stage drift, the uncer-
tainty in the mean position of the fluorophore over the entire duration of observation needs
to be identified. This is known as the localization precision. The localization precision of a
stationary fluorophore can be measured from a time lapse video of the fluorophore.
Consider a stack of N frames corresponding to a video of a stationary fluorophore, with
Non being the subset of frames in which the fluorophore is in the fluorescent ‘on’ state. The
Gaussian fit to the PSF of the particle can be used to obtain the coordinates (xi, yi) of its
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mean position in the ith frame in the series of Non frames. Then, the mean position of the
fluorophore during the observation window can be calculated as (xc, yc) given by equation
3.6:
{〈xc〉, 〈yc〉} = 1
Non
Non∑
i=1
{xi, yi} (3.6)
and, the standard deviation along x and y may be calculated using equation 3.7
{42x,42y} =
1
Non − 1
Non∑
i=1
{(xi − 〈xc〉)2, (yi − 〈yc〉)2} (3.7)
Then, the localization precision is calculated using equation 3.8
δr = (42x,42y)
1
2 (3.8)
Evidently, an accurate measurement of the localization precision depends on the size of
Non.
In order to identify the localization precision of a quantum dot, we followed a previously
described method [117]. Estimates for the localization precision of QD605 conjugated to
DNA were found to be 33 nm ± 2 nm and 36 nm ± 3 nm along orthogonal directions. This
value corresponds to a length of 100 bp of DNA. This indicates that two colocalized quantum
dots on DNA may be resolved with a resolution of 100 bp.
3.2 ANALYSES OF SINGLE PARTICLE TRAJECTORIES
The interaction of single particles on DNA is complex, with theoretical predictions as well
as experimental observations of extremely complex modes of motion ranging from immobile
complexes to particles participating in diffusive (unrestricted, confined) and directed trans-
port. Single particle tracking thus enables the distinction between these various types of
transport mechanisms. Single particle trajectories can be analyzed to measure two physical
characteristics of the interactions: the diffusion constant D and the lifetime (τ) of interac-
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tion. These two quantities can then be used to identify the nature of the motion and also
the existence and affinities of multiple biomolecular intermediates.
3.2.1 Measurement of the diffusion constant
For particles which perform a 1-dimensional diffusion, for example, DNA binding proteins
diffusing on stretched DNA, the analysis of the data involves identification of the trajectory
to identify the nature of the diffusion. It is important to note that, in the analysis of
diffusive particle trajectories, the measurement of the diffusion constant does not require
high temporal or spatial resolution.
The analysis of the single particle trajectory depends on the experimental set up in question.
In this work, we will consider the diffusion of DNA bound proteins on DNA tightropes
stretched between beads in the absence of flow. The diffusion constant of a particle diffusing
along a single line may be calculated in two ways.
In the first method, the position of the fluorescent probe is measured by fitting the point
spread function to a two dimensional Gaussian function for each frame in a stack of frames.
This approach yields the localization of the probe in 2-D space as a function of time. Let
(xi, yi) represent the mean position of the probe in the i
th frame. Let n represent the number
of frames skipped between frames used in the calculation of the diffusion constant and let N
represent the total number of frames acquired. Then, the mean square displacement of the
particle is calculated as:
MSD(n,N) =
1
N − n
N−n∑
i=1
{(xi+n − xi)2 + (yi+n − yi)2} (3.9)
Alternately, making use of the configuration of the DNA in the assay, and taking into
account that the DNA binding protein is restricted to 1-D motion on the DNA, the data
may be transformed into a kymograph. In a kymograph, the data are presented such that
the y-axis represents the position of the probe along a vector with an arbitrary origin (ri) in
the ith frame, aligned along the length of the DNA and time is represented along the x-axis.
Thus, a kymograph represents the time dependent position of the particle along the length
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of the DNA molecule. In this case, the mean square displacement (∆r) of the particle is
calculated as:
MSD(n,N) =
1
N − n
N−n∑
i=1
{(ri+n − ri)2} (3.10)
For a particle exhibiting a purely diffusive behavior, the MSD demonstrates a linear
dependence on the time step (∆t) as:
MSD(n,N) = ∆r2 = 2D∆t(n) (3.11)
For true Brownian motion, the relationship between the MSD and time is linear. This
means, that the displacement of a diffusing particle is a linear function of
√
t. However, it has
been observed that in practice, the displacement of a particle does not always exhibit a linear
relationship with
√
t, prompting the development of new models for fitting the experimental
data. One alternate model suggested in the literature describes a sub-diffusive phenomenon.
In this case, the MSD is related to the diffusion constant as:
MSD(n,N) = 2D∆t(n)α (3.12)
where α represents the anomalous diffusive exponent.
3.2.1.1 Factors affecting the estimation of the diffusion constant
The estimate of the diffusion constant depends on several factors. Some of these are
discussed here.
1. The accuracy of measurement of the diffusion constant depends on the accuracy with
which the particle is localized. This in turn, depends on the quality of the Gaussian fit
to the point spread function.
2. The ability to localize a diffusing fluorophore in turn depends on the length of the expo-
sure time.
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3. The estimate of the diffusion constant also depends on the length of the acquisition win-
dow. The observation window must be large enough to accommodate the heterogenous
diffusive behaviors of single particles. Importantly, when fitting the mean square dis-
placement to a Brownian diffusion model, it is important to check whether the sum of
consecutive displacements is zero.
3.2.2 Lifetime analysis
3.2.2.1 Describing a Poisson process for a system shuttling reversibly between
two states
Consider a system which reversibly shuttles between two observable states Si and Sk.
Here, we define a ‘state’ as a configuration of the biomolecule in consideration with a unique
Gibbs free energy. The differences in these states arise from differences in the spatial positions
of the constituent atoms in the macromolecule wrt each other. In this work we will consider
the reversible interaction of DNA bound proteins with DNA and so the two states may be
thought of as the DNA bound state and the DNA free state. Assume that the decay from
the ith state to the kth state (and vice versa) is experimentally measurable.
For a Poisson process (Ti), the escape from the Si state to the Sk state is given by
equation (3.13)
Ti(t) ≡ exp{−kd,it} (3.13)
where, kd,i represents the rate constant for the decay process and the mean lifetime for
the Si state is obtained as τi =
1
kd,i
. A similar Tk process can be described for the reverse
reaction.
3.2.2.2 Cumulative residence time distribution analysis for transients on DNA
Dissociation kinetics of a population of proteins bound to DNA as a single intermediate
may be described by a Poisson process. For a heterogeneous population of intermediates, let
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the number of the molecules in the population participating in the ith kinetic intermediate
(described by the ith Poisson process Ti) be given by:
ni(t) = aiTi(t) (3.14)
Here, ni(t) represents the number of molecules of the i
th kinetic intermediate remaining
on the DNA as a function of time, starting with an initial population of ai observations.
In general, the dissociation kinetics of populations decaying according to Np distinct
Poisson processes are described by:
n(t) =
Np∑
i=1
aiTi (3.15)
Equation 3.15 describes the total number of molecules which remain associated with the
DNA as a function of time for all the different kinetic intermediates taken together. The
normalized fraction f(t) represents the cumulative residence time distribution (CRTD).
3.2.2.3 CRTD analysis of particles dissociating from DNA
DNA bound proteins which dissociate during observation represent another class of molecules.
For this class of molecules, we can count the number of particles that dissociate as a function
of time and performed a similar CRTD analysis. The CRTD was parametrized by fitting a
number of Poisson processes essentially as described by equation 3.15.
3.2.2.4 On the detectability of decay processes
Importantly, the measurement of Poisson processes should be invariant under the type of
observation. That is, both types of analyses (the analysis of transient and of dissociat-
ing molecules), should reveal the same Poisson processes, if all processes are represented
adequately. The ability to detect a decay process depends on at least the following factors:
1. the frequency with which an event occurs (ν)
2. the decay constant (τ)
3. the time resolution (ts) and
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4. the length of the observation window (L).
Our ability to measure a Poisson process depends directly on ν and L, and inversely on τ
and ts. Processes which occur with low ν and τ = O(ts) or τ = O(L) may not be measured
accurately.
3.2.3 Statistical analysis of experimental data
Pairs of parameters were tested for statistical significance by performing Welch t-tests (Stu-
dent’s t-test with unequal sample size and unequal variances) on the mean values and the
standard deviations (obtained from the 95%CI) of the parameters obtained from fitting. Fit-
ting was performed using the ‘cftool’ package in MATLAB by fitting the data to appropriate
equations and using Occam’s razor to choose between comparable fits.
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4.0 FROM STRUCTURE TO DYNAMICS: HOW DOES UV-DDB SEARCH
FOR AND RECOGNIZE DAMAGE IN DNA?
UV-DDB is the initiator of GG-NER. The recognition of CPD lesions in UV-damaged chro-
matin is mediated by the UV-damaged DNA binding protein (UV-DDB), composed of the
tightly associated heterodimer of DDB1 (p127) and DDB2 (p48) [16, 17]. Following surveil-
lance and CPD recognition by UV-DDB, NER proceeds via lesion handover to XPC-HR23B-
centrin2 followed by damage verification, helix opening and stabilizing of the repair inter-
mediates, dual incision of the DNA in the context of the lesion, repair synthesis and DNA
ligation [9, 25, 121, 29, 5].
In vivo, UV-DDB is constitutively associated with Cullin4A or 4B and RBX1, forming
the CRL4DDB2 E3 ligase complex [25, 31, 122]. In this complex, DDB2 is a DNA damage
recognition factor and functions as an adapter protein which targets the E3 ligase activity to
sites of UV-induced photoproducts, promoting chromatin relaxation, and enabling access to
subsequent repair factors [28, 26, 18]. Recombinant DDB2 has been demonstrated to bind
a variety of DNA structures including 6-4 photoproducts, abasic sites, two base mismatches
with extremely high affinity and CPD lesions and cisplatin adducts with relatively lower
affinity [105, 18]. Molecular defects in DDB2 lead to a slower loss of UV-induced photoprod-
ucts and presentation of the skin cancer prone xeroderma pigmentosum complementation
group E (XP-E) [123, 30]. Molecular analysis of DDB2 from XP-E patients revealed ge-
netic defects which lead to structural defects in DDB2 such as truncations, misfolding or a
modification of the DNA binding interface [123, 30]. In the case of the XP82TO patient, a
point mutation was observed in lysine 244 to glutamate (K244E) in DDB2 which results in
significantly reduced DNA binding activity and damage specificity [30, 18, 121].
A current working model for damage recognition in GG-NER is that UV photoproducts
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are first recognized by UV-DDB (Figure 4.1) [29]. Stable binding of UV-DDB to sites of
damage activates the ubiquitination activity of CRL4DDB2 which targets histones, primarily
H2A, and enables nucleosome disassembly and subsequent recruitment of the XPC-HR23B-
centrin2 (XPC) complex, which is also a ubiquitination substrate [29, 25, 121, 28, 26, 27,
124]. Lesion handover between CRL4DDB2 and XPC is thought to be achieved by the
autoubiquitination of DDB2 at lysines in the intrinsically disordered N-terminus of DDB2
[29, 25]. This autoubiquitination of DD2 serves to flag the repair factor for degradation
[124].
Recent reports have identified that the N-terminus of DDB2 is also PARylated in vivo
in response to UV-damage, resulting in stabilization of UV-DDB in damaged chromatin
[125, 126]. While the molecular mechanisms of these two post-translational modifications
remain to be fully elucidated, it appears that these modifications compete for substrates
in the N-terminus of DDB2 and oppositely regulate each other, with implications on the
residence of UV-DDB on DNA at sites of damage. The N-terminus of DDB2 also plays
an important role in damage binding. This flexible domain has been recently implicated in
dimerization of UV-DDB at sites of damage. In our previous work, we provided structural
and biophysical evidence that UV-DDB dimerizes at sites of damage [102].
The identification of this dimeric UV-DDB complex on DNA reveals a previously unantic-
ipated complexity in damage recognition and raises several important questions in the initial
damage recognition step of human GG-NER: How do approximately 180,000 molecules of
UV-DDB interrogate four billion base pairs of genomic DNA to find relatively rare lesions in
DNA? How does UV-DDB proofread the DNA to achieve remarkable specificity in damage
discrimination? How does dimeric UV-DDB modulate the specificity of damage discrimina-
tion? How do mutations in the DNA binding interface found in the K244E mutant of DDB2
influence the kinetics of DNA binding and damage recognition?
To address these questions, we have conjugated WT and K244E mutant of UV-DDB to
streptavidin coated quantum dots (SA-QD) and observed their interactions in real time with
elongated damaged DNA substrates in a DNA tightrope assay [115, 127].
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Figure 4.1: Model for lesion handover between UV-DDB and XPC
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4.1 VISUALIZING THE SEARCH MECHANISM FOR UV-DDB
The question of target site search by DNA binding proteins has received extensive atten-
tion previously using biochemical methods and more recently, several search modes have
been proposed (section 1.6, Figure 1.6), experimentally validated and visualized using single
molecule methods [128, 129, 127, 130, 131]. We have previously developed a DNA tightrope
assay which enables the visualization of DNA mediated QD conjugated protein-protein and
protein-DNA interactions [115, 127]. Briefly, in this assay, λ-DNA tight ropes are elongated
between five micron poly-L-lysine coated beads that are deposited on a pegylated cover slip.
Biomolecular interactions on DNA tightropes in the absence of buffer flow are visualized
by oblique angle fluorescence microscopy imaging. This strategy also enables observations
in the absence of surface interactions. A schematic of the flow cell and a YOYO-1 stained
image of a typical string-up of DNA obtained using oblique angle fluorescence microscopy
are shown in Figure 4.2.
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Figure 4.2: Schematic of flow cell used in DNA tightrope assay
Schematic of flow cell used in the DNA tightrope assay and oblique angle fluorescence microscopy
image of YOYO-1 stained λ-DNA tightropes between poly-L-lysine coated beads. Arrows indicate
DNA between beads.
4.2 QD CONJUGATION STRATEGIES
The goal of these studies was to understand the dynamics of UV-DDB on damaged DNA
substrates. To achieve this goal, we first systematically tested three strategies for conjugating
QDs to UV-DDB.
4.2.1 Using the biotinylated trisnitrilotriaceticacid compound
We first tested the conjugation strategy involving a biotinylated trisnitrilotriaceticacid (BT-
NTA) compound [132]. We assayed DNA binding of QD conjugated UV-DDB (FLAG−HisDDB1-
DDB2) by the use of an agarose based EMSA with a 5’ 32P radiolabeled AP36 substrate
(Figure 4.3). Using the BT-NTA compound, we found that under the conditions tested,
UV-DDB exhibits a super shift in DNA binding upon conjugation with BT-NTA (Lane 4,
Figure 4.3); however, this super shift is lost upon conjugation to QDs (Lane 5, Figure 4.3).
Indeed, BT-NTA conjugated QD-UV-DDB exhibits a small super shift, but also leads to
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a significant loss of DNA damage binding ability, suggesting that the short length of the
BT-NTA linker to the QD inhibits the stable binding of UV-DDB to DNA through steric
hindrance.
4.2.2 Using the FLAG Ab sandwich approach
We next tested an antibody sandwich approach [133] using a primary anti-FLAG antibody
and IgG coated QDs (Figure 4.4) to conjugate FLAG−HisDDB1-DDB2 to IgG coated QDs. We
found that QD-FLAG Ab-UV-DDB exhibits a measurable super shift in the agarose EMSA
corresponding to DNA bound QD-FLAG Ab-UV-DDB complexes on 177bp UV-irradiated
DNA (Figure 4.4). Evidence for these complexes was also observed by AFM when QD-FLAG
Ab-UV-DDB was incubated with UV-irradiated 517 bp DNA containing on average 1 lesion
per fragment (Figure 4.5). This experiment was performed by Dr. Hong Wang.
4.2.3 Using the His-Ab strategy
We performed electrophoretic mobility shift assays (EMSAs) to measure the binding of
His-Ab [131] conjugated QD-UV-DDB to AP36 (Figure 4.6) [18]. We found that His-Ab
conjugated UV-DDB (FLAG−HisDDB1-DDB2) demonstrated a measurable super-shift cor-
responding to UV-DDB-His-Ab-QD:DNA complexes (Figure 4.6, lane 6). Additionally, no
non-specific binding of either the His-Ab or QDs binding to DNA was detected (Figure 4.6:
lanes 3 and 4). We also tested other UV-DDB constructs (HisDDB1-FLAGDDB2 and DDB1-
FLAG−HisDDB2) and found that in all cases, DNA binding activity was retained (Figure 4.6:
lanes 7-9 and 10-12 resp.).
Further, we tested different UV-DDB:His-Ab:QD ratios such as 1:5:1, 1:5:2.5 and 1:5:5
and found super-shifted bands for all the conditions tested (Figure 4.7). However, we used
a ratio of 1:5:1 for our experiments, since under these conditions, the biotin binding sites on
the streptavidin coated quantum dots are completely saturated [131].
The His-Ab conjugation strategy was found to be robust and we therefore decided to
proceed with this strategy for observing the interactions of UV-DDB with DNA in real time
in the DNA tightrope assays. Importantly, UV-DDB is a tightly associated complex of DDB1
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Figure 4.3: Agarose EMSA to assay activity of QD-BT-NTA-UV-DDB
Agarose EMSA showing supershift of 2.5 nM AP36 substrate (lane 1) upon binding of UV-DDB
(FLAG−HisDDB1-DDB2; Lane2). Lane 3 demonstrates lack of detectable interaction of DNA with
BT-NTA. Lane 4 shows biotinylated NTA compound conjugated to UV-DDB
(FLAG−HisDDB1-DDB2), and subsequent loss of DNA binding upon conjugation to QDs (lane 5).
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Figure 4.4: Agarose EMSA to assay QD-FLAG Ab-UV-DDB activity
Agarose based electrophoretic mobility shift assay showing supershift of 7.5 nM 177 bp
UV-irradiated radiolabeled probe (lane 1) when bound to UV-DDB FLAG−HisDDB1-DDB2 alone
(lanes 2 and 3, [UV-DDB] = 28.5 nM and 57 nM resp) or when conjugated using the primary
anti-FLAG antibody (lanes 4 and 5 [UV-DDB] = 28.5 or 57 nM and [Ab] = 66 nM) to goat
anti-mouse IgG secondary antibody coated QDs ([UV-DDB]=57 nM, [Ab] = 66 nM and [QD] =
100 nM or 500 nM lanes 6 and 7 resp). Higher bands in the EMSA correspond to either
end-binding, higher oligomeric states of UV-DDB or binding to distinct photoproducts.
Figure 4.5: AFM image of QD-FLAG Ab-UV-DDB bound to UV-irradiated 517 bp DNA
AFM image (250 nm x 250 nm x 3nm) with 3D rendering, showing goat anti-mouse IgG coated
QDs co-localized to UV-irradiated 517 bp PCR product in the presence of the anti-FLAG
antibody conjugated to FLAG-HisDDB1-DDB2.
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Figure 4.6: Agarose EMSA to assay QD-His Ab-UV-DDB binding
Agarose EMSA showing that 5’ 32P 36mer containing AP site (lane1) can be bound by UV-DDB
(lane2). Lanes 3 and 4 are negative controls indicating that neither the His-Ab nor the QD
non-specifically bind 36 mer DNA substrate. Lane 5 indicates a complete shift in the presence of
His-Ab and lane 6 indicates a super shift in the presence of streptavidin coated QD. For these
experiments, 2.5 nM dsDNA substrate containing an abasic site was incubated with either
UV-DDB only (FLAG-HisDDB1/DDB2: 50 nM, HisDDB1/FLAGDDB2: 29 nM,
DDB1/FLAG-HisDDB2: 37 nM, Lanes 2, 7 and 10 resp) and Penta-His Ab ([UV-DDB]:
[Penta-His Ab] ≡ 1:5, Lanes 5, 8 and 11 resp) and 655 nm streptavidin coated Qdots ([UV-DDB]:
[Qdots] ≡ 1 :1, Lanes 6, 9 and 12 resp).
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Figure 4.7: Agarose EMSA assaying QD-His Ab-UV-DDB activity as a function of QD
ratio
Agarose EMSA showing that 5’ 32P labeled 36mer containing AP site (2.5 nM) alone (lane 1) or
in the presence of His-Ab (lane 2) or 655 SAQD (lane 3) or incubated with
FLAG-HisDDB1/DDB2 (lane 4) and antibody (lanes 5-8) and QD (lanes 6-8) ratios were varied
as indicated in the lanes keeping UV-DDB concentration constant (Lane 6: P:Ab:QD≡1:5:1, Lane
7: P:Ab:QD≡1:5:2.5 and Lane 8: P:Ab:QD≡1:5:5).
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and DDB2 and previous reports have reported similar diffusion constants for the complex
containing DDB1 and DDB2 when either subunit was fluorescently tagged inside living cells
[134]. Given these results, we believe that conjugating the DDB1 subunit with QDs serves
as an accurate reporter for the behavior of DDB2 on DNA.
4.3 IMAGING IN THE ABSENCE OF YOYO-1 DYE
Consistent with a recent report, we observed shattering of DNA tightropes incubated with
YOYO-1 during imaging, presumably via the formation of single strand breaks followed by
double strand breaks [135]. In order to enable long observation times for UV-DDB binding
to DNA with minimal DNA damage (which could create binding sites for UV-DDB), the use
of YOYO-1 was avoided in these experiments.
4.4 QD-UV-DDB PERFORMS A 3D SEARCH ON UNDAMAGED AS
WELL AS UV-DAMAGED DNA
We next wanted to characterize the binding of QD-UV-DDB to long undamaged DNA sub-
strates, as well as, DNA containing UV-induced lesions using the DNA tightrope assay. Upon
incubating QD-UV-DDB with undamaged or UV-damaged λ DNA tightropes containing on
average 1 photoproduct in 2200 bp of DNA (see figure 4.9), we were able to observe the
binding of UV-DDB to the DNA tightropes (Figure 4.8, mov 1 and mov 2).
For both undamaged, and UV-damaged DNA, four classes of binding events were iden-
tified in a typical 900 s observation window (Figure 4.10); those that associate, dissociate,
persist and are transient. In the majority of cases (>98%), upon incubation with either un-
damaged or UV-damaged DNA, QD-UV-DDB molecules associated with the DNA primarily
as non-movers (see mov1 and mov2). Less than 2% of observations (12 out of 990 events)
exhibited one dimensional sliding of UV-DDB within the limits of our spatial and temporal
resolutions (36 nm, 100 ms). Since these assays were performed in the absence of flow, we
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Figure 4.8: Still image of QD-UV-DDB bound to undamaged λ-DNA tightrope
Image of QD-UV-DDB binding to unstained DNA tightropes between beads. Arrows indicate
bound QD-UV-DDB.
Figure 4.9: UV-induced photoproduct frequency per λ-DNA is a linear function of UV-dose
as measured by qPCR.
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Figure 4.10: Four types of binding events observed in the DNA tightrope assay
Kymographs of individual QD-UV-DDB molecules that: A) dissociate from DNA during
observation B) associate with DNA during observation C) are present during the entire
observation window D) both associates and dissociates during observation. E) and F) pie chart of
percentage of each of the observations described above for undamaged DNA (n = 347) and
UV-damaged DNA (n = 643), respectively.
were able to observe macroscopic dissociation and re-association behavior of UV-DDB on
vicinal DNA molecules, a phenomenon which is characterized as jumping (Figure 4.11; mov1:
an example of transient binding of QD-UV-DDB to DNA) [115].
Figure 4.11: Kymograph of UV-DDB jumping between vicinal DNA molecules in field of
view.
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4.5 UV-DAMAGE IN DNA SHIFTS THE BINDING EQUILIBRIUM TO
LONGER LIVED STATES
A comparison of the percentage of observations that are represented in each of the four
classes of observations on undamaged (Figure 4.10 E, n = 347) and UV-damaged DNA and
(Figure 4.10 F, n = 643) reveals that the fraction of molecules that:
1. dissociate is 2.2 fold higher for UV-damaged DNA (compare 4.9% vs. 10.6%)
2. associate is 8 fold higher for UV-damaged DNA (7.9% vs. 0.9%)
3. persist is 2.5 fold higher for UV-damaged DNA (13.7% vs. 5.5%)
4. are transient is 1.3 fold lower (88.8% vs. 67.8%) for UV-damaged DNA.
These data reveal that across all these classes of binding events, UV-DDB associates with
and persists on DNA for longer time periods when the DNA tightropes contain UV-damage,
while showing lower transient behavior.
4.6 SINGLE MOLECULE VISUALIZATION REVEALS MULTIPLE
KINETIC INTERMEDIATES OF UV-DDB
We then analyzed the kinetics of transient binding on both undamaged and UV-damaged
DNA to understand the heterogeneity in dwell times and to extract dissociation rate con-
stants. Dissociation of UV-DDB complexes on DNA can be modeled as a first order decay
process (Poisson process) from the DNA bound intermediate state (Si) to the DNA free state
(S0). With the objective of quantifying this process, we performed a cumulative residence
time distribution analysis (CRTD; see 3.2.2) [136, 137]. The CRTD may be interpreted
as a type of survival curve representing the fraction of the population of DNA bound pro-
teins remaining on DNA as a function of time. Fitting the CRTD to a Poisson process
(Ti ≡ exp{−kd,it}) yields the decay rate (here dissociation rate (kd,i) and consequently the
mean lifetime (τi) of particles participating in the Poisson process describing the escape from
the Si state into the S0 state (Si ↔ S0; here describing the reversible and spontaneous two
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state transition of a DNA binding protein from the DNA bound state to the DNA free state).
For systems with multiple intermediates, the CRTD may be fit to a number of exponential
terms, each of which corresponds to a measurable intermediate. This yields the total number
of Poisson processes, that describe the population.
The CRTDs describing the data for transient binding to undamaged DNA and damaged
DNA are presented in Figure 4.12. A log rank test indicated that the survival functions are
not significantly different (p = 0.075), suggesting that that the aggregate survival functions
for UV-DDB interacting with undamaged DNA and damaged DNA are similar. Next, we
proceeded to parameterize these CRTDs by fitting a sum of exponentials to the data (red
line, Figure 4.12 A and B). In each case, to fit all the features of the data it was necessary to
fit three exponentials corresponding to three independent decay processes (see section 4.6.1).
4.6.1 Best fit of the experimental data
The CRTD was fit to a sum of Np Poisson processes starting with n = 1 , . . . , Np. Fit
parameters for double (Np = 2) and triple (Np = 3) are provided in the table 4.1. Log-
log plots for the experimental data and double exponential fit (dashed blue line) and triple
exponential fits (solid, red) are presented in figure 4.13 for undamaged and damaged DNA.
From these plots, it is evident that all the features of the data are only captured when Np
= 3. Since, SSE/DOF was found to be smaller for Np = 3, we proceeded with fitting the
population to 3 Poisson processes (Table 4.1).
We denote the three independent Poisson processes for transient binding to undamaged
DNA as T1,ud, T2,ud, and T3,ud (where T ≡ exp{−kt}). These processes describe the dissoci-
ation of UV-DDB from the DNA bound state to the DNA free state (corresponding to the
transitions S1,ud → S0, S2,ud → S0 and S3,ud → S0; subscript ‘ud’ corresponds to undamaged
DNA, see table 4.2, 3.2.2). Similarly, dissociation from UV-damaged DNA was found to
follow the three processes T1,d, T2,d, and T3,d (corresponding to the transitions S1,d → S0,
S2,d → S0 and S3,d → S0; subscript ‘d’ corresponds to damaged DNA, see table 4.2, 3.2.2).
From the data displayed in table 4.2, it is evident that in each case, the three lifetimes of
interactions differ from each other by an order of magnitude. In summary, our data reveals
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Figure 4.12: CRTD analysis of transient UV-DDB binding
Cumulative residence time distribution plots for transient UV-DDB binding to A) undamaged
DNA and B) UV-damaged DNA with triple exponential fits (red).
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Figure 4.13: Log-Log CRTD plots
Log-Log Cumulative residence time distribution plots for transient UV-DDB binding to A)
undamaged DNA and B) UV-damaged DNA with triple exponential fits (red) and double
exponential fits (dashed, blue).
Table 4.1: Fit parameters for double and triple exponential fits to the CRTD
DOF R-sq SSE SSE/DOF DOF R-sq SSE SSE/DOF
Undamaged
DNA
343 0.9929
3.82
×10−2
1.11
×10−4 341 0.9972
1.61
×10−2
4.72
×10−5
UV-
damaged
DNA
639 0.9658
1.59
×10−1
2.49
×10−4 637 0.9938
2.91
×10−2
4.57
×10−5
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the presence of three decay processes (Ti for intermediates on undamaged, as well as, UV-
damaged DNA) and four intermediate states (a DNA free state S0 and three DNA bound
states for dissociation from undamaged and damaged DNA each).
Table 4.2: Estimates for kinetic parameters from analysis of transient molecules
N a1 kd,1(s
−1) τ1 a2 kd,2(s−1) τ2 a3 kd,3(s−1) τ3
Undamaged
DNA
307 0.7863 1.217 0.8 0.3884 0.1233 8.1 0.07354 0.008853 113.0
LB of
95%CI
0.7587 1.127 0.8 0.677 0.1071 7.2 0.05296 0.004502 75
UB of
95%CI
0.8138 1.306 0.9 0.409 0.1396 9.3 0.09413 0.0132 222.1
Damaged
DNA
436 1.107 3.033 0.3 0.251 0.1249 8.0 0.2119 0.007895 126.7
LB of
95%CI
1.029 2.782 0.3 0.2369 0.1087 7.1 0.2001 0.007125 115.4
UB of
95%CI
1.185 3.248 0.4 0.265 0.1412 9.2 0.2238 0.008664 140.4
4.6.2 The T1,ud process is significantly different from T1,d process
To identify the relationships between the pairs of processes {T1,ud, T1,d}, {T2,ud, T2,d} and
{T3,ud, T3,d}, we next examined if the rate constants for each pair were significantly different.
For T1,ud we obtained τ1,ud = 0.3s (0.3s, 0.4s) (see table 4.2; reported as mean (LB, UB),
where LB and UB represent the lower and upper bound of the 95% confidence interval on the
estimate of the mean value; values are rounded to the temporal resolution of the instrument)
compared to τ1,d = 0.8s (0.8s, 0.9s) for T1,d (table 4.2). Using a Welch T-test, we identified
that the rate constants derived from the fits for these two processes were significantly different
with p <0.0001, indicating that the kinetics of the T1,ud process are significantly different
compared to T1,d. This suggests that the T1,ud and T1,d processes are unique. The fraction
of the S1 intermediate for both undamaged and UV-damaged DNA transient binding, which
does not decay according to the T1 process, must transition to a more stable intermediate
(possibly the S2 intermediate). It is noteworthy that the T1 process identified here does not
correspond to non-productive collisions that are found to occur on an approximately 100X
faster timescale (≈ 5 ms) [130].
4.6.3 T2 represents a damage verification process; whereas T3 represents disso-
ciation from a stable damage bound state
We next examined the T2 and T3 processes for both undamaged and UV-damaged DNA and
found that the rate constants for each process were not significantly different (table 4.2, p
>0.05), indicating that τ2,ud = τ2,d = τ2 = 8s (7.2s, 9.2s) and τ3,ud = τ3,d =τ3 = 126s (115.4s,
140.4s). To better understand how the presence of photoproducts in the DNA changes the
kinetics of UV-DDB interaction, we first identified that the estimates for the amplitudes of
the pairs of the decay processes were significantly different from each other (p <0.0001). We
then normalized the fitted data to identify the relative fractions of the kinetic intermediates
that decay according to the three different processes for transient binding to undamaged
versus UV-damaged DNA (Figure 4.14 A and B).
In the population of molecules bound to undamaged DNA, 58% were found to dissociate
with a lifetime of τ1,ud compared to 57% for UV-damaged DNA with a lifetime of τ1,d.
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Figure 4.14: Pie chart showing the percentage of molecules participating in decay processes
Pie chart showing the percentage of molecules participating in each of the Poisson processes
observed in the transient binding events for binding to undamaged DNA (A; n = 307) or
UV-damaged DNA(B; n=436), respectively.
Similarly, 35% (1.5 fold higher) were found to dissociate from undamaged DNA compared
to 23% for UV-damaged DNA with a lifetime of τ2 and 7% of the molecules dissociated with
a lifetime of τ3 compared to 20% (2.9 fold higher) for binding to UV-damaged DNA (Figure
4.14 C and D). From these data, we infer a greater fraction of the S2,ud population dissociates
from DNA according to the T2 process compared to the S2,d population. We conclude that
the increase in the S3,d population which comes with an accompanying loss of the S2,d
population is a consequence of UV-DDB interacting with damaged DNA. This suggests that
the T2 process represents a damage verification process. This model suggests that the fraction
of the S2 intermediate that does not decay according to the S2 intermediate is converted to
the S3 intermediate. Further, these data reveal a dependence of the stabilization of kinetic
intermediates of UV-DDB on the presence of damage on DNA: upon introduction of UV-
damage, we find that the S3,d population is enriched, indicating that a greater fraction of
the UV-DDB is stably bound to UV-damaged DNA.
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4.6.4 Analysis of dissociating molecules reveals an additional long lived inter-
mediate
Further evidence for the presence of long lived complexes was the class of observations that
are present at the beginning of data acquisition and dissociate during observation (Figure
4.10 A). We performed a CRTD analysis for this class of particles and obtained the survival
curves presented in figure 4.15 for undamaged DNA (n = 16, blue) and damaged DNA (n =
67, red).
For the case of undamaged DNA, the CRTD was found to best fit a double exponential
(Figure 4.16A), one of which was statistically indistinguishable from the T2,ud process (p
= 0.0749) and the other exponential fit (T4,ud) was statistically different from the T3,ud (p
<0.0001) process. Parameterization of the CRTDs revealed the presence of the T2,ud process
and a new T4,ud process for dissociation from undamaged DNA.
Similarly, from the CRTDs of UV-DDB dissociating from UV-damaged DNA, a new
process (T4,d) was identified which was consistent with the T4,ud process. In the case of
UV-damaged DNA, the CRTD was dominated by a single exponential (Figure 4.16B) corre-
sponding to a single process (T4,d). Although this exponential was found to be distinct from
the T4,ud process (p <0.0001) it was found to possess a decay rate which was very similar to
that of the T4,d process. It is likely that the T4,ud and T4,d processes are identical, and the
differences in the values arise from poor estimation of the of the T4,ud process due to low
sample size (n = 11).
We wondered if it was possible that the T4 and T3 processes were identical. The data set
of dissociating molecules represents those molecules for which tassoc ≥ tmeas (where tassoc rep-
resents the total time of association; and tmeas represents the measured time of association.
Note that tassoc >tmeas). We examined the limiting case that tassoc = tmeas (i.e. the molecules
associated with the DNA at the instant prior to the start of observation) and plotted the
decay of 16 molecules present for undamaged DNA (or 67 in case of UV-damaged DNA)
molecules for the cases where τ = {τ3,ud, τ3,ud+, τ3,ud−} and τ = {τ4,d, τ4,d+, τ4,d−}, where τi,j+
represents the upper limit of the 95% CI and τi,j− represents the lower limit of the 95% CI
(see Figure 4.17). In all cases we found no overlap of the curves, consistent with the results
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Figure 4.15: Survival curves for dissociating UV-DDB
Estimated survival functions for dissociating molecules from undamaged DNA (blue, n = 16) and
UV-damaged DNA (red, n = 67).
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Figure 4.16: Exponential fits to the CRTDs of population of dissociating molecules
CRTD vs. t plot for dissociating UV-DDB from undamaged DNA A. and UV-damaged DNA B.
with exponential fits (blue) to the experimental data (closed black circles).
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of the hypothesis indicating that the T3 and T4 processes represent distinct intermediates.
The fraction of molecules participating in the T4 process was 3.3 fold higher and was cal-
culated as fraction decaying according to T4 process for damaged DNA (67/643)/ fraction
decaying according to T4 process for damaged DNA (11/347). Importantly, the T4 process
is statistically distinguishable from the corresponding T3 process suggesting the presence of
a fourth kinetic intermediate S4,ud and S4,d that binds DNA as a function of damage.
4.7 WT UV-DDB IS PERSISTENT ON UV-DAMAGED DNA AND
SLIDES AT HIGH IONIC STRENGTH
In addition to the intermediates detected above, the tightrope platform also revealed a
population of molecules which persisted during the entire observation window of 900 seconds
(Figure 4.10 C, mov 2). For this class of molecules, the association time was indeterminate
since individual persistent molecules were found to persist up to 90 minutes (data not shown).
4.7.1 Persistent UV-DDB are enriched on damaged DNA
Importantly, these persistent molecules represent a distinct, stable intermediate (S5) that
does not decay according to any of the T1, T2, T3 or T4 processes and is not a remnant of
the slow T3 or T4 process.
From our previous analyses, we identified that the number of molecules that participate
in T3 and T4 decay processes for undamaged DNA is: 21 and 16 respectively, while that
for UV-damaged DNA is: 87 and 67 respectively. Using the values of the rate constants
measured for these processes, the number of molecules that will survive for 900 s can be
calculated to be <1 for the first three cases and 4 for the last case. In comparison, the total
number of persistent molecules was found to be 20 (out of 347 observations) for binding
to undamaged DNA, and 88 (of 643 observations) for UV-damaged DNA. This tremendous
enrichment in the number of persistent molecules strongly suggests that these molecules
participate in a process (assume Poisson; T5 - with a mean lifetime of τ5) which is far slower
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Figure 4.17: Simulated decay of longlived UV-DDB
Simulated decay of population of molecules dissociating with mean lifetimes of τ3 (red) or τ4
(blue) on A. undamaged DNA and B. UV-damaged DNA. Each set of three curves corresponds to
the simulated decay assuming a time constant of τ or tau+ corresponding to the upper limit of
the 95% CI or τ− corresponding to the lower limit of the 95% CI.
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than any of the processes that are measureable in our experiments.
4.7.2 Persistent UV-DDB molecules exhibit salt dependent mobility
To eliminate the possibility that the persistent UV-DDB molecules observed in the DNA
tightrope assay were irreversible aggregates of UV-DDB on DNA, we washed the chamber
with four chamber volumes of a high salt buffer. After the buffer exchange, we observed
a significant loss (>90%) of DNA binding events due to dissociation in the presence of
high ionic strength. Of the few molecules that remained on the tightropes, we observed
that previously stationary UV-DDB on DNA now performed a rapid 1D random walk on
DNA (mov 3, Figure 4.18 A) with an average diffusivity of 0.21 (±2.1) µm2s−1 (geometric
mean ± geometric standard deviation, where D is the diffusivity, equivalently this represents
the geometric mean; n=31, Figure 4.18 B). Importantly, the mean uncorrected diffusion
constants we measured were an order of magnitude greater than the upper limit for rotational
diffusion proposed by Schurr [138], suggesting that UV-DDB does not rotationally track the
DNA when sliding under conditions of high ionic strength. Further, all of these complexes
were found to be stable on DNA for at least the duration of acquisition (120 s), suggesting
that these complexes possess a molecular topology which constrains them to the DNA.
The percentage of these observations increased 2.5 fold from 5.5 % for undamaged DNA
to 13.7 % for UV-damaged DNA. This dependence on the presence of UV-damage in DNA
indicates that these persistent molecules are on a kinetic pathway toward stable damage
discrimination.
4.8 CREATION OF DNA DAMAGE ARRAYS: UV-DDB CO-LOCALIZES
AND IS PERSISTENT AT SITES OF LESIONS
In our work, we have identified five kinetic intermediates S1, S2, S3, S4, S5; in increasing
order of stability in the interaction of UV-DDB with undamaged and UV-damaged DNA.
Additionally, we have measured the kinetics of dissociation from each of these states to the
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Figure 4.18: Effect of high ionic strength on UV-DDB interaction with DNA
A. Representative kymograph of UV-DDB sliding on DNA at high ionic strength. B. Histogram
of diffusion constants for UV-DDB sliding on DNA at high ionic strength. Horizontal scale bar
represents 1s and vertical scale bar represents 2 µm (n = 31).
DNA-free state S0. The experiments so far have not revealed the molecular configurations of
UV-DDB bound to DNA in each of these states. We next probed whether dimeric UV-DDB
participated in the kinetic pathway was represented in any of these intermediates. Further
we wanted to directly test whether long-lived UV-DDB arises from interactions with sites of
damage.
To better understand the nature of the long-lived UV-DDB complexes we created sub-
strates with engineered lesions at defined sites (see section 2.3.1.3). To this end, we in-
troduced an oligonucleotide containing an abasic site analog with a 3’ biotin modification
(‘APbiodT’) within a plasmid using a previously described protocol [114]. Linearized plas-
mids were tandemly ligated to form long damage arrays (>40 kb) which were strung up
between beads in the DNA tight-rope assay. Upon incubation with SA QDs, we were able
to observe QD arrays on these substrates marking sites of lesions (Figure 4.19A).
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Figure 4.19: Use of defined lesion substrates in DNA tightrope assay
Oblique angle fluorescence microscope image of array of quantum dots on DNA tightrope of a
long DNA molecule containing a defined abasic site analog with a proximal biotin marking the
site of the lesion.
A histogram of pair-wise distances between QDs revealed a series of peaks centered
at lengths consistent with integral multiples of the linearized plasmid length of 0.65 µm
(Figure 4.20 A). We were able to fit the histogram of inter-QD distances for pairs of adjacent
QDs in a DNA damage array to a multiple Gaussian fit (up to three terms, see Figure
4.20 B) and found that 46.7% of inter-QD distances on these DNA damage arrays were
0.697 µm apart (95% CI: (0.6899, 0.7044)), 37.8% were 1.348 µm (CI:(1.336, 1.359)) and
8.9% were 2.076 µm (95%CI: (2.022, 2.131)) apart (Figure 4.20 C). The measured distances
between adjacent QDs on DNA agree very well with the predicted distances between two
QDs if they are one (0.65 µm) or two (1.30 µm) or three (1.95 µm) plasmid lengths apart.
Thus, 85% of the quantum dots were either one or two plasmid lengths apart (Figure 4.20
C). We believe that the missing sites reflect a lack of QD conjugation or dark quantum
dots rather than sites where the oligonucleotide is not incorporated as restriction digests
of the parental damage engineered plasmid indicated that >99 % had the oligonucleotide
correctly incorporated (data not shown). These data demonstrate that DNA damage can be
introduced and specifically marked in these DNA tight-rope substrates efficiently.
To investigate whether long-lived UV-DDB molecules bound DNA at sites of DNA dam-
age, we performed dual color experiments involving the incubation of QD-UV-DDB conju-
gates with QD conjugated APbiodT DNA tightropes. We found persistent UV-DDB co-
localized to sites of damage (n = 21, Figure 4.21, mov4). Significantly, this general method
of creating long DNA substrates with site specific modifications provides new possibilities for
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Figure 4.20: Characterization of defined DNA damage arrays
A) Histogram of pairwise distances between QDs marking sites of introduced lesion. B. Gaussian
fit to the histogram of measured distances between adjacent QDs on DNA substrate. C.
Histogram of percentage counts of plasmid lengths between adjacent QDs on DNA tightrope
containing defined lesion.
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Figure 4.21: Persistent co-localization of QD-UV-DDB with QD marking sites of DNA
damage
Kymograph of UV-DDB (red) co-localized to sites of defined lesion (green) for 900 s (see mov4)
indicating the formation of long lived UV-DDB at sites of damage. 1 pix = 40 nm along y-axis.
studying site specific interactions of DNA repair proteins in the DNA tight-rope platform.
4.9 DIMERIC UV-DDB IS PERSISTENT AT SITES OF DAMAGE
We next sought to understand the molecular nature of the kinetic intermediates found for
UV-DDB binding to DNA. To address the nature of UV-DDB stoichiometry, we incubated
together UV-DDB molecules which had been separately labeled with two differently colored
QDs with UV-damaged DNA tight-ropes. We found that, co-localization of both colors could
be observed, representing dimerization of WT-UV-DDB (mov5, Figure 4.22 A). Further for
72% of observations (n = 18), co-localization was found to persist during the entire observa-
tion window of 900s, suggesting that, UV-DDB dimers are long lived on UV-damaged DNA.
Further evidence for persistent UV-DDB dimers was obtained from experiments involving
the incubation of dual colored UV-DDB with APbiodT substrates. Even in this case, we
were able to observe long lived UV-DDB dimers (n = 18, mov5, Figure 4.22 B).
4.10 UV-DDB (K244E) DIMERIZES AND SLIDES ON DNA
To gain insight into the nature of the complex binding kinetics of WT UV-DDB, we turned
our attention to a XP causing mutant of UV-DDB containing a lysine to glutamate mutation
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Figure 4.22: Co-localization of UV-DDB monomers on DNA substrates containing lesions
Dual color kymographs of long-lived UV-DDB dimer on A) UV-damaged DNA and B) APbiodT
substrate respectively. 1 pix = 40 nm along y-axis.
in position 244 in DDB2. The K244E mutation affects a crucial DNA binding residue and
results in a greatly reduced affinity and specificity for damage [18, 121].
We probed the DNA binding ability of recombinant UV-DDB (K244E) in a pull-down
experiment (see Figure 4.23). In this experiment, UV-DDB or UV-DDB (K244E) were
incubated with UV-irradiated or undamaged bio-517-dig bp DNA (this is a fragment of
DNA containing a biotin on one end and a digoxigenin on the other end, see Figure 4.23)
bound to streptavidin coated magnetic bead and blocked (or not) on the other end with
an anti-dig antibody (Figure 4.23). Pulled-down UV-DDB or UV-DDB (K244E) was then
probed using α-DDB1 and α-DDB2 antibodies.
We found that, both WT and mutant UV-DDB (K244E) exhibited strong end binding,
which was lost upon blocking with the anti-dig antibody (compare lanes 1,2 and 5,6 and
3, 4 and 7, 8, Figure 4.24). Further, WT UV-DDB exhibited a 4 fold increased binding to
UV-damaged DNA containing on average 1 photoproduct per fragment (compare lane 5 vs.
lane 6, Figure 4.24). In contrast, UV-DDB (K244E) failed to exhibit any specific binding for
UV-damaged DNA (compare lane 7 vs. 8, Figure 4.24). These results are consistent with a
previous report [121], which reported that the UV-DDB (K244E) mutant lacks the ability
to discriminate UV-damage in DNA.
This finding was further confirmed by atomic force microscopy experiments in which
UV-DDB (K244E) was incubated with undamaged 517 bp DNA fragments (Figure 4.25).
Consistent with the results of the pull-down experiment, we found that, UV-DDB (K244E)
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Figure 4.23: Schematic of pulldown experiment.
Schematic of pulldown experiment indicating either undamaged or UV-damaged 517 bp DNA
containing a biotin and a digoxigenin on either end, bound to streptavidin coated beads. This
experiment allows for the pulldown of WT or mutant UV-DDB from undamaged or UV-damaged
DNA with free or blocked ends.
Figure 4.24: Western blot of pulldown experiment.
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Figure 4.25: AFM images of UV-DDB (K244E) bound to undamaged DNA
AFM image of UV-DDB containing K244E mutant of DDB2 bound to A. 517 bp undamaged
DNA B. pUC18 plasmid DNA.
was capable of binding DNA at ends and non-specifically over the length of the DNA. A
comparison of percentage of binding events to DNA ends vs. internal sites revealed marginal
preference for ends over internal sites (55% vs. 45%, n = 410 binding events, Figure 4.26).
We observed that the UV-DDB (K244E) could bind a single DNA molecule non-specifically
(20%), a single DNA end (6%), two DNA ends (16%), one DNA end and an internal site
forming a three-way junction (50%), two DNA molecules at internal sites forming four-way
junctions (9%). 74% of the bound UV-DDB (K244E) (see below) participated in binding to
two DNA molecules compared to 26% bound to single DNA molecules (n = 216 UV-DDB
(K244E)-DNA complexes). Interestingly, dimeric WT UV-DDB was found to bind two DNA
helices only 20% of the time [102].
To obtain dynamic information describing the binding of UV-DDB (K244E) to DNA,
we incubated QD-UV-DDB (K244E) with undamaged λ-DNA in the DNA tightrope assay
and found that, in stark contrast to the WT UV-DDB, UV-DDB (K244E) showed sliding
behavior. We performed a CRTD analysis on UV-DDB (K244E) and found that 69% of UV-
DDB (K244E) dissociated from DNA with a mean lifetime of 1.9s (1.7s, 2.1s), whereas 31%
dissociated from DNA with a mean lifetime of 34.7 s (30.4s, 40.4s) (n = 99, Figure 4.27). UV-
DDB (K244E) was also found to slide on APbiodT DNA (mov6, Figure 4.28). We calculated
diffusion constants for UV-DDB (K244E) molecules which were found to slide on DNA for the
entire observation window of 120s. Sliding QD-UV-DDB (K244E) exhibited heterogeneity
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Figure 4.26: Quantification of end vs. non-end binding of UV-DDB
Plot of end binding vs. non-end binding of UV-DDB (K244E) on 517 bp DNA.
in its diffusive behavior spanning three orders of magnitude (Figure 4.29). Importantly, the
diffusive behavior of UV-DDB (K244E) on DNA (both undamagedλ-DNA and APbiodT)
was found to have a mean diffusion constant of 0.11 ± 0.2 µm2s−1, with an anomalous
diffusive exponent (α) of 0.5 ± 0.22 (n = 31, Figure 4.29). This subdiffusive behavior of
UV-DDB (K244E) with DNA suggests that UV-DDB (K244E) retains interactions with the
DNA as it diffuses on the DNA.
Unexpectedly, the DNA tightrope assay provided further insight into the interaction
of UV-DDB (K244E) with DNA. We identified, albeit rarely, events which suggest that
dimerization of UV-DDB (K244E) is DNA dependent and proceeds via random collisions
of UV-DDB (K244E) molecules on DNA (mov7, Figure 4.30). This observation prompted
us to examine the stoichiometry of UV-DDB (K244E) bound to DNA. We have previously
used AFM to identify the stoichiometry of WT UV-DDB bound to DNA using a calibration
curve relating the AFM volume of the complex to its molecular weight (Figure 4.31) [102].
Volume analysis of DNA bound UV-DDB (K244E) revealed a peak at 564.3 ± 10.1 nm3
corresponding to a molecular weight of 388.6 ± 11.8 kDa, consistent with that of dimeric
UV-DDB (K244E) bound to DNA (n = 171, Figure 4.32). These data demonstrate that a
mutation in the DNA binding interface of DDB2 does not inhibit dimerization of UV-DDB.
However, in contrast to WT UV-DDB [102], dimeric UV-DDB (K244E) is more likely to
be stabilized on two DNA molecules in a damage independent manner. In summary, our
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Figure 4.27: CRTD of UV-DDB (K244E) on DNA
Figure 4.28: Kymograph of diffusing UV-DDB (K244E) on APbiodT
UV-DDB (K244E) slides on AP-biodT DNA substrate without apparent pausing at damage sites.
Scale bars represent 5 s along the x-axis and 1 µm along y-axis.
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Figure 4.29: Plot of anomalous diffusive exponent (α) vs. Diffusivity for UV-DDB (K244E)
sliders
study indicates that UV-DDB (K244E) retains the ability to dimerize on DNA, but lacks
specificity for lesions and consequently slides on DNA. This dimerization proceeds via the
formation of kinetic intermediates which are distinct from those that describe dimerization
of WT UV-DDB.
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Figure 4.30: Dimerization of UV-DDB (K244E)
DNA dependent dimerization of UV-DDB (K244E) showing the intensity of individual
QD-UV-DDB (K244E) before and after dimerization.
4.11 DISCUSSION
In this study, we sought to understand the initial recognition step of NER by using single
molecule techniques to examine the dynamics of UV-DDB interactions at sites of damage
without ensemble averaging. We have identified that UV-DDB consisting of DDB1 and
DDB2, performs a 3D search for damage sites in DNA. Using DNA substrates containing
UV-induced photoproducts or AP sites, we discovered a complex kinetic pathway of damage
recognition by UV-DDB that culminates in the formation of long-lived dimers of UV-DDB
at sites of damage. Additionally, we studied the stoichiometry and dynamics of the XP
causing K244E mutant of DDB2 on DNA and identified that UV-DDB (K244E) dimerizes
and slides on DNA, but does not associate to damaged sites.
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Figure 4.31: Calibration curve relating the molecular mass of a protein to its measured
AFM volume
Figure 4.32: Volume histogram of UV-DDB containing the K244E mutant of DDB2
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4.11.1 Jumping as a mechanism for target search implications for search
In the work presented here, we have directly visualized jumping of UV-DDB from one λ-DNA
molecule to another in real time using a single molecule DNA tightrope assay (mov1). Of the
total DNA bound WT UV-DDB molecules observed, less than 2% showed perceptible diffu-
sion. Our work provides direct evidence for a 3D search mechanism and rules out 1D sliding
mechanisms as the primary means for target search. Multiple reports have demonstrated
that in vivo, UV-DDB exists as part of a larger E3 ligase complex bound to the COP9
signalosome (CSN − CRL4DDB2) [31, 122]. In this complex, DDB2 is the DNA damage
binding factor and damage recognition is not known to be determined by the other factors.
Based on this work, we propose that the CSN − CRL4DDB2 complex also performs a 3D
search in vivo. The presence of other DNA binding proteins and higher order chromatin or-
ganization may serve as a barrier for search if a sliding mechanism were the primary mode of
target site location. Rapid sampling of exposed DNA by a 3D search mechanism minimizes
the need to overcome such obstacles. Indeed, it has been demonstrated that nucleosomal
core particles containing site specific UV-photoproducts exhibit spontaneous unwrapping of
the DNA via a mechanism that is thought to provide access to damage recognition enzymes
[139]. Our findings on the association of UV-DDB with naked DNA are consistent with a
recent report on the promoter search employed by E. coli RNA polymerase which posits that
target search is favored via a 3D diffusion mode, over a facilitated mode of diffusion in a
concentration dependent manner [130]. Since UV-DDB exists in about 180,000 copies per
human cell nucleus [18], we propose that UV-DDB rapidly surveys the genome employing
3D diffusion and examines the DNA for damaged bases in discrete kinetic steps in an excess
of undamaged DNA.
4.11.2 Damage recognition is a multi-step kinetic cascade culminating in UV-
DDB dimerization
Analysis of data describing the association lifetimes of UV-DDB with either undamaged
or damaged DNA substrates revealed five different repair intermediates {S1,ud, S2,ud, S3,ud,
S4,ud, S5,d; and their damaged DNA counterparts}, which decay to the DNA free state
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{S0}, according to five different decay processes {T1,ud, T2,ud, T3,ud, T4,ud, T5,ud; and their
damaged DNA counterparts} on each of the DNA substrates. In our experiments, the
{T1,ud, T2,ud, T3,ud, T4,ud; and their counterparts on damaged DNA} decay rates were measur-
able whereas the T5 decay rate was found to be slower than the time scale of data acquisition.
These decay processes represent the set of measurable decay processes in our setup. It is
possible that there exist intermediates outside our detection range.
Of the measurable processes, the T1 process was found to possess a significantly different
decay rate for dissociation of UV-DDB from undamaged DNA compared to UV-damaged
DNA. This means that the S1,ud state decays to the S0 state at a slower rate than that at
which the S1,d state decays into the S0 state. Statistical analyses revealed that the T2, T3 and
T4 decay rates were identical for dissociation from undamaged or damaged DNA. This means
that each of the pairs of decay processes {S2,ud → S0, S2,d → S0}, {S3,ud → S0, S3,d → S0} and
{S4,ud → S0, S4,d → S0} occur at the same rate. However, the number of molecules partici-
pating in these processes was very different for undamaged vs. damaged DNA (Figure 4.14).
0.65X fewer complexes participated in the T2 decay process for damaged DNA compared to
undamaged DNA (Figure 4.14). On the contrary, 3X more UV-DDB-DNA complexes de-
cayed according to each the T3 and T4 decay process in the presence of damage respectively
(Figure 4.10). Since the decay rates for the pairs of process {S2,ud, S2,d}, {S3,ud, S3,d} and
{S4,ud, S4,d} show no dependence on the presence of damage, we can assume that they arise
from isoenergetic repair intermediates. Under this assumption, we find that the 12% loss of
molecules in the S2 state on damaged DNA corresponds to an enrichment of the S3 state
(Figure 4.14), indicating that the T2 process is a damage verification process, while the T3
process is a damage stabilizing process. Some of these longer lived intermediates may arise
from endogenous damage in commercially available λ-DNA (for example from depurination)
that is recognized by UV-DDB [18].
Some of the slower decay processes are consistent with previously available bulk esti-
mates. Bulk estimates of the kinetics of dissociation of UV-DDB from UV-damaged DNA in
cellular chromatin are difficult to obtain because of the complex and unclear interaction be-
tween UV-DDB and XPC and its dependence on the ubiquitylation of each of these factors.
Kinetic studies of C-terminally tagged murine DDB2-EYFP in XP20MA cells (XP-C cells)
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revealed a half-life of 110s for dissociation from UV-damaged chromatin [122]. Previous bio-
chemical analysis of the dissociation kinetics of recombinant UV-DDB from photoproducts
were found to be lesion dependent with a slow off rate for a high affinity lesion such as the
6-4 PP (8.1× 10−4s−1) and faster off-rates for the Dewar isomer of the 6-4 PP and T[t,s]T
(2.9×10−3 and 3.7×10−3s−1 resp.) and even faster off-rates for the dissociation from T[c,s]T
photoproducts (4.6×10−2s−1) [140]. However, in these studies, the estimated rate constants
represent bulk dissociation rates, from not just the site-specific lesion, but also end bind-
ing, irrespective of the oligomeric state of UV-DDB bound to the DNA substrate or in the
presence of other interacting partners or post-translational modifications that may influence
these estimates.
These kinetic intermediates progress along a kinetic cascade and culminate in the forma-
tion of an enriched and distinct population of persistent molecules on UV-damaged DNA.
Additionally, we found that dimeric UV-DDB was also persistent and that the persistent
molecules were not irreversible aggregates of UV-DDB on DNA. We believe that the dimeric
molecules observed in this work are structurally consistent with the dimeric UV-DDB struc-
ture we elucidated recently and represent specific binding at sites of lesions [102]. While
the crystal structure suggests that UV-DDB requires two DNA molecules to dimerize on
DNA, our AFM data reveal that dimeric UV-DDB can form even on single DNA molecules
containing damage [102]. In fact, AFM experiments revealed that only 1 in 5 complexes
were composed of dimeric WT UV-DDB mediating the binding of two DNA molecules [102].
In contrast, 76% of UV-DDB complexes containing the K244E mutant of DDB2 on DNA
were found to be dimeric, and bound to two molecules of DNA(Figure 4.25). These findings
indicate that while the presence of two DNA molecules in the UV-DDB DNA complex is
sufficient for dimerization of UV-DDB, it is not a necessary requirement.
We predict that these long-lived dimers of UV-DDB at sites of lesions could inhibit the
progression of NER if these highly stable UV-DDB dimers are not dismantled. In support of
this hypothesis, introduction of excess recombinant UV-DDB to in vitro reconstituted NER
reactions resulted in inhibition of repair of 6-4 PPs [17]. Studies of fluorescently tagged
UV-DDB binding in vivo have reported immobile binding of UV-DDB to DNA for up to 4
h in XP-A cells [134]. In a study involving siRNA knock-down of Cullin4A, fluorescently
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tagged UV-DDB exhibited delayed disappearance from CPD foci in HeLa cells [141]. In-
hibition of the proteasome using MG132 also resulted in inhibited recruitment of XPC to
sites of CPD lesions in mammalian cells [142]. We believe that the highly stable, persistent,
dimeric UV-DDB complexes detected in our studies represent a distinct species on the ki-
netic pathway to recognize damage with high specificity and affinity. How post translational
modifications of DDB2 such as phosphorylation [143], SUMOylation [144], ubiquitylation
[29] and PARylation [125, 126], as well as, interacting partners such as XPC and XPA [145]
influence the intermediates of UV-DDB and the transition rates measured in our system will
be investigated in future experiments.
4.11.3 Damage recognition involves dynamic conformational changes in both
UV-DDB and DNA
What might be the physical basis of this heterogeneity observed in the lifetimes of the
repair intermediates? Crystal structures of UV-DDB in the apo and DNA damage bound
forms reveal some of these states (PDB ID: 3EI1, 4A0A, 4A0K, 4E54). The protein in
the apo state (PDB ID: 3EI4) upon binding to damaged DNA undergoes an FQH-hairpin
(F334-Q335-H336) transition which probes the major groove of the DNA for the presence of
damage (see Figure 4.33; PDB ID: 4E45, see mov8) [25, 16, 102].
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Figure 4.33: Model of DDB2 in the apo and DNA bound state. Here the FQH motif is
shown in light green (apo structure, PDB ID: 3EI4) and dark green (DNA bound
conformation, PDB ID: 4E54). Similarly, the K244 residue is shown in light blue (apo
structure, PDB ID: 3EI4) and dark blue (DNA bound structure, PDB ID:4E54).
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At sites of damage, this conformational change in DDB2 is accompanied by base-flipping
of the damaged bases in DNA (consisting of the photoproducts in the case of UV dam-
age, alternatively the abasic site and the adjacent 3’ base) to an extrahelical conformation
and stabilization in the lesion binding pocket of DDB2 (PDB ID: 3EI1, 4A0A, 4A0K; see
Figure 4.34) [25, 16]. Stable damage recognition is thought to induce folding of the intrin-
sically disordered N-terminus an α-paddle structure, which along with the β-wing, forms a
winged helix structure upon DNA binding (PDB ID: 4E54; see figure 4.35) [102]. Damage
recognition may be considered to progress along a reaction coordinate which describes a
series of dynamically interconverting structural intermediates. Some of the highly transient,
short lived binding intermediates observed here might reflect abortive attempts at damage
recognition by UV-DDB. These species may correspond to metastable intermediates that
participate in varying extents of lesion engagement, failing to stabilize at sites of damage.
Indeed, previous work has demonstrated that the assembly and disassembly of subunits of
large macromolecular complexes such as the spliceosome proceeds via a kinetic pathway
which rejects non-productive sub-complexes along the reaction coordinate [146].
Heterogeneous lifetimes may arise from the nature of the lesion or the repair intermediate.
Indeed, different lesions are differentially recognized by UV-DDB [140, 18] and this may
explain some of the multiple long-lived populations observed here. Future work will focus
on examining the interaction of UV-DDB with damaged DNA substrates containing defined
6-4PPs and CPD lesions using the DNA damage arrays and the tightrope assay described
here.
4.11.4 Specific damage recognition depends on K244 switching
We have tested a human disease causing mutant of UV-DDB (K244E) and found that this
mutant still maintained the ability to dimerize and displayed residual DNA binding. How-
ever, as opposed to WT UV-DDB, UV-DDB (K244E) mutation exhibited sliding on the
DNA. This finding suggests that proofreading of damaged DNA is contingent upon the suc-
cessful sandwiching of the undamaged base 3’ to the two damaged bases, between the FQH
hairpin and K244 (see figure 4.33, 4.34).
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Figure 4.34: Model of DDB2 in the DNA bound state. Here the abasic site analog and the
adjacent base to it constitute the lesion and are shown in orange. The DNA is bound to
DDB2 via a constellation of electrostatic interactions shown in light blue. The FQH lesion
(green) occupies the interhelical space vacated by the flipped out lesion (orange). The
undamaged base adjacent to the lesions is shown in red and stacks with the glutamine
residue and is pinned between the FQH motif and the K244 (dark blue spheres).
Figure 4.35: Model of damage recognition by DDB2. See description in text.
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Figure 4.36: Model of UV-DDB (K244E) binding to DNA. UV-DDB (K244E) dimerizes on
DNA but fails to stably engage the lesion due to the positive charge of the glutamate
residue. See description in text.
Dimerization of UV-DDB (K244E) probably occurs by rapid 3D diffusion of one UV-
DDB molecule colliding with another the long-lived UV-DDB molecule sliding on the DNA,
trapping this dimer in a topologically constrained complex on the DNA, which is not actively
engaged in a damage detection conformation (Figure 4.36). The sub-diffusive nature of the
sliding indicates that this complex performs a constrained Brownian walk on the DNA,
suggestive of interactions with it [131]. This explains the observations by us and others,
that UV-DDB (K244E) retains weak DNA binding ability, but lacks specificity for damage
[121, 18].
4.11.5 Conformational proofreading is a candidate mechanism for damage recog-
nition
As evidenced from the crystal structures, both UV-DDB and the DNA undergo a series
of concerted conformational changes that ensure successful damage recognition (PDB ID:
3EI4, 3EI1, 4A0A, 4A0K, 4E54). This problem of damage recognition by UV-DDB falls
under a category of problems in molecular recognition in which proteins utilize conforma-
tional changes to achieve highly specific recognition in a noisy environment. This mecha-
nism termed conformational proofreading [109] utilizes a ‘structural mismatch’ between the
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protein binding pocket and the ligand such that binding of the correct ligand facilitates a
conformational change in the protein which stabilizes the binding, while the incorrect lig-
and is unlikely to allow this conformation change and is therefore rejected. Conformational
proofreading operates in the absence of energy consumption and is an alternative to kinetic
proofreading [109].
A working model for damage recognition by UV-DDB is presented here (figure 4.37).
Each of the states Si can be considered to be comprised of a protein configuration Pi and
a DNA configuration Di. Here, the apo protein and the DNA interconvert between ensem-
bles of conformers {Pi} and {Di}. Collisions between the protein and DNA result in the
formation of interconvertible repair intermediates {Si}, some of which are relatively stable
and observable (such that their decay to the DNA-free state {S0} is measurable). In this
work, we have provided evidence for the existence of five such intermediates and measured
the decay from four of these states. We propose that during the initial stages of damage
recognition by UV-DDB, target specificity arises from the ability of the repair intermediate
to cross energy barriers between the various states, whereas additional affinity arises from
the dimerization of UV-DDB, which then locks the repair factor to the site of damage.
In our system, both UV-DDB and the DNA exhibit candidate structural mismatches
- the FQH open-close transition and the intrahelical-extrahelical base flipping transitions
respectively. While the FQH transition is necessarily required for probing, the specificity for
damage arises from the deformability and stabilization of the damaged bases in the lesion
binding pocket. We propose that the critical ‘structural mismatch’ corresponds to the ability
of the DNA to deform. Given the high penalties of flipping undamaged DNA bases compared
to damaged DNA bases, an undamaged patch of DNA which is being proofread by UV-DDB
is unlikely to access the base-flipped, deformed DNA configuration, and this is the structural
mismatch which inhibits stable binding by UV-DDB at sites of undamaged DNA.
Our work reveals that even a relatively simple step of damage binding is highly regulated
even in the absence of protein partners and supports the hypothesis that multiple layers of
damage recognition and verification are needed before the final commitment to repair DNA
is made [9]. Previous work has suggested that damage verification in NER proceeds via an
ATP-dependent kinetic proofreading mechanism performed by the XPD helicase in TFIIH
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Figure 4.37: Conformational proofreading model for molecular recognition by UV-DDB. Pi
represent conformations of protein, Di represent conformations of DNA and Si represent
protein-DNA complexes. Ti represent the decay processes that are measured in this work.
See description in text.
[107, 110]. Here, we propose that prior to kinetic proofreading by TFIIH, damage recognition
by UV-DDB proceeds via the formation of multiple repair intermediates in a kinetic cascade,
via a mechanism which resembles conformational proofreading [109]. Further, we hypothesize
that this conformational proofreading is a common feature of damage recognition in the
absence of energy consumption and is also employed by the XPC complex to discriminate
damage. In this regard it is interesting to note that conformational and kinetic proofreading
mechanisms have been found to operate together for highly specific recognition of homologous
sequences during homologous recombination [147, 111]. We believe that this synergy of
damage detection mechanisms is required for the successful navigation of the complex kinetic
and thermodynamic landscape of DNA damage recognition while achieving high specificity
by rejecting non-optimal repair intermediates. Future studies will help reveal whether the
combination of proofreading mechanisms is a universal feature of DNA damage recognition.
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5.0 CONCLUSION AND FUTURE WORK
This work has identified a previously unknown and unanticipated complexity in damage
recognition by the UV-DDB protein. We found that damage recognition by UV-DDB pro-
ceeds along a kinetic pathway comprised of multiple intermediates and culminates in the
formation of long-lived dimeric UV-DDB on DNA at sites of lesions. These findings raise
several questions and testable hypotheses that can elucidate the initial stage of damage
recognition by UV-DDB.
1. What is the contribution of lesion chemistry on heterogeneity observed in the interme-
diates? We identified at five measurable intermediates of UV-DDB on DNA. Our assays
do not reveal the nature of these intermediates. Some of the heterogeneity in the mean
lifetimes of these intermediates may be explained by the various structural intermediates
formed by UV-DDB during damage recognition. Alternately, some of this heterogene-
ity may be explained by the nature of the lesion. Previous research has identified that
UV-DDB recognizes 6-4 PPs more efficiently and binds more tightly than CPD lesions
[18]. We hypothesize that the longer lived intermediates reflect lesion specific interac-
tions. This hypothesis may be tested using DNA damage arrays containing UV-DDB
substrates in the DNA tightrope assay and measuring the mean lifetimes of long-lived
intermediates.
2. Previous work has revealed that the N-terminus of DDB2 is intrinsically disordered [25]
and is structured upon binding to DNA [102]. How does the N-terminus of DDB2
determine the stability of UV-DDB on DNA? Based on the crystal structure of dimeric
UV-DDB, we hypothesize that interactions of the folded N-terminus of DDB2 contribute
additional affinity for the DNA at sites of lesion. This hypothesis may be tested by using
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a mutant version of DDB2 involving a deletion of the N-terminus of DDB2 [UV-DDB
(∆ N-terminus)]. A prediction of this hypothesis is that UV-DDB (∆ N-terminus) will
exhibit a reduced fraction of long-lived intermediates compared to WT UV-DDB.
3. Our work reveals that UV-DDB forms long-lived dimers on DNA at sites of lesions. This
dimerization is known to involve the N-terminus of DDB2 [102]. We hypothesize that
deletion of the N-terminus of DDB2 abrogates dimerization of UV-DDB. A prediction
of this hypothesis is that UV-DDB (∆ N-terminus) would form primarily monomers on
DNA. Evidence for this hypothesis may be obtained from AFM experiments which have
the ability to reveal stoichiometry of UV-DDB on DNA. Further evidence may be a loss
of the persistent population of UV-DDB on DNA at sites of lesions, when assayed in the
DNA tightrope assay.
4. The N-terminus of DDB2 is heavily post-translationally modified [143, 144, 29, 125, 126].
Ubiquitination is known to destabilize the UV-DDB DNA interaction [29], whereas,
PARylation is shown to promote it [125, 126]. Further, these modifications are known to
occur at lysines in the N-terminus of DDB2 [25]. How do post-translational modifications
affect the stability of the DNA bound intermediates identified in this work? The effect
of PARylation on UV-DDB dwell times on DNA, may be tested using in-vitro PARy-
lated DDB2 followed by direct observation in the DNA tightrope assay with appropriate
controls.
5. Testing the effect of ubiquitination on the dwell times of UV-DDB on DNA, requires QD
conjugated CRL4DDB2 which retains ubiquitination activity. QD-CRL4DDB2 may then
be directly visuallized in the DNA tightrope with appropriate controls. Experiments in
the absence of ATP will reveal the influence of Cullin4/RBX1 on the stability of interme-
diates formed by CRL4DDB2 compared to WT UV-DDB tested in this work. The binding
of CRL4DDB2 in the presence of ATP may reveal a dependence of ubiquitination of the
N-terminus of UV-DDB on DNA binding. However, several control experiments need
to be performed, including the UV-DDB (∆ N-terminus) mutant described previously.
Further, an orthogonal labeling strategy to identify the presence of ubiquitin on DDB2
is required.
6. UV-DDB is known to hand-over the lesion to the global damage sensor XPC. However,
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observation of a ternary complex involving UV-DDB, XPC and DNA has been elusive.
It is likely that this complex is transient in the presence of functional CRL4DDB2 or
that existing assays may not be able to trap detectable amounts of this ternary complex.
The single molecule DNA tightrope assay used in this work has the ability to reveal
intermediates which may escape detection by bulk methods. Indeed preliminary data
suggests that UV-DDB and XPC colocalize within the resolution of the microscope.
7. Recent research has provided direct evidence that UV-DDB recognizes lesions in nu-
cleosomal DNA [25]. However, several questions remain. Does UV-DDB dimerize on
nucleosomes containing damage? Does damage recognition in nucleosomal DNA proceed
via the formation of the kinetic intermediates described in this work? This hypothesis
may be tested using ‘chromatinized’ long DNA substrates in the DNA tightrope assay.
Long DNA substrates containing nucleosomes may be created by reconstituting nucleo-
somes on arrays of the 601 positioning sequence. An orthogonal strategy to label histone
cores should be used to identify colocalization of QD-UV-DDB with nuclesomes.
In this work, we have implemented a single molecule DNA tightrope assay which serves
as a platform to study interactions of biomolecules with DNA. Further, we have identi-
fied reagents and strategies to permit multicolor observation of QD conjugated DNA repair
proteins. We have also developed and characterized new DNA substrates that permit obser-
vations of site specific interactions of DNA repair proteins with introduced custom chemical
modifications at defined lesions. These reagents overcome significant limitations in the family
of DNA stretching assays and provide new possibilities in probing site specific interactions.
We believe that the assays developed here in combination with mutational analyses will en-
able the characterization of structure-function relationships that govern specific protein-DNA
interactions. Further, the use of single molecule methods used here enables the observation
of the stochastic nature of protein-DNA interactions, as proteins assemble and disassem-
ble at sites of custom chemical modifications in DNA in real time. Ultimately, we believe
that these technologies will be useful in the study of other DNA repair pathways beyond
nucleotide excision repair.
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APPENDIX A
ABBREVIATIONS
6-4 PP - 6-4 photoproduct
Ab - antibody
CPD - Cyclobutane pyrimidine dimer
CRL4DDB2 - Cullin4A/B-RBX1-DDB1-DDB2 E3 ligase
CS - Cockayne syndrome
CSN - COP9 signalosome
DNA - Deoxyribonucleic acid
ERCC1 - Excision Repair cross complementation protein 1; obligate heterodimer of XPF
GG-NER - Global genomic nucleotide excision repair
NER - Nucleotide excision repair
nt - nucleotide
Polδ - Eukaryotic DNA polymerase δ
Pol - Eukaryotic DNA polymerase 
PSF - Point spread function
RPA - Replication protein A; single strand DNA binding protein; eukaryotic homolog of
bacterial single strand DNA binding protein (SSB)
TC-NER - Transcription coupled nucleotide excision repair
TFIIH - General transcription factor IIH
TTD - Trichothiodystrophy
UV-DDB - DNA damage recognition factor; Ultraviolet induced DNA damage binding pro-
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tein, consisting of DDB1 and DDB2
XP - Xeroderma pigmentosum
XP-A - Xeroderma pigmentosum group A phenotype
XPA - Repair factor defective in XP-A
XP-B - Xeroderma pigmentosum group B phenotype
XPB - 3’-5’ helicase defective in XP-B
XP-C - Xeroderma pigmentosum group C phenotype
XPC - Repair factor found to be defective in XP-C
XPC complex - DNA damage recognition factor; comprised of XPC, HR23A/B and Centrin2
XP-D - Xeroderma pigmentosum group D phenotype
XPD - 5’-3’ helicase defective in XP-D
XP-E - Xeroderma pigmentosum group E phenotype
XP-F - Xeroderma pigmentosum group F phenotype
XPF - Structure specific 5’ endonuclease deficient in XP-F
XP-G - Xeroderma pigmentosum group G phenotype
XPG - Structure specific 3’ endonuclease deficient in XP-G
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Human telomeres are composed of duplex TTAGGG repeats
and a 3 single-stranded DNA tail. The telomeric DNA is pro-
tected and regulated by the shelterin proteins, including the
protection of telomeres 1 (POT1) protein that binds telomeric
single-stranded DNA. The single-stranded tail can fold into
G-quadruplex (G4) DNA. Both POT1 and G4 DNA play impor-
tant roles in regulating telomere length homeostasis. To date,
most studies have focused on individual quadruplexes formed
by four TTAGGG repeats. Telomeric tails in human cells have
on average six times as many repeats, and no structural studies
have examined POT1 binding in competition with G4 DNA
folding. Using single molecule atomic force microscopy imag-
ing, we observed that the majority of the telomeric tails of 16
repeats formed two quadruplexes even though four were possi-
ble. The result that physiological telomeric tails rarely form the
maximum potential number of G4 units provides a structural
basis for the coexistence of G4 and POT1 on the same DNA
molecule, which is observed directly in the captured atomic
forcemicroscopy images.We further observed that POT1 is sig-
nificantlymore effective in disrupting quadruplex DNA on long
telomeric tails than an antisense oligonucleotide, indicating a
novel POT1 activity beyond simply preventing quadruplex
folding.
Cells with linear chromosomes must solve the following two
problems: the progressive lagging strand shortening with each
cycle of DNA replication and the need to protect the ends of
linear chromosomes from unwanted DNA damage responses
(1). As a solution to both these problems, telomeres stand at
the junction between aging, genomic stability, and cancer.
Telomeres are composed of the “shelterin complex” of proteins
and TTAGGG repeats of duplex DNA along with an ssDNA
overhang or “tail” of 50–500 nucleotides (1). The ssDNA tail
can fold into G-quadruplex DNA (G4DNA),4 which consists of
three tetrads of four guanines that form Hoogsteen base pairs
with each other (Fig. 1A). These tetrads are in a square planar
conformation and are stacked atop one another with the TTA
sequences forming linker loops (2, 3). The formation of G4
DNA has been shown to inhibit the telomere-lengthening
enzyme complex telomerase in vitro (4), although a recent in
vivo study of Saccharomyces cerevisiae telomerase found that
G4 DNA can promote the activity of yeast telomerase (5).
Protection of telomeres 1 (POT1) is part of the shelterin pro-
tein complex and binds to single-stranded telomeric TTAGGG
repeats (6, 7). POT1 protects mammalian chromosome ends
from the ataxia telangiectasia mutated and Rad3-related
(ATR)-dependent DNA damage response, inhibits 5 end
resection at telomere termini, and regulates telomerase-medi-
ated telomere extension (8). Although POT1was shown to trap
an oligonucleotide with four telomere repeats in an unfolded
state to prevent G4 formation (4), the biological significance of
this result is unclear. First, POT1 could not bind the short four
telomere repeat substrate when the oligonucleotide was pre-
folded into G4 DNA (4), and second, the telomeric tail has
upwards of 30 tandem repeats in human cells (1). Thus, these
studies imply that POT1 cannot actively load on telomeric tails
in vivo unless the G4 structures are melted by a helicase, yet
POT1 cellular function is not reported to depend on G4
unwinders and helicases. On the contrary, we reported that
POT1 pre-loading on telomeric DNA regulates the unwinding
activity ofWRNhelicase (9–12). At the late G2 phase of the cell
cycle, POT1 levels at the telomeres decrease, and the telomeres
are temporarily unprotected and recognized as DNA damage
before POT1 relocalizes to the telomeres (13). Because the
unprotected tail can spontaneously fold intoG4DNAandblock
POT1 binding, the mechanism of POT1 reloading on the
exposed telomeric tail is unknown.
Studying POT1 loading on physiological telomeric tails is
complicated by a lack of information on G4 DNA formation
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and distribution on long ssDNA strands. X-ray crystallographic
and NMR studies of G4 DNA have focused on individual qua-
druplexes formed from four TTAGGG repeats (3, 14–18). Pos-
sible heterogeneity of the long telomeric ssDNA substrates
makes them unamenable to conventional crystallographic and
NMR studies (19). Furthermore, bulk biochemical assays, such
as native gel electrophoresis, circular dichroism, and UV melt-
ing analysis, can only provide a mean value. Results from ther-
mal melting assays support the hypothesis that longer telo-
meric ssDNAs form a beads-on-a-string G4 assembly in which
individual quadruplexes are separated from each other by a
TTA linker (Fig. 1B) (19), although some data and extrapola-
tions from an NMR structure of individual G4 support a
“stacked” arrangement of quadruplexes (20, 21). The discrep-
ancies between these studies underscore the need to examine
the formation of G4 structures on physiologically relevant telo-
meric tails.
Atomic force microscopy (AFM) offers a powerful single
molecule approach that allows one to examine distinct nucleic
acid structures (single-, double-, and triple-stranded) and their
distribution within a heterogeneous population (22, 23). Previ-
ous AFM studies established the visualization of human telo-
meric single G4 DNA units by AFM (24). However, the quan-
titative distributions of various quadruplex numbers and
arrangement ensembles of individualmoleculeswithin a poten-
tially heterogeneous population of long single-stranded telo-
meric molecules have not been addressed. Even more impor-
tantly, POT1 coats the 3 ssDNA tail of the telomere (6, 25, 26).
However, the potential modulation of G4 folding by POT1 on
physiologically relevant telomeric tails has not been investi-
gated, and whether G4 DNA and POT1 can coexist on a telo-
meric tail is unknown. AFM has been used extensively to study
protein-DNA interactions (27, 28), validating its application for
the visualization of telomeric tail structures in the presence and
absence of POT protein at the single molecule level.
First, to visualize the formation of G4 DNA on realistic telo-
meric tails, we performed single molecule AFM imaging of
defined DNA substrates with a duplex stem followed by single-
stranded TTAGGG repeats (4, 8, or 16) and conducted detailed
quantitative analysis of the length and height of the G4 struc-
tures. At physiological salt concentrations, the majority of
(TTAGGG)16 molecules form only two G4 structures, instead
of the maximum of four, so that not all the POT1-binding sites
are occluded. Consistent with this, the AFM images revealed
that POT1 coexists with G4 DNA on some 3 tails. We report
that POT1 addition shifts the population distribution toward
telomeric molecules that have fewer G4 units or that are com-
pletely unfolded. Importantly, POT1 was significantly more
effective in disrupting G4 DNA on (TTAGGG)16 molecules
than an antisense oligonucleotide, indicating an activity beyond
simply preventing G4 folding as proposed previously (4). Our
data are consistent with amodel in which POT1 acts as a “steric
driver” on long telomeric ssDNA to promote unfolding of
neighboring G4 structures.
MATERIALS ANDMETHODS
DNA Substrates—All oligonucleotides were purchased from
Integrated DNA Technologies and were purified using PAGE
by the manufacturer. The sequences of the oligos are listed in
supplemental Table S1. DNA substrates that contain a 5
duplex region and a 3 ssDNA tail were formed by incubating
equal molar amounts of oligonucleotides in 1 phosphate
buffer (10 mM potassium phosphate and 150 mM KCl) or 1
POT1buffer (40mMHepes, pH 7.5, and 50mMKCl) at 85 °C for
5 min, followed by slow cooling to room temperature. Linear
dsDNA substrate, PCR517, used as an internal size standard
was made by PCR amplification of nucleotides 1374–1890 on
pUC18 plasmid and purification using Illustra GFXTM PCR
DNA and a gel band purification kit (GE Healthcare).
Protein Purification—Recombinant GST-tagged and un-
tagged POT1 proteins were purified using a baculovirus/insect
cell expression system and an AKTA Explorer FPLC (GE
Healthcare) as described previously (10). Protein concentra-
tions were determined using Coomassie staining along with a
standard of known concentration. Proteins used in this study
are more than 90% pure based on SDS-PAGE and Coomassie
staining (supplemental Fig. S2F).
AFM Sample Preparation and Imaging—All DNA substrates
and POT1 protein were diluted in 1 POT1 buffer containing
additional 10 mM MgCl2 for AFM imaging. All buffers were
heated at 65 °C for 15–30 min to dissolve small salt particles
that may have accumulated during storage. Samples of DNA
with and without POT were prepared using the same buffer.
POT1 and DNA were incubated at 37 °C for 10 min before
deposition onto mica. The G-wire solution was prepared by
incubating a 270 M solution of G4T2G4 monomer in 100 mM
potassium phosphate buffer, pH 7, at 90 °C for 10min and slow
cooling to room temperature, followed by incubation at 4 °C for
12 h. For experiments using the antisense oligo, C-oligo (sup-
plemental Table S1) was incubated with Tel16 DNA (prepared
by annealing Tel16 top and bottom oligos, supplemental Table
S1) at 37 °C for 10 min. All samples for AFM imaging were
prepared by depositing samples onto a freshly cleavedmica (SPI
Supply, West Chester, PA), followed by washing with Milli-Q
water and drying under a stream of nitrogen gas. All images
were collected using aMultiModeVmicroscope (Veeco Instru-
ments, Plainview, NY) using E scanners in tapping mode.
Pointprobe plus noncontact/tapping mode silicon probes
(PPP-NCL, Agilent) with spring constants of 50 newtons/m
and resonance frequencies of 190 kHz were used. Images
FIGURE 1. Base pairing in G-quadruplex DNA and the beads-on-a-string
model.A,planar tetradof guaninesboundbyHoogsteenbasepairing. Image
was createdonVisualMolecularDynamics (Urbana, IL) using theProtein Bank
2JPZ structure (20). B, schematic illustration of the beads-on-a-string model
(18, 19). In this model, long single-stranded telomeric DNA form a beads-on-
a-string G4 assembly in which individual quadruplexes are connected by an
ssDNA linker.
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were captured at a scan size of 1 1 m, a scan rate of 2–3 Hz,
a target amplitude of 0.30 to 0.35 V, and a resolution of 512 
512 pixels.
Combinatoric Model for G4 Formation—Statistical analyses
of G4 formation on Tel8, Tel13, Tel14, Tel15, and Tel16 were
calculated by treating them as a sequence of 8 and 13–16 lat-
tices, respectively. It was assumed that G4 structures can form
by four consecutive TTAGGG repeats and that individual G4s
can fold randomly along the entire length of the lattice. The
number of possible arrangements of the h items (G4s and
unstructured repeats) can be described as shown in Equations 1
and 2,
hCi 
h!
i!h  i!
(Eq. 1)
where i is the number ofG quadruplexes. For example, for Tel8,
5C1 
5!
1!5  1!
 5 (Eq. 2)
there are five ways to arrange a single quadruplex, and only one
way to arrange two quadruplexes.
Statistical Analysis of AFM Images—The length measure-
ment was done using the Nanoscope7.30 software; unless
stated otherwise, structures over 1 nm were noted as G4 DNA
on Tel4, Tel8, and Tel16. G4 length was measured along the
longest axis at the cutoff height. On Tel16, 92% of the G4
structures form straight lines, whereas 8% of the molecules dis-
play a curvature of less than 30°. For the latter molecules, two
intersecting lines were drawn following the center line of the
contours. Consequently, the alignment of multimers of G4 on
Tel16 does not significantly affect the measurement of G4
length. Two discernable G4 peaks on Tel16 were defined as the
presence of two local maxima over 1 nm with a trough in-be-
tween that was at least 0.2 nm lower than the shorter peak.
When using PCR517 fragments as internal standards for the
height and length measurements, at least 20 measurements
were done of peak height or full-width at half-maximumheight
on 517PCR. The adjusted peak height or G4 length was calcu-
lated as F D R, where F is the adjusted value for height or
G4 length;D is the value from direct measurement, and R is the
ratio of the mean value measured from multiple depositions of
PCR517 alone (n  20) using different imaging probes to the
mean value of the PCR517 internal standards (n  20). The
mean values of height and full-width at half-maximum height
for PCR517 are 0.44 and 10 nm, respectively. For AFM volume
analysis, the dimensions of proteins were measured using
Image SXM software (28–30). The AFM volume of a particle
was calculated asV S (HB), whereV is the AFMvolume;
S is the area generated at the base of a protein using “density
slice” function of the SXMsoftware;H is the average height, and
B is the background height. Two-tailed Student’s t test was con-
ducted for statistical analysis of the height measurement.
RESULTS
Physiological Telomere Tails Rarely Form the Maximum
Number of Quadruplexes—Prior to studying POT1modulation
of G4 DNA on physiological telomere tails, we set out to eluci-
date G4 DNA structures on these molecules in the absence of
POT1. Previous AFM studies of G4 DNA used either short
telomeric sequence (four repeats), 3 tails of unknown lengths,
or did not provide quantitative or distribution analysis of the
images (31–33). Consequently, detailed information regarding
the distribution and types of conformations of physiological
telomeric tails was lacking. We designed a series of defined
DNA substrates that have a 34-bp duplex stem at the 5 end
followed by a 3 ssDNA overhang of 4, 8, or 16 TTAGGG
repeats (Tel4, Tel8, and Tel16, respectively, supplemental
Table S1). Tel4, Tel8, and Tel16 can potentially form a maxi-
mum of 1, 2, and 4 G4 units, respectively. We reasoned that
comparison of G4 structures formed on these substrates as
visualized through AFM imaging would provide quantitative
information regarding the number of G4 units present on each
molecule. AFM field view image and surface plots of Tel4, Tel8,
and Tel16 show that all three telomeric substrates formed
structures with heights between 1 and 2 nm (Figs. 2,A–C, and 3
and supplemental Fig. S1), which were not observed in images
of duplex DNA or an ssDNA substrate that lacks G4-forming
sequences (supplemental Fig. S2A and Fig. 2E, respectively).
The heights of the peaks observed for the Tel4, Tel8, and Tel16
substrates are consistent with the height measurements from
previous AFM studies of single G4 units (31). Evaluation of the
AFMheight at different target amplitudes indicated that within
the range of target amplitudes used in this study (0.30 to 0.35V),
the height variation in our AFM images is 15% of the total
height (supplemental Fig. S3A). Because the height difference
between G4 (1.32  0.22 nm) and duplex DNA (0.44  0.11
nm) exceeds the possible variation in height measurement, we
used 1 nm as the height cutoff to measure the length of DNA
with G4 character (Fig. 3). A previous AFM study reported a
very similar average and standard deviation of G4 peak height
on nontelomeric G4-forming sequences (1.30 0.07) (34).
The number of G4 units formed on Tel4, Tel8, and Tel16
molecules was delineated by comparing lengths of G4 regions.
To standardize the length measurement, we measured the full-
width at half-maximum height of the PCR fragments (517 bp)
deposited along with the telomeric DNA substrates (supple-
mental Fig. S2). The standardized G4 lengths of Tel4, Tel8, and
Tel16 (see under “Materials and Methods”) are shown in Fig.
2D, and yielded similar patterns as the nonstandardized lengths
(supplemental Fig. S1D). The mean standardized lengths of G4
DNA at 1-nm height of Tel4 and Tel8 are 10 nm. The mean
length of DNA with G4 character on Tel16 (20 nm) is only
about twice that of Tel4, even though Tel16 could theoretically
form a maximum of four quadruplexes as compared with Tel4
which can only form one G4. Further analysis of G4 DNA at
higher salt andDNAconcentrations and incubation times of up
to 2 days did not yield an increase in G4 DNA formation, as
judged by the AFM G4 DNA length and volume of Tel16 (data
not shown). Together, our data indicate that the majority of
molecules with 8 or 16 telomeric repeats only fold into one and
two G4 units, respectively, which is 50% of the expected
number.
To investigate the mechanism underlying the underfolding
(i.e. formation of less than the maximum number of quadru-
plexes) for Tel8 and Tel16, we constructed a first-principles
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combinatoric model (see “Materials and Methods”) consider-
ing each telomeric repeat as a lattice point which can either be
extended or folded into G4 DNA (Fig. 4A). The model shows
that the formation of a single G4 in Tel8 is nearly five times
more probable than two G4 structures. For Tel16, the most
striking insight from the combinatoric model is that formation
of four G4 structures on Tel16 is a rare event, which is consis-
tent with our experimental data. In addition, the folding of two
quadruplexes was the most probable conformation, but three
quadruplexes were almost as probable as two (Fig. 4B). This did
not fit the normalized experimental data inwhich the lengths of
G4 regions on Tel16 were divided by the mean G4 length from
the Tel4 data (Fig. 4B). Similarly, a previous study suggested an
oligonucleotidewith 13 telomeric repeats formedonly twoqua-
druplexes based on circular dichroism spectra with a G4 ligand
(35). To assess whether the combinatoric model was consistent
with our data, we calculated the probability distributions for
DNA containing 13–15 repeats. Tel13 and Tel14 both exhib-
FIGURE 2.Quantification of the number of G4 structures formed on Tel4, Tel8, and Tel16. A–C, schematic drawings and representative AFM surface plots
of Tel4 (A), Tel8 (B), and Tel16 (C) DNA substrates. Thin arrowspoint to singleG4 structures, andwide arrowsdenote twodistinct G4 structures on individual Tel8
or Tel16 molecules. See supplemental Table S1 for sequences. All DNA substrates were incubated in a buffer containing 150 mM KCl and deposited at 500 nM
concentration (seeunder “Materials andMethods”).Minorparticles inAare likely contaminants in theTel4preparation (i.e.acrylamide fromthegelpurification)
rather than unfolded molecules because these images differ from unfolded Ctrl16 structures. D, histogram of G4 length (cross-section at 1-nm height)
standardized using themean full-width at half-maximumheight of PCR fragments fromAFM images of Tel4 (open bars, n 50molecules), Tel8 (gray bars, n
50molecules), and Tel16 (black bars, n 50molecules). The black lines represent the Gaussian fit to the data (R2	 0.93), which are centered at 10 nm (Tel4 and
Tel8) and 20 nm (Tel16), respectively. E, representative AFM surface plot of Ctrl16 DNA,which contains eight TTAGGGTTAGTG repeats (supplemental Table S1)
anddoesnot formG4structures. The trianglepoints to an individual Ctrl16molecule. All images are500500nm, and the color bar corresponds toheight from
0 to 2 nm (from dark to bright).
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ited maxima for two G4s, but for Tel15 three G4s was highly
probable as well (Fig. 4B).
Physiologically Relevant Telomeric Tails Form Structures
That Resemble Beads-on-a-String—Differentmodels have been
proposed to describe the intra-molecular assembly of multiple
G4 units on long telomeric ssDNA (19, 36, 37). In a beads-on-
a-string model, two G4 units are connected by one linker with-
out stacking interactions between the units (Fig. 1B). In the
stacking model, every G4 unit stacks onto adjacent G4, with
residues on the TTA loops interacting with each other (19, 21,
38). Among all the Tel16 molecules observed, 23% displayed
two distinct peaks in the AFM images (Fig. 3B). Although the
height difference between the two distinct peaks on individual
Tel16 molecules is 0.3 nm, the heights of the lower peaks are
still above 1 nm at 1.3 ( 0.3) nm. Themean interpeak distance
of Tel16 molecules with two distinct peaks is 20 nm, which
corresponds to 7 TTAGGG repeats between the individual
quadruplexes (supplemental Fig. S4). In the AFM images of
Tel16 molecules, a small population (1%) of molecules exhib-
ited three distinct peaks (Fig. 3C). The assembly of multiple
defined peaks resembles individual beads-on-a-string. It is
worth noting that because of limitations in theAFM resolution,
results from AFM imaging could underestimate the number of
Tel16 molecules forming the beads-on-a-string structure (see
supplemental calculations).
To further differentiate between the beads-on-a-string and
the stacking models, we imaged G-wires that are long com-
plexes of highly ordered self-assembly of inter-molecular G4
units (Fig. 5A). G-wires are long, uniformly quadruplectic
structures with heights greater than 1 nm in AFM images (39).
AFM images of G-wires formed by the short oligonucleotides
G4T2G4 are shown in Fig. 5, B and C. Because the G-wires
involve stacking of the adjacentG4 units, regular well separated
peaks were not apparent in the AFM images as expected, even
for G-wires that were the same length as Tel16 molecules (Fig.
5, C andD). In addition, G-wires exhibited a statistically signif-
icant (p
 0.008) greater average height (1.63 0.17 nm) com-
pared with the Tel16 structures (1.32  0.22 nm) (nonstan-
FIGURE 3. Subpopulations of Tel16molecules display structures that resemble beads-on-a-string.A representative AFM image (left panel) and sectional
analysis (right panel) of a Tel16molecule inwhich individual G4 structures cannot be resolved (A), amoleculewhich contains twodistinct peaks (B), or onewith
three distinct peaks (C) are shown. Thewhite lines in AFM images indicate the lines drawn for section analysis. The solid lines with arrows in the section analysis
indicate the length of G4 measured at 1-nm height; the dashed lines with arrows indicate the interpeak distances. The number at the top right corner of each
image indicates the percent of each molecule conformation in the total population of Tel16 molecules. The AFM images are 250 250 nm, and the color bar
corresponds to a height from 0 to 2 nm (from dark to bright).
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dardized). These results suggest that the G-wires appeared to
be more rigid possibly because of the direct stacking interac-
tions between adjacent G4 units, which lead to less compres-
sion by the mechanical AFM imaging process. The distinctly
different structure of the G-wires compared with the Tel16
molecules revealed by AFM imaging suggest that G4 structures
on Tel16 molecules are inconsistent with a stacked model of
multiple G4 units.
Oligomeric State of POT1—A key issue in understanding the
mechanism of action by POT1 is its oligomeric state. Despite
evidence showing a monomeric state for the N-terminal
domain of human POT1 (7), information on the oligomeric
state of full-length human POT1 proteins was lacking. To eval-
uate the oligomeric state of full-length POT1, wemeasured the
volume of POT1 in AFM images compared with other known
proteins of various sizes. AFM-derived volumes of proteins can
be correlated to their molecular masses, permitting determina-
tion of oligomeric states (see under “Materials and Methods”)
and protein-protein interactions (28, 30). Purified POT1 pro-
tein after removal of the GST tag appeared as monodispersed
particles in the AFM images (Fig. 6A). At three different con-
centrations (20, 200, and 1000 nM), the distribution of the cal-
culated AFM-derived volumes of POT1 is Gaussian and cen-
tered at22 nm3 (for 200 nM POT1, see Fig. 6B, other data not
shown), which is consistent with the expected value for a POT1
monomer based on the calibration curve for globular proteins
(supplemental Fig. S5). These results demonstrate that POT1
exists as a monomer in solution under the AFM imaging con-
ditions tested. In contrast, AFM images of GST tagged POT1
protein (GST-POT1) revealed particles consistent with GST-
FIGURE 4. Longer telomeric tails rarely form themaximumpotential number of quadruplexes. A, schematic examples and calculations of the number of
possible arrangements of G4 DNA on Tel16 (see under “Materials andMethods” for equations). B, probability of forming 1–4 G4 structures on substrates with
13–16 (Tel13–16, respectively) based on the combinatoric calculations detailed under “Materials andMethods.” The Tel16 data curve is based on the length of
G4 regions on Tel16 molecules normalized using the length of single G4 measured from AFM images of Tel4 (supplemental Fig. S1D).
FIGURE 5. AFM imaging of G-wires reveals a smooth surface without distinct peaks. A, proposed model for G-wire formation. B, AFM field view image of
G-wires. The image is 1 1 m at 2-nm height scale. C, AFM surface plot of G-wires. The image is 250 250 nm at 2-nm height scale. Thewhite line denotes
the line for section analysis. D, section analysis of G-wire highlighted in C.
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POT1 dimers and tetramers (data not shown). Therefore, only
untagged POT1 was used in all the imaging experiments with
the DNA substrates. Importantly, the standardized height of
POT1 (0.65 0.14 nm) is significantly different from the stan-
dardized height for G4 DNA on Tel4 (1.36  0.30 nm) and
Tel16 (1.40 0.18 nm) (Fig. 6C). The nonstandardized heights
showed the same result (supplemental Fig. S3B). Thus, height
measurement provides a robust criterion to differentiate
between POT1 and G4 structure when POT1 and Tel16 are
mixed together.
POT1 Binding Competes with G4 Formation on Physiologi-
cally Relevant Telomeric Tails—To study the binding of POT1
to physiological telomeric tails using AFM, we utilized two
DNA substrates, Tel16 and Ctrl16 (supplemental Table S1).
Ctrl16 is the same length as the Tel16 DNA substrate, but every
other TTAGGG sequence in Ctrl16 is changed to TTAGTG,
which eliminates G4 folding (Fig. 2E). The minimum DNA
sequence that is required for high affinity binding of human
POT1 in vitro is TTAGGGTTAG (7). Accordingly, both Tel16
and Ctrl16 substrates have a maximum of eight POT1 DNA
binding sites. Electrophoresis mobility shift assays (EMSA)
showed that under the same conditions POT1 binds Tel16 and
Ctrl16 substrates to a similar extent (supplemental Fig. S6B).
The appearance of more than one shifted band suggests that
multiple POT1 molecules can bind to the Tel16 or Ctrl16
substrates.
In the AFM images of Ctrl16 with POT1, arrays of tandem
POT1 proteins were observed (thin arrow, Fig. 7A), which were
not present in the POT1-alone images (Fig. 6A). The mean
height of these POT1 arrays is statistically similar to the POT1
height in the protein-alone images (supplemental Fig. S3B).We
used the statistically significant height difference between
POT1 and G4 DNA to differentiate between POT1 and G4
structures (Fig. 6C for standardized and S3B for nonstandar-
dized heights). When POT1 (200 nM) was incubated with a
5-fold molar excess of Tel16 (1 M), the percent of molecules
that exhibited G4 DNA structures (peak heights 	1 nm) was
greatly reduced from 100% of the Tel16-alone molecules, to
24% (98:405) of the molecules visualized after coincubating
Tel16 with POT1 (Fig. 7C). The majority of molecules (76%,
307:405) showed only structures that were characteristic of
POT1. Importantly, of the G4 DNA structures observed (98:
405), 23 molecules displayed multiple peaks with differing
heights that were consistent withG4DNAand bound POT1 on
the samemolecule (compare Fig. 7D for POT1Tel16 and Fig.
7B for POT1 Ctrl16). The height of the lower peaks is 0.7 (
0.1) nm (n 23 complexes), which is statistically different from
the lower peaks on Tel16 molecules displaying two or more
peaks in the absence of POT1 (1.3  0.3 nm) and very closely
matches the standardized peak for POT1 alone (Fig. 6C). These
images indicate that G4 DNA and POT1 can coexist on the
same molecule. The length distributions of POT1-bound
regions for Ctrl16 and Tel16 (supplemental Fig. S6C) both
exhibited a long right-sided “tail” representing similar numbers
of POT1 proteins bound to Tel16 and Ctrl16 molecules. The
length of longer POT1 arrays (45–60 nm) is consistent with the
length of ssDNA (48 nm, assuming ssDNA as 0.5 nm/base) on
fully extended Tel16 molecules. Together, these data indicate
that POT1 binding can successfully compete with G4 DNA
folding on telomeric ssDNA.
Previous work suggested that POT1 and an antisense 13-mer
oligonucleotide, which base pairs with telomeric ssDNA, share
the same mechanism of trapping a short oligonucleotide
GGG(TTAGGG)3 in an unfolded state to preventG4 formation
(4). To further investigate the mechanism of G4 disruption on
long telomeric ssDNA, we quantified the G4 structures on the
Tel16 substrate after incubation with the antisense oligonu-
cleotide (C-oligo, supplemental Table S1) for comparison with
FIGURE6.Full-lengthPOT1isamonomerinsolutionandexhibitsaheightinAFMimagesdistinctfromG4DNA.A, representativeAFMimageofuntaggedPOT1
protein at 200nMconcentration. The image is 250250nmat 2-nmheight scale.B,AFMvolumedistributionof POT1 from imagesof POT1at 200nMconcentration.
The dashed line represents theGaussian fit to the data (n 664molecules, R2 0.96), which is centered at 22 nm3 and corresponds to POT1monomer based on the
standardcalibrationcurve (supplementalFig.S5).C,comparisonof thestandardizedpeakheightsofTel4,Tel16,andPOT1molecules (n50each) inAFMimages.The
peak heightwas standardized using PCR517DNA fragments as internal standards (see under “Materials andMethods”).
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the images of POT1 added to Tel16. When Tel16 and C-oligo
were incubated at a 1:1molar ratio,most (92%) of themolecules
displayed peaks at a height consistent with G4 structures (	1
nm). Thus, POT1 was more effective in decreasing the popula-
tion of molecules with G4 character (24%), even though POT1
was present at lower stoichiometric amounts (5-fold less) com-
pared with the C-oligo. An excess of C-oligo over Tel16 (5:1) is
required to fully trap the G4 structures in an unfolded state
(supplemental Fig. S7), which indicates that C-oligo can bind
the Tel16 ssDNA. However, at this ratio the disruption of G4
structure by C-oligo is through elimination of consecutive sin-
gle-stranded TTAGGG repeats that can form G4. At a 5-fold
molar excess, if the oligo is evenly distributed, the distance
between individual C-oligos is5 nucleotides.
One caveat of our experiment is that a fraction of the Tel16
molecules that lack G4 character (76%) upon POT1 addition
may represent POT1unbound toDNA.This is unlikely because
Tel16 is present at a 5-fold excess over POT1, which represents
a 40-fold excess of POT1-binding sites. However, for a more
rigorous analysis, we measured the length of the G4 regions on
the Tel16 molecules that showed G4 peaks in the presence
of POT1 (24%) orC-oligo (92%). For theC-oligo, themajority of
FIGURE 7. POT1 ismore effective at disruptingG4DNAon Tel16molecules than an antisense oligonucleotide. A, representative AFM surface plot of the
non-G4 forming Ctrl16 (1M) substrate in the presence of POT1 (200 nM). The triangle points to individual POT1molecules. The thin arrow points to a structure
with multiple POT1 proteins. B, cross-section of the molecule highlighted in A by the dotted line showing two POT1 molecules on the same telomeric tail.
C, representative AFM surface plot of Tel16 (1M) in the presence of POT1 (200 nM). The thick arrow points to a structure with folded G4. The triangle points to
an individual POT1molecule. The thin arrow points to a structure with multiple POT1 proteins. D, cross-section of themolecule highlighted in C by the dotted
line demonstrating that G4 (left peak) and POT1 (right peak) coexist on the samemolecule. E, representative AFM surface plot of Tel16 (1M) in the presence of
C-oligo (1M). F, histogram of the length of G4 DNA regions (stretch of DNAwith peaks	1 nm)measured fromAFM images of Tel16 (1M) in the presence of
POT1 (200nM,openbar,n50molecules) andC-oligo (1M,blackbar,n50molecules). Theblack lines represent theGaussian fit to thedata (R2	0.96),which
are centered at 10 (POT1) and 20 nm (C-oligo), respectively. The G4 length values were standardized using PCR517 DNA fragments as internal standards (see
“Materials and Methods”). The AFM images are 350 350 nm at 2-nm height scale.
SingleMolecule Studies of G-quadruplex DNA and POT1
7486 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 9•MARCH 4, 2011
the G4 structure lengths were consistent with the existence of
two G4 units similar to Tel16 alone (15–20 nm, standardized
lengths, Fig. 7F and Fig. 2D). It is worth noting that the peaks for
two G4 units on Tel16 with the C-oligo are less well defined
compared with Tel16 alone, perhaps because of the oligo
annealing to the region (7 repeats or 40 nucleotides, sup-
plemental Fig. S4) between the G4 units. In stark contrast, the
lengths of the G4 regions remaining on Tel16 after POT1 addi-
tion were about half as long as G4 regions on Tel16 with or
without C-oligo (Fig. 7F and supplemental Fig. S6D). This is
consistent with POT1 inducing a shift from two to one G4 unit
on those Tel16molecules that retain G4 folds. In summary, our
data indicate that contrary to results with short telomeric tails
(4), POT1 ismuchmore effective at disruptingG4DNAon long
telomeric tails, compared with an antisense oligonucleotide.
DISCUSSION
POT1 binding to (TTAGGG)4 substrates prevents G4 DNA
folding (4, 40). However, the arrangement of G4 DNA and the
competition with POT1 binding on long, physiologically real-
istic telomeric tails were unknown. In this study we used single
molecule imaging to examine the assembly of G4 units onDNA
substrates containing 4 (Tel4), 8 (Tel8), and 16 (Tel16)
TTAGGG repeats, with the latter representing themid range of
the telomeric overhang length in human cells (1). Telomeric
DNA with well defined lengths allowed us to study the length-
dependent formation of G4 structures at the single molecule
level.We demonstrated that G4DNA assemblies on physiolog-
ically relevant telomeric tails rarely form the maximum poten-
tial number of G4 units. We observed via AFM imaging that
full-length POT1 is monomeric and stabilizes the ssDNA, driv-
ing the (TTAGGG)16 structural equilibrium toward an
extended protein-bound state. This study is the first to report that
bound POT1 can coexist with G4 DNA on the same Tel16 mole-
cule. Compared with an antisense oligo that statically binds the
telomeric ssDNA, POT1 is much more effective in disrupting G4
structures on long telomeric tails.Our results are consistentwith a
novel and more dynamic mechanism of POT1 G4 disruption, in
contrast to a simple static trapping of unfolded DNA.
We applied a first principles combinatoric approach to
understand the mechanism underlying the underfolding, and
we found that the model prediction for ssDNA with 13 repeats
(Fig. 4) is consistent with a bulk circular dichroism study that
suggested oligonucleotides with 13 telomeric repeats formed
on average only two quadruplexes (35). However, the normal-
ized G4 distributions of Tel16 images demonstrated a sharp
peak at two quadruplexes, whereas the probabilistic model
based on the first-principles combinatoric approach predicted
a nearly equal quantity ofmolecules with three quadruplexes as
well (Fig. 4). The discrepancy between our experimental
observations and the probabilistic models may be explained
by differences in the probability of forming G4 at different
positions along the length of Tel16 and that the model does
not take into account free energy of folding. A previous study
using dimethyl sulfate footprinting and exonuclease hydrol-
ysis with T24(TTAGGG)7 DNA substrates revealed that the
probability of forming G4 rapidly decreases toward the
5-flanking sequence (41), from 55.8% at the 3 end (0 position)
to 21.8, 14.5, and 7.9% at the first, second, and third positions
(next to 5-flanking sequence), respectively. Our model (Fig. 4)
presumes that probabilities of forming G4 along the 3 G-rich
tail of Tel16 are the same. The dramatic decrease in the proba-
bility of formingG4 units when the repeat positions are close to
the 5-flanking region effectively shortens the number of avail-
able repeats for G4 folding on Tel16. This explains the close
agreement of the normalized G4 distributions from the exper-
imental data with the theoretical G4 distributions of two
shorter substrates with 13 and 14 repeats (Fig. 4B). A previous
report indicated that GGG(TTAGGG)3 forms the most stable
G4, and as repeat number increases (n 7–16), the quadruplex
molecules become less thermostable (42). The presence of
loops with various lengths on the tetraplex sides can potentially
lead to irregularities in G4 structure and consequently cause
structure destabilization. Current literature suggests that loop
length and composition strongly influence the quadruplex sta-
bility, and quadruplexes formed by (TTAGGG)5 with a 9-nu-
cleotide loop were less stable than quadruplexes formed from
four consecutive repeats (41).
The arrangement of G4 DNA on longer physiological telo-
meric tails has been controversial. One thermal melting study
supported a beads-on-a-string conformation whereby long
telomeric substrates fold into themaximumnumber of quadru-
plexes that do not directly interact with each other (19).
Another study found support for a stackedmodelwhereby indi-
vidual quadruplexes fold in a way that their loop reactions
interact, and a more rigid superstructure is formed (21, 38).
Direct visualization of individual molecules in our study
revealed that 23% and 1% of themeasured Tel16molecules had
two and three discernable peaks, respectively. These results
support a beads-on-a-string model whereby the quadruplexes
form as individual G4 units separated by stretches of ssDNA,
creating a more flexible structure with discernable peaks (Figs.
2 and 3, for interpeak distance distribution see supplemental
Fig. S4). Although not all the molecules displayed distinct
peaks, this was likely due to the resolution limits of the AFM
under the current imaging conditions. If two quadruplexes are
linked by a TTA linker, the AFM cannot resolve two individual
peaks; roughly 1.5 telomeric repeats are required to resolve two
peaks (for the calculation of AFM resolution see supplemental
material). Also, although the average nonstandardized height of
the Tel16molecules was 1.32 ( 0.22) nm, the average height of
the G-wires was 1.63 ( 0.17) nm, suggesting that Tel16 G4
DNA is more flexible, corroborating a beads-on-a-string
arrangement.
Previous studies indicated that POT1 binding to substrates
with four repeats trapped the molecules in an extended state,
shifting the equilibrium from a folded G4 unit to an extended
conformation (4, 40). However, POT1 binding to physiologi-
cally relevant telomeric tails had not been examined. Our find-
ing that the majority of Tel16 molecules only form two G4
structures has important implications for POT1 loading on
realistic telomeric tails. POT1 cannot bind the short GGG(T-
TAGGG)3 substrates until the equilibrium shifts from G4
structure to an extended state (4). In contrast, on the physio-
logically relevant Tel16 substrates, an underfolded Tel16 mol-
ecule constantly has multiple ssDNA sites available for POT1
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binding (Fig. 3), and thus, POT1 loading does not require ther-
mal melting of existing G4 DNA.
We propose that POT1 promotion of G4 disruption on long
telomeric DNA is not simply by trapping thermally melted G4
structures, as described for short substrates (4). This is because
POT1 is more effective in disrupting G4 DNA than a 13-mer
antisense oligonucleotide on long telomere tails (Fig. 7F) but
not on short tails (4). At equal concentrations of antisense oligo
and Tel16, the length of the majority of the G4 structures is
consistentwith twoG4units (Fig. 7F). This suggests that similar
to the proposed passive model (4), the 13-mer antisense oligo
can bind to the unfolded ssDNA on Tel16, but it cannot signif-
icantly influence the adjacent remaining G4 folds. On the con-
trary, for POT1 at amuch lower protein to Tel16 ratio (1:5), the
majority ofmolecules were unfolded, and the distribution ofG4
length was shifted to one G4 unit. Our results clearly demon-
strate that POT1 can disrupt G4 structures more efficiently
than the antisense oligo (Fig. 7F).
We propose that POT1 binds to the unfolded ssDNA regions
and sterically impairs adjacent telomeric repeats from folding
into G4 DNA, thereby promoting unfolding into extended
ssDNA (Fig. 8B). This is in contrast to the previous passive
model based on experiments using short oligos, in which POT1
and the antisense oligo share the same ability to trap the short
telomeric DNA in an unfolded form (Fig. 8A). We propose a
steric driver model for the mechanism of G4 disruption by
POT1 at 3 telomeric tails based on the following two nonmu-
tually exclusive mechanisms. First, POT1 binding can destabi-
lize adjacentG4 structures. Recently, it was demonstrated using
an isothermal differential hybridizationmethod that binding of
a 46-kDa antidigoxin antibody fragment adjacent to a G4 fold
dramatically destabilized the G4 structure (43). Another possi-
ble mechanism of G4 disruption by POT1 is through dynamic
one-dimensional sliding and/or microscopic dissociation and
re-association to adjacent sequences. Precedent for one-di-
mensional diffusion of single-stranded DNA-binding proteins
has been described for Escherichia coli single-stranded DNA-
binding protein based on the single molecule studies (44). The
steric driver model is consistent with results from AFM imag-
ing ofCtrl16 andTel16with POT1 (Fig. 7 and supplemental Fig.
S6). Specifically, upon addition of POT1, the equilibrium shifts
from a majority of Tel16 molecules forming two quadruplexes
to one quadruplex and/or multiple POT1 monomers bound
(Fig. 7F and supplemental Fig. S6). Importantly, multiple POT1
molecules bind Tel16 and the non-G4-forming Ctrl16 sub-
strate to similar extents, leading to protein arrays of roughly
equal length distributions (supplemental Fig. S6C). If POT1 can
only capture the ssDNA when the G4 DNA thermally melts,
then we would expect a greater number of molecules with long
POT1-bound arrays for Ctrl16 relative to Tel16, because POT1
does not need to compete with G4 folding to bind Ctrl16.
In summary, we propose a model whereby POT1 acts not as
an active DNAunwinder but rather as a steric driver by binding
to underfolded telomeric tails and thereby destabilizing the
adjacent remaining G4 structures on the molecule (Fig. 8B), as
evidenced by the reduction of G4 DNA structures upon POT1
addition (Fig. 7F and supplemental Fig. S6C). Our results dem-
onstrate that on a long telomeric substrate, the mechanism of
action by POT1 is different from the simple static trapping
mechanism utilized by an antisense oligo. POT1 binding com-
petition with G4 DNA folding on physiologically relevant 3
telomeric tails suggests an importantmechanism for preserving
telomere stability. Because a telomeric tail that is exposed dur-
ing replication of the telomere can spontaneously fold into G4
DNA, this raises the issue of how POT1 reloads on the telo-
meric tail to promote telomerase activity or telomere remodel-
ing into a capped structure (13). Another study demonstrated
that a G4-stabilizing agent induced an ATR-dependent DNA
damage response but that POT1 levels at the telomere ends
remained unchanged (45), implying that G4 DNA and POT1
may coexist at telomere ends. The AFM images in this study
show that the underfolding (i.e. less than themaximumnumber
ofG4units) of long telomeric ssDNAprovides a route for POT1
binding and a mechanism for POT1 and G4 DNA coexistence
on the same molecule. The direct visualization of single mole-
cules that resemble physiologically relevant telomeric tails pro-
vide a mechanistic basis for understanding the modulation of
telomere structure and function by POT1 and G4 DNA.
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FIGURE 8. Static passive anddynamic steric drivermodels of POT1modula-
tionofG4DNAat telomeric tails.A3 telomeric tail with 16 TTAGGG repeats is
shownasanexample. POT1 is shownasgrayovals.A,passivemodelwherebyG4
DNA is arranged as a beads-on-a-string,maximally folded telomeric tail. POT1 or
an antisense oligo could not bind the telomeric sequence until theG4 thermally
meltedtoanextendedstate.ThenPOT1ortheantisenseoligotrapsthemolecule
intheunfoldedstatewithoutalteringadjacentG4folds.B, inastericdrivermodel,
at equilibrium the telomeric tails rarely form themaximum number of G4 units.
POT1 is able tobindunfolded telomeric repeats anddestabilize existingG4DNA
onthesamemoleculepossibly through twononmutually exclusivemechanisms
(represented by the black arrows) as follows: dynamic movements on DNA
including one-dimensional sliding, hopping, and jumping and/or its ability to
destabilize adjacent G4 structures.
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UV light-induced photoproducts are recognized and removed by
the nucleotide-excision repair (NER) pathway. In humans, the
UV-damaged DNA-binding protein (UV-DDB) is part of a ubiquitin
E3 ligase complex (DDB1-CUL4ADDB2) that initiates NER by recog-
nizing damaged chromatin with concomitant ubiquitination of
core histones at the lesion. We report the X-ray crystal structure
of the human UV-DDB in a complex with damaged DNA and show
that the N-terminal domain of DDB2 makes critical contacts with
two molecules of DNA, driving N-terminal-domain folding and
promoting UV-DDB dimerization. The functional significance of
the dimeric UV-DDB [ðDDB1-DDB2Þ2], in a complex with damaged
DNA, is validated by electron microscopy, atomic force microscopy,
solution biophysical, and functional analyses. We propose that the
binding of UV-damaged DNA results in conformational changes in
the N-terminal domain of DDB2, inducing helical folding in the con-
text of the bound DNA and inducing dimerization as a function
of nucleotide binding. The temporal and spatial interplay between
domain ordering and dimerization provides an elegant molecular
rationale for the unprecedented binding affinities and selectivities
exhibited by UV-DDB for UV-damaged DNA. Modeling the DDB1-
CUL4ADDB2 complex according to the dimeric UV-DDB-AP24 archi-
tecture results in a mechanistically consistent alignment of the E3
ligase bound to a nucleosome harboring damaged DNA. Our find-
ings provide unique structural and conformational insights into the
molecular architecture of the DDB1-CUL4ADDB2 E3 ligase, with sig-
nificant implications for the regulation and overall organization of
the proteins responsible for initiation of NER in the context of chro-
matin and for the consequent maintenance of genomic integrity.
UV damage ∣ ubiquitin-proteosome system ∣ X-ray crystallography
Genome integrity is under constant challenge and various cel-lular mechanisms exist to maintain DNA fidelity. In human
cells, the nucleotide-excision repair (NER) pathway is responsi-
ble for the repair of a variety of DNA lesions (1). Although the
mechanism of damage detection in chromatin is not well-under-
stood, various studies have identified two principal initiators of
the global-genome branch of NER (GG-NER), XPC-human
RAD23B (XPC-HR23B) (2), and the UV-damaged DNA-bind-
ing protein complex UV-DDB (3–5). UV-DDB is composed of
two proteins, a 127-kDa protein (DDB1) and a 48-kDa protein
(DDB2) encoded by theDDB1 andDDB2 genes, respectively (6).
Mutations in DDB2 cause a cancer prone autosomal recessive
disease, xeroderma pigmentosum (XP) complementation group
E (XP-E), and are associated with a partial deficiency in GG-
NER (7–9). Through the DDB2 subunit, UV-DDB binds avidly
to fragments of DNA containing various types of damage, such as
UV-induced 6-4 pyrimidine-pyrimidone (6-4PP) and cyclobutane
pyrimidine dimers (CPD) (10, 11). Detection of CPD in nontran-
scribed DNA by XPC is inefficient, indicating that the UV-DDB
complex plays a primary and crucial role in the detection and
repair of CPD in the context of chromatin (4, 12).
The ubiquitination pathway has recently been shown to play an
important regulatory function in the initiation of NER (13, 14).
The DDB1 protein is part of the substrate-recruiting module for
two closely related types of E3 ligases, the cullins CUL4A and
CUL4B, which target proteins for ubiquitination (15, 16). The
DDB1-CUL4A complex belongs to a superfamily of cullin-RING
ligases (CRL) (17–19), which participate in various aspects of the
UV-damage response for maintaining genome stability (20–22).
DDB2 is both a binding partner and a substrate receptor for
the DDB1-CUL4A-based E3 ligase, DDB1-CUL4ADDB2 (11, 21,
23, 24). Following UV exposure of cells, DDB2 recruits the
DDB1-CUL4ADDB2 complex to the site of damaged chromatin,
regulating the initiation of GG-NER by modifying core histones
around the site of the lesion (13, 24, 25). Available data show a
connection between DDB1-CUL4ADDB2 and the monoubiquiti-
nation of the core histones (i.e., H2A, H3, and H4) in the cellular
response to UV-irradiation (23, 24). Following initial damage re-
cognition, the DDB1-CUL4ADDB2 E3 ligase ubiquitinates XPC
and auto-ubiquitinates DDB2 (13), however with different con-
sequences. Ubiquitination stabilizes XPC, increasing its affinity
for damaged DNA, whereas polyubiquitination of DDB2 reduces
its affinity for damaged DNA and ultimately leads to its degrada-
tion (13, 26). This paradoxical UV-dependent degradation of a
protein [i.e., DDB2 (27–29)] that is intrinsically involved in
the recognition of radiation-induced DNA damage is not fully
understood. It has been speculated that this sequence of events
is necessary for the accessibility of repair factors at the lesion
site—i.e., for reducing the affinity between DDB2 and DNA to
facilitate the handover of the damaged DNA from the DDB1-
CUL4ADDB2 E3 ligase complex to XPC-Rad23 and for regula-
tion of the cellular response to DNA damage (26, 30). It is
currently unknown how DDB2 interacts with the substrate when
E3 is anchored to damaged DNA nor how DDB2 targets multiple
substrates of various sizes for mono- or polyubiquitination.
Recent progress in understanding the structural basis of NER
initiation came from crystal structures of the yeast XPC ortholo-
gue Rad4 (31) and of the zebrafish UV-DDB bound to UV-
damaged DNA (11). In these structures, these DNA-binding
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proteins (i.e., XPC, DDB2) appear to recognize conserved
perturbations to the DNA topology induced by the lesions.
UV-irradiation-induced modifications, such as CPD and 6-4
PP, are believed to disrupt the dynamics and helical topology
through DNA bending, altering base-pairing interactions, and
widening the major groove, features that are recognized by the
NER apparatus through a bidentate recognition process (11,
31–34). The means by which UV-DDB can efficiently scan
DNA for damage, while at the same time binding damaged
DNA with the highest affinity of any damaged DNA-binding pro-
teins (10, 35) remain unknown. The crystal structures of UV-
DDB bound to DNA containing 6-4 PP or an abasic site showed
contacts between DDB2 and DNA to be limited to the β-loops,
exhibiting largely identical interactions (11).
We report here the crystal structure of full length human
UV-DDB bound to damaged DNA, revealing the unique structur-
al motif of the N-terminal helical domain of DDB2. Using biophy-
sical methods of analysis to monitor and characterize the changes
in molecular associations and dynamics initiated upon damaged
DNA binding, we propose that this helical domain participates
in forming the high-affinity binding state of UV-DDB. Mechan-
istically, the conformational dependence of the N-terminal do-
main of DDB2 on damaged DNA binding illuminates how UV-
DDB can efficiently scan the genome to detect DNA damage,
while enabling high-affinity DNA interactions to be formed once
damage is detected. In the context of DNA repair, modeling the
cullin-RING E3 ligase nucleosome complex on the dimeric UV-
DDB-AP24 architecture facilely aligns the numerous molecular
components, revealing spatial orientations likely significant in
substrate ubiquitination. These results support the role of oligo-
merization in modulating molecular flexibility, affinities, and spe-
cificities in cullin-RING E3 ligase receptor-substrate complexes.
Results
Electron Microscopy and X-ray Crystal Structure Reveal a Dimer of
Human UV-DDB in a Complex with Damaged DNA. EM characteriza-
tion of the full-length human UV-DDB in the presence of varying
amounts of DNA identified solution conditions that stabilized
the dimeric state of the complex. A central apyrimidic lesion
was generated by introducing a tetrahydrofuran moiety at posi-
tion 11 (THF11) in a 24-basepair oligodeoxynucleotide (AP24).
Several ratios of AP24 were incubated with UV-DDB before EM
imaging (Fig. 1) (additional details can be found in SI Appendix).
Prior to DNA binding, our negative stain EM studies revealed
predominantly spherical particles with a minor fraction exhibiting
elliptical profiles (Fig. 1 and SI Appendix, Fig. S1). In the absence
of DNA, the distribution of the projected protein surface area
yielded a well-defined peak at approximately 3;600 Å2, corre-
sponding to a spherical particle of approximately 70 Å in dia-
meter, consistent with the dimension of a monomer of UV-DDB
(i.e., a heterodimer of DDB1 and DDB2; Fig. 1). However, in the
presence of damaged DNA substrate (i.e., AP24), a second peak
appeared with an area that is consistent with that predicted for
dimeric UV-DDB [ðDDB1-DDB2Þ2], approximately 7;200 Å2
(Fig. 1 and SI Appendix, Fig. S1). Notably, particle size distribu-
tions shifted dramatically from monomeric to dimeric UV-DDB
at a molar ratio of 3 AP24 to 1 UV-DDB (3∶1)—the ratio used
for crystallization screening (described below).
Crystallization protocols were devised using an analytical
approach (36) to systematically identify chemical and additive
conditions that stabilized conformational states of UV-DDB in
solution. Single crystals of native or selenomethionine (SeMet)-
substituted human DDB1 and DDB2 proteins, in complex with
the same damaged DNA substrate analogue used in the EM ana-
lysis, AP24 (at a molar ratio of 1∶3UV-DDB∶AP24), were grown.
UV-DDB-AP24 crystallized in monoclinic and orthorhombic
lattices, depending on the crystallization condition. The unit cell
parameters of the orthorhombic (referred to as “ortho-UV-DDB”)
crystal form are very similar to the monoclinic (“mono-UV-
DDB”) (Table 1), except for a doubling along one axis in the
orthorhombic dataset. The early native and anomalous datasets
used to phase and refine the dimeric UV-DDB-AP24 complex
model were most favorably processed in a monoclinic P21 space
group setting. Similarly, the highest resolution dataset used to
build missing regions in DDB2, add nucleotides to the DNA sub-
strate, modify loop conformations of DDB1, and fully refine the
humanUV-DDB-AP24 complex structure was also most favorably
processed in monoclinic lattice setting (Table 1, first column). In
the final cross-validation stage, orthorhombic data collected from
crystals optimized using alternative additive conditions were used
to independently verify the overall backbone tracing and subunit
configuration of the dimeric UV-DDB-AP24 crystal structure.
Combinations of bromide and selenomethionine (SeMet)
anomalous dispersion methods, in tandem with partial model mo-
lecular replacement approach, were applied for initial phasing
and refinement. The quality of the early maps was significantly
improved by combining the phases calculated from the SeMet
heavy atom positions together with phases calculated from the
coordinates of human DDB1 and a partial poly-Ala model of
the zebrafish DDB2 (residues 100–400; PDB ID code 3EI2).
Fig. 1. Visualization and size estimation of UV-DDB particles by negative stain
electron microscopy. Representative areas are shown in A without DNA and
in B with AP24 oligodeoxynucleotide at a ratio of 1∶3. (Top) Images from
electron micrographs and (Bottom) after global and local filtering and thresh-
olding to yield countable particle areas. (C) Histograms collected from micro-
graphs of particle areas for different ratios of UV-DDB to AP24 oligodeoxynu-
cleotide, as indicated, and normalized by particle count (in parentheses). The
peak at approximately 36 nm2 evident in the absence of DNA corresponds to a
circle of diameter approximately 7 nm that is consistent with a monomer of
the UV-DDB1-DDB2 complex. Increasing concentrations of AP24 oligodeoxy-
nucleotide causes the peak shifts to approximately 72 nm2 consistent with
a population of dimers. Examples of monomer-sized areas are indicated with
arrowheads in A and dimers with double-arrowheads in B.
E2738 ∣ www.pnas.org/cgi/doi/10.1073/pnas.1110067109 Yeh et al.
Although the double-stranded (ds) AP24 oligodeoxynucleotide
substrate molecule was deliberately omitted from the initial phas-
ing model, strong contiguous densities at the surface of the β-bar-
rel domain of human DDB2 were apparent in solvent-flattened,
positively contoured difference Fourier maps, verifying the da-
maged-DNA bound state of the DDB2 subunit in UV-DDB crys-
tals. Molecular features evident even in the initially phased
electron density maps permitted the structure of the central ap-
proximately 18 bases in both the damaged and undamaged
strands of AP24 molecule to be built according to map densities.
Iterative cycles of model building to incorporate the sequence of
human DDB2, to adjust regional conformational differences in
DDB1 and DDB2, and to extend the AP24 oligodeoxynucleotide
molecule gradually improved map and model quality. Once
approximatley 90% of the structure of the complete human UV-
DDB-AP24 complex was modeled and refined, phase combina-
tion utilizing a native monoclinic dataset increased data comple-
teness, intensities, and redundancy of wide angle reflections
enhancing the overall data quality, resulting in more distinct
electron densities radiating from N-terminal region of DDB2
truncated in the UV-DDB model. Importantly, regions of UV-
DDB that were missing or altered in conformation could be pro-
gressively modeled as map definitions steadily improved com-
mensurate with data extension to 2.85 Å. Distinct regions of
contiguous electron densities radiating from residue 100 of
DDB2 allowed additional approximately 80 residues at the N-
terminal domain of DDB2 to be traced, monitoring R factors
and other statistical factors until refinement converged. To vali-
date the human UV-DDB-AP24 structure we also solved an
orthorhombic UV-DDB SeMet dataset to 3.2 Å resolution by
ab-initio SAD phasing. The structure of the orthorhombic crystal
form independently confirmed the N-terminal-domain fold and
subunit organization in the dimeric UV-DDB (refinement statis-
tics for both crystal structures are shown in Table 1). In both
monoclinic and orthorhombic datasets, an elongated configura-
tion of the dimer is recapitulated, mirroring the molecular envel-
ope of UV-DDB seen in EM images taken in the presence of
damaged DNA. Altogether, the EM and crystal data support
the substrate-dependent dimerization of UV-DDB (Fig. 2).
Crystal Structure of the Dimeric UV-DDB Complex. DDB1 is a large
tri-β-propeller substrate adaptor protein. Following nomencla-
ture defined previously (19), the DDB1 β-propeller domains
are denoted as BPA, BPB, and BPC, with a C-terminal helical
domain referred to as CTD (37). The structure of the human
DDB2 substrate receptor is composed of a large seven-bladed
WD40 β-propeller domain (residues 103–421), preceded by an
N-terminal domain (residues 1–102) (Fig. 2 A and B) (11).
The dimeric DDB2 forms the core of the UV-DDB complex, with
a twofold axis located close to blade 6 of the major seven-bladed
β-propeller domain of DDB2 (Fig. 2 A and B; yellow), the con-
served WD40 structural motif.
Distinct Topological Motifs Mediate Associations Between DDB1 and
DDB2. In the human UV-DDB dimeric complex structures, the
previously missing N-terminal helical domain of DDB2 (11)
has been built by modeling into experimentally phased electron
density maps. The N-terminal region preceding the β-propeller
domain of DDB2 is composed of approximately the first 102 re-
sidues and topologically distinguished by predominantly helical
features. The first 66 residues fold into three helical segments ar-
ranged into a triangular topology (α-paddle, in red, Fig. 2 A–C),
followed by an extended helix-turn-helix (residues 67–102) that
inserts into the BPA-BPC double-propeller cleft (Fig. 2 A
and B). The variations in conformation and domain organization
in the dimeric relative to the monomeric states of UV-DDB are
primarily centred at the DDB2 component.
The interface formed between BPA-BPC double propellers of
DDB1 displays significant hydrophobic characteristics, concen-
trated mainly on the surface of the BPA domain (SI Appendix,
Fig. S2A; hydrophobic surfaces in white, defined by a dotted yel-
low oval) facing the cleft where the β-propeller domain of DDB2
docks. Upon initial complex formation, extensive hydrophobic
contacts are formed between residues on the BPA domain and
aliphatic loop residues extending from the β-propeller domain
of DDB2 (SI Appendix, Fig. S2B; hydrophobic surfaces in white,
defined by a dotted blue rectangle). In contrast, interactions be-
tween the BPC domain of DDB1 (SI Appendix, Fig. S2A; negative
electrostatic surfaces in red, positive in blue, defined by a dotted
violet oval) and the N-terminal-α-helical region preceding the
β-propeller domain of DDB2 are largely electrostatic in nature
(SI Appendix, Fig. S2B; negative electrostatic surfaces in red, po-
sitive in blue, defined by a dotted green rectangle). The helical
topology of the N-terminal domain of DDB2 is important for
aligning clusters of acidic/basic residues on surfaces facing the
BPA domain, enabling charge complementation at the intermo-
lecular interface (SI Appendix, Fig. S2C). The α-paddle helical
fold of DDB2 segregates aromatic residues to the opposite face
of the N-terminal domain of DDB2, juxtaposing hydrophobic
patches to form favorable contacts to the BPC domain of DDB1.
The helical conformation of the N-terminal domain of DDB2 is a
key topological feature that enables the precise spatial alignment
of residues at intermolecular interfaces, mediating multiple mo-
lecular associations in the context of the complete complex.
Damaged DNA Binding Induces Helical Folding of the N-terminal
Domain of DDB2. Another novel structural feature found in the
dimeric UV-DDB-AP24 complex is at the region encompassing
residues 356–370 of DDB2, which forms a well-ordered loop that
extends from blade 6 of the seven-bladed β-propeller domain of
DDB2, forming a fold defined herein as β-wing (Fig. 2 A–C). The
closest contacts between two DDB2 subunits within the dimer are
at the β-wing regions of DDB2, centred at Asn360. The twofold
axis is located between two Asn360 side chains, which form of
H-bonds with favorable geometries and distances [Fig. 2A; 2.8 Å
between neighboring twofold related Oδ1 (red) and Nδ2 (blue)
atoms of Asn360].
In the dimeric DDB2, the β-wing loops are sandwiched be-
tween two DNAmolecules, with β-wing residues forming contacts
to both the DNA immediately bound and to its neighboring DNA
bound to the second β-propeller domain (SI Appendix, Fig. S3).
At one end of the β-wing turn, an electrostatic network stabilizes
the undamaged DNA strand immediately opposite the lesion
(SI Appendix, Fig. S2A; defined by a dotted yellow oval). Bonds
between the β-wing residues to the DNA are predominantly
electrostatic in nature, contacting anionic phospho-deoxyribose
backbone atoms of the DNA, similar in nature to those formed
Table 1. Refinement Statistics for the Human UV-DDB Complexes
UV-DDB-AP24
‘monomeric form’
UV-DDB-AP24
‘orthorhombic dimeric form’
Bravais Lattice Monoclinic Orthorhombic
Resolution (Å) 31.74–2.85 41.09–3.22
Rwork∕Rfree 0.22∕0.24 0.25∕0.26
Number of atoms 13010 13010
Protein 12033 12033
Ligand/ion (DNA) 977 977
Water 0 0
hB-factorsiaverage
All atoms 35.4 39.4
Proteins 32.2 35.2
DNA 33.5 35.7
Water — -
R.m.s deviations
Bond lengths (Å) 0.0052 0.0059
Bond angles (°) 1.363 1.012
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by the N-terminal domain of DDB2. In comparison, contacts
formed at the lesion site between the insertion loop of DDB2
and the damaged strands are nucleobase specific. Explicit con-
tacts centred within a 3-nucleotide window on the duplex DNA
are limited by atomistic and spatial constraints dictated by the
DNA topology and chemical functionality of DDB2’s insertion
loop residues.
Located in the N-terminal-α-paddle domain of DDB2 are nu-
merous arginines, lysines, glutamates, aspartates, and glutamines,
aligned by the helical topology along a face of the α-paddle, pre-
senting charged residues (Arg46, Arg47, Asp51; shown as sticks,
Fig. 2C) to the phospho-deoxyribose backbone of the DNA. Ad-
ditional charged residues contributed by the adjacent β-propeller
domain of DDB2 further enhance the highly cationic electrostatic
surface of the N-terminal domain of DDB2 (SI Appendix,
Fig. S2B; positive electrostatic surfaces shown in blue). These
form complementary electrostatic molecular interfaces for bind-
ing both the DNA and the BPC domain of DDB1 (SI Appendix,
Fig. S2 A–C). As noted earlier, the helical motif of the N-terminal
domain of DDB2 is important for aligning charged residues on
one face of the helices and projecting hydrophobic residues on
the other, enabling these to simultaneously interact with the hy-
drophobic BPA domain of DDB1 and the highly anionic nature of
the DNA phosphor-deoxyribose backbone as well as the largely
cationic surface features of the BPC domain of DDB1.
The dimer interface of DDB2 modulates multiple intermole-
cular contacts, providing a structural rationale for the remarkably
high binding affinities to damaged DNA found in biochemical
studies of UV-DDB (10, 35, 38). In the current studies, the
24-bp oligodeoxynucleotide (AP24) is substantially longer than
the 14-and 16-bp oligodeoxynucleotides used in the earlier struc-
tural studies, affording unique insight to the interactions beyond
those formed directly at the lesion site. Four distinct networks
of contacts are formed between DDB2 and the DNA. At the
lesion site, DDB2 residues (His333, Phe334, Gln335, His336,
represented by orange spheres and rectangles; SI Appendix,
Fig. S3 A–C) insert at the abasic site, resulting in flipping of
the immediate upstream nucleotide, which is stabilized in an ex-
tra-helical conformation through a second group of DDB2 con-
tacts (yellow spheres; SI Appendix, Fig. S3 A–C). Beyond the
lesion, interactions between DDB2 and the deoxyribose-phos-
phate backbone atoms upstream (green spheres, rectangles;
SI Appendix, Fig. S3 A–C) and downstream (purple spheres, rec-
tangles; SI Appendix, Fig. S3 A–C) on the damaged DNA strand
Fig. 2. Structure of the dimeric human UV-DDB in a complex with damaged DNA. (A) The dimeric UV-DDB subunit organization, shown in ribbon depiction,
with each domain colored and labeled accordingly: yellow, DDB2 β-propeller; red, DDB2 N-terminal-α paddle; blue, DDB1 BPA; green, DDB1 BPC; and purple,
DDB1 BPB. The 24-bp oligodeoxynucleotide (AP24) contains an abasic lesion site (THF11), with the phosphor-deoxyribose backbone of the damaged strand
colored in red and the undamaged strand colored in blue. Each DDB2 subunit is bound to an AP24 oligonucleotide, with DDB2 residues Asn360/Asn360’
straddling the twofold symmetry axis, forming H bonds across the dimer interface. The surface of the Asn360/Asn360’ pair (colored using standard atom
convention) is located in a loop spanning two antiparallel β-strands (β-wing). The abasic lesion site in AP24 is marked by the surface mesh drawn around
nucleotides THF11/dC12 in their flipped, extra-helical configuration. The β-wing is sandwiched between the two AP24 oligodeoxynucleotides, astride of
the twofold axis of rotation relating the monomer subunits in the dimeric DDB2. Residues on the leading β-strand and loop form contacts with the undamaged
DNA strand whereas residues on the loop and the retreating β-strand form contacts with the neighboring undamaged DNA strand. Both sets of contacts are
predominantly electrostatic in nature, thus largely sequence independent. (B) Same as A but rotated 90 degrees and tilted slightly to show both DNA mo-
lecules. (C) Electrostatic potential surfaces of the DDB2 N-terminal domain complement the charge characteristics of the DDB1 BPC domain and the DNA
phosphor-deoxyribose interfaces, resulting in favorable electrostatic neutralization. Contacts between residues on the β-wing region form contacts with
the DNA bound at its immediate active site and with the neighbouring DNA molecule bound to the second monomer of DDB2 in the dimer. Extensive inter-
actions between residues on the N-terminal-helical domain (α-paddle) and the neighboring DNA molecule augment the intermolecular associations, contri-
buting to the high affinity of damaged DNA binding. (D) The skewed positioning of the DNA binding surface can now be understood in terms of the DDB2
dimer interface, located adjacent to the DNA binding site, at a loop bridging blades 6 and 7 of the β-propeller (β-wing) of DDB2. To accommodate the steric
constraints imposed through dimerization along with DNA binding, the two adjacent sites are positioned diametrically across one face of themolecular surface
of DDB2, readily seen in the dimeric DDB2-DNA (AP24) complex.
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further serve to clamp the DNA. The distinct nature and multiple
levels of interactions found between the DNA molecule and
DDB2 in the crystal structure are highly suggestive that the ad-
ditive contributions from the multiple sites of contacts are a
major factor for the high overall avidity of binding exhibited by
UV-DDB for damaged DNA.
DNA Binding Promotes Dimerization of the DDB1-DDB2 Heterodimer
(DDB1-DDB2). To further probe the oligomeric states of UV-DDB
under physiologically relevant solution conditions, atomic force
microscopy (AFM) was used to characterize the molecular topol-
ogy of UV-DDB and to monitor substrate-induced changes in in-
termolecular interactions. AFM-derived volumes have been used
extensively in studies examining the oligomeric states of multi-
component complexes and to ascertain the nature of protein–
protein interactions of globular proteins (39, 40). For our AFM
studies, 517-bp PCR fragments were produced as the undamaged
DNA substrate and the fragments were subjected to UV-irradia-
tion to generate the damaged DNA (41, 42). AFM analyses of
UV-DDB in the presence of undamaged DNA (SI Appendix,
Fig. S4 A and B), UV-damaged DNA (Fig. 3), and in the absence
of substrate binding (Fig. 3) found clearly distinguishable changes
in the oligomeric states of UV-DDB. To quantitate the volumes
and molecular mass derived from the AFM data, a standard curve
was generated using proteins with well-defined oligomeric states,
shapes, and molecular masses (additional experimental details
are provided in SI Appendix, SI Materials and Methods). Convert-
ing the apparent AFM volumes of the UV-DDB molecules in
the absence of DNA to molecular mass using the standard curve
(SI Appendix, Fig. S5) shows that the peak at approximately 66
10 nm3 (three depositions) corresponds to a protein with a mo-
lecular mass of 184 23 kDa, a value consistent with the size of
monomeric UV-DDB (i.e., heterodimeric DDB1-DDB2, with a
combined theoretical molecular mass of 175 kDa). A second peak
at approximately 190 nm3, corresponding to a molecular mass of
approximately 505 kDa, represents a complex mixture of higher
Fig. 3. AFM imaging shows that damaged DNA binding promotes the dimerization of the DDB1-DDB2 heterodimer. (A) A representative surface plot of
UV-DDB (50 nM) in the absence of DNA. The thin and wide white arrows point to molecules consistent with the size of the UV-DDB monomer (DDB1-
DDB2 heterodimer) and trimer of UV-DDB, respectively. (B) Representative surface plot of UV-DDB (50 nM) in the presence of UV-irradiated 517 bp PCR frag-
ments (25 nM). The yellow and red arrows point to dimeric UV-DDB [ðDDB1-DDB2Þ2] binding to one and two molecules of duplex DNA, respectively. (C) AFM
volume analysis of free UV-DDB (n ¼ 1; 160). (D) AFM volume analysis of UV-DDB on one strand (gray bars, n ¼ 339) and two strands (black bars, n ¼ 79) of
duplex DNA. The images in A and B are at 500 nm × 500 nm and 3 nm in height. (Bottom) The dashed lines (C, free in solution, andD, bound to DNA) represent
Gaussian fits to the data. Field view images of UV-DDB binding to separate DNA molecules (E) or two different regions of the same DNA molecule (F). The
images are at 300 nm × 300 nm and 2 nm in height.
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order oligomeric states (Fig. 3C and SI Appendix, Fig. S5). Con-
sistent with the EM results, no distinct peak at a volume corre-
sponding to a dimer of UV-DDB [ðDDB1-DDB2Þ2] is found in
the absence of DNA.
When UV-DDB was incubated with UV-irradiated DNA at a
molar ratio of 2∶1, approximately 96% of the UV-DDB mole-
cules were found to be bound to DNA molecules (Fig. 3 B
and D and SI Appendix, Fig. S4C). In addition, among all of
the UV-DDB molecules bound to DNA, 18% of the molecules
bound to two DNA molecules simultaneously. These binding
events included both middle to middle (Fig. 3 E and F) and
end to middle sites (Fig. 3B, red arrow) on two separate DNA
molecules. The AFM-derived volume of UV-DDB bound to one
molecule of DNA is Gaussian centred at approximately 133 nm3
(Fig. 3D; gray histogram) which is consistent with the size of
dimeric UV-DDB [ðDDB1-DDB2Þ2]. The AFM volume of UV-
DDB simultaneously binding to two molecules of DNA is
approximately 139 nm3, which is slightly larger than UV-DDB
binding to only one molecule (Fig. 3D; black histogram). These
oligomeric states and substrate interactions found from the AFM
analysis of UV-DDB in the presence of damaged DNA contrasts
dramatically to those found when UV-DDB is in the presence of
undamaged DNA substrate.
The interactions found between UV-DDB and the undamaged
DNA fragment from the AFM analysis indicates that UV-DDB
binds undamaged DNA to a significantly reduced extent (ap-
proximately 37% of the total UV-DDB was bound to DNA) com-
pared to those formed when UV-damaged DNA is present (96%)
(SI Appendix, Fig. S4C). These AFM results are consistent with
those found earlier by EMSA analysis, which showed that small
but measureable amounts of UV-DDB bound undamaged DNA
(38, 43). Analysis of the volumes of these nonspecific UV-DDB
complexes observed on DNA indicated that a majority (approxi-
mately 75%) * of the complexes were monomeric consisting of
only one molecule of DDB1 and DDB2 (SI Appendix, Fig. S4B).
These volume measurements are in striking contrast to the AFM-
derived volume of UV-DDB when bound to UV-irradiated
PCR fragments, inducing volume changes in UV-DDB that were
consistent with a dimeric UV-DDB [ðDDB1-DDB2Þ2] bound to
damaged DNA.
While EM and AFM studies involved different sample pre-
paration procedures and different criteria for evaluating size
(projected area vs. volume), these complementary techniques
can provide insights into the molecular topologies, organization,
and nature of interactions in multi-component complexes. Com-
pounding the innate methods-related differences described
above, the sizes of the damaged DNA substrates used in the EM
and AFM studies represented different lesions types (THF in
AP24 versus UV-induced lesions in 517-bp PCR fragments).
Yet the EM and AFM studies provided corroborating data ver-
ifying that the shorter abasic site mimic (AP24) induced similar
dimerization upon damaged DNA binding as found when UV-
DDB bound the 517-bp UV-irradiated DNA fragments. Notably,
the remarkable agreement between the dimensional values and
molecular profile obtained by the negative-stained EM, AFM,
and derived from the X-ray diffraction crystal structure supports
our proposal that UV-DDB dimerizes as a function of damaged-
DNA binding. To summarize, EM and AFM imaging revealed
that (i) in solution, UV-DDB exists as a monomer (composed
of DDB1-DDB2 heterodimer) and no significant dimer popula-
tion of UV-DDB [ðDDB1-DDB2Þ2] was observed; (ii) binding to
damaged DNA promotes the dimerization of UV-DDB, which
can simultaneously bind to two DNA molecules; (iii) the organi-
zation and dimensions of the dimeric UV-DDB-damaged DNA
complex found in the AFM and EM analyses are consistent with
those found in the crystal structure of the dimeric complex. It is
important to note that whereas the DDB1-CUL4ADDB2 ubiquitin
ligase complexed to a nucleosome modeled according to the di-
meric architecture captured in our crystal structure leads to a sur-
prisingly rational organization of the individual molecular
components (Fig. 4), the dimeric state does not necessarily con-
strain the number of lesions that can be simultaneously bound nor
inform about the number of lesions required to induce dimeriza-
tion; but the assumption that a single lesion can induce the
dimeric form is reasonable.
Dimeric UV-DDB Binds Damaged DNA with Approximately Fourfold
Higher Affinity than in the Monomeric State. The role of oligomer-
Fig. 4. Model of DDB1-CUL4ADDB2 ubiquitin ligase complexed to a nucleosome. (A) Modeling of the complex with CUL4A-Rbx (gray, light blue) onto the
dimeric UV-DDB2 (domains colored as in Fig. 2); the region defined by two adjacent AP24 oligodeoxynucleotides (AP24-1 & AP24-2, in orange) used for the
docking of a nucleosome; (B) Docking of the nucleosome in the dimeric UV-DDB, showing the fit of one AP24-1 (in orange) relative to the nucleosome (in blue);
(C) fit of the nucleosome onto both oligomers showing that the distance between the two oligonucleotides can readily accommodate the nucleosome mo-
lecule (second DNA molecule, AP24-2, shown in orange) with minor adjustments of the second DDB2 component, as needed. The dimeric scaffold accom-
modates the numerous proteins that transiently assemble and disassemble on the DDB1-CUL4ADDB2 ubiquitin ligase complex at the vicinity of the lesion site in
the subsequent DNA repair process. The dimeric architecture also spatially aligns the various molecular subunits in the reactions monoubiquitinylating histones
and polyubiquitinylating substrate receptors (i.e., DDB2) for proteasomal degradation and verified by docking the E2 ubiquitin transferase enzyme onto the
DDB1-CUL4ADDB2 ubiquitin ligase complex, resulting in E2 bridging distances to histones. In this figure, the histone and E2 proteins are omitted for clarity.
*Percentage value calculated from the integration of the number of molecules under two
Gaussian fits after deconvoluting the peaks shown in (SI Appendix, Fig. S4B), Inset.
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ization in mechanisms involving DCAF proteins and, more
specifically, the dimerization of DDB2, has been proposed earlier
(44, 45). In our study, numerous lines of structural evidence from
crystallography, EM, and AFM results, when combined with
earlier published results (10, 44) coherently implicates the invol-
vement of dimeric UV-DDB [ðDDB1-DDB2Þ2] in mediating mo-
lecular interactions at specific stages along the DNA repair
pathway. To experimentally validate the premise derived from the
structural results, that dimerization mediates DNA-binding activ-
ities, dynamic light scattering (DLS) and surface plasmon reso-
nance (SPR) were used to characterize the interactions between
monomeric and dimeric UV-DDB to AP24. Unlike EMSA or
DNA footprinting gel-based assays that require labeling and
are end points measurements that do not allow for kinetic ana-
lysis, DLS and SPR monitor molecular interactions in real time,
permitting delineation of concentration dependencies and other
solution effects on molecular interactions.
Characterization by DLS clearly shows that the binding of da-
maged DNA results in the formation of a distinct, monodisperse
state of UV-DDB, with dimensions in agreement with the EM
and AFM values for the dimeric UV-DDB [ðDDB1-DDB2Þ2]
(SI Appendix, Tables S2 and S4). Furthermore, dimerization of
UV-DDB is readily promoted by binding AP24, even at dilute
protein concentrations, whereas in the absence of damaged
DNA binding, a mixture of monomers and dimers is found even
at high protein concentrations. The kinetics and binding affinities
of UV-DDB to AP24 differ in the monomeric versus dimeric
states, according to the SPR data, which clearly show that the
dimerization of UV-DDB is stimulated by damaged DNA binding
and that, moreover, the kinetics of both the association and dis-
sociation steps are modified, resulting in >four-fold† enhance-
ment in the damaged DNA binding affinities in dimeric com-
pared to the monomeric states (SI Appendix, Table S3). The
combination of data from AFM, EM, and biophysical analysis
(SI Appendix, Tables S2–S4) presented here supports the biolo-
gical relevance of the dimeric state of UV-DDB as revealed in
the crystal structure.
Discussion
Our comprehensive study has elucidated the structure of dimeric
UV-DDB in a complex with damaged DNA, utilizing a combina-
tion of structural, biophysical, and biochemical approaches that
collectively support thepivotal role that dimerizationplays inmod-
ulating intermolecular associations and in organizing the architec-
ture of the multi-component cullin-RING E3 ligase receptor-
substrate complexes. The dimeric UV-DDB structure presented
in this paper provides the first high-resolution views of a cullin-
RING E3 ligase receptor-substrate complex captured in a high-
affinity state, with direct mechanistic and functional implications.
Dimer Interface is Adjacent to the Damaged DNA Binding Site in DDB2.
The primary damaged DNA binding site is located at the narrow
end of the β-propeller, opposite to the DDB1 interaction surface
in DDB2 (Fig. 2). The DNA spans the surface of the DDB2,
surprisingly offset from the center of the seven-bladed β-propel-
ler. This offset can now be explained in terms of the constraints
arising from the dimerization interface. To accommodate these
constrains along with DNA binding, the two neighboring binding
sites are located diametrically across a molecular face of the
β-propeller domain of DDB2, leading to the offset. The location
of the dimer interface on the same molecular surface as the DNA
binding site allows for cooperativity between DNA binding and
dimerization (SI Appendix).
A High-Affinity DNA Binding Motif is Formed by Dimerization of
UV-DDB. Given the overwhelming binding preference exhibited
by UV-DDB to UV-induced lesions, a mechanism based on sub-
strate-driven conformational folding of the N-terminal-domain of
DDB2 would permit specificities and binding affinities to be
tuned, optimizing interactions according to the specific chemical
nature of the lesion site. This mechanism ensures that high affi-
nity interactions are formed only when damage is found. Multiple
unique sites of DNA contacts are found in the dimeric UV-DDB,
interactions that are absent in the monomeric state and mediated
by the N-terminal-α-helical paddle and the β-wing regions of
DDB2.
The α-paddle helical fold adopted by the N-terminal domain of
DDB2 aligns residues so contacts to the DNA immediately bound
and to a neighboring DNA molecule are formed in tangent, pro-
moting the dimerization of UV-DDB. The β-wing loop of DDB2
is located at the interface of two DNA molecules within the
dimeric UV-DDB. These interactions independently augment
DNA contacts but when analyzed together resemble a “winged
helix” motif that has been found in numerous DNA-binding pro-
teins (46). Analogous to those found in other winged-helix DNA
binding proteins, the β-wings in UV-DDB form direct contacts to
the backbone atoms of the DNA. Additionally, the conformation
and the apparent function of the β-wings of DDB2 in dimeric UV-
DDB resemble those shown in the transcription factors, Ets-1,
and the tripartite factor X, RFX, by linking and modulating nu-
cleotide binding affinities with dimerization (47, 48). In these
winged-helix proteins, exposed patches of hydrophobic residues
are displayed, causing conformational changes to present new
protein–protein interaction surfaces and inducing dimerization
as a function of nucleotide binding (SI Appendix). Thus, the
N-terminal domain of DDB2 modulates molecular affinities, in-
dependently and in conjunction with its β–wing domain, while
further coordinating dimerization. The specific α-paddle helical
motif enables multi-molecular contacts to be formed without per-
turbing interactions with DDB1 and, presumably, without block-
ing the subsequent binding of proteins involved in DNA repair.
The dimeric DDB1-CUL4ADDB2 ubiquitin ligase complexed to a
nucleosome, modeled according to the molecular architecture of
the UV-DDB-AP24 complex (Fig. 4), demonstrates that the mul-
ti-component complex can be accommodated within the dimeric
framework, providing additional support for the plausibility that
dimerization of UV-DDB regulates and modulates association to
DNA lesions.
Dimerization Accommodates Spatial Constraints for Substrate Ubiqui-
tination. Recently, the concept that dimerization is the key mole-
cular determinant in enabling interactions with the vast and
diverse set of proteins targeted by CRLs and their complexes
has gained prominence. The dimeric state would be advantageous
to monomeric E3 in targeting proteins of different sizes and
in regulating auto-ubiquitination of the substrate receptor. The
functional importance of CRL dimerization is supported by
the observation that mutations of substrate-recognition regions
retain their dimerization properties but act in a dominant-nega-
tive fashion, in vivo (45). Formation of higher-order oligomers
can be initiated by receptor association or through another E3
component (49).
Consideration of the holocomplex containing the E3 ligase
indicates that the molecular architecture of the DDB1-
CUL4ADDB2 complex should complement the ubiquitination
machinery in the assembled state. The cullin subunit is an elon-
gated moiety in all cases, consisting of a long stalk and a globular
domain RING finger adapter protein, RBX1, which docks
through an intermolecular β-sheet, forming a two-subunit cataly-
†Determined by accounting for the presence of both monomeric and dimeric states, using
the mass distributions found from the DLS measurements, conducted using identical pro-
tein concentrations and experimental conditions, and estimating respective contributions
of monomeric and dimeric states to the kinetic and affinity parameters calculated from
the SPR data.
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tic core that recruits the ubiquitin-conjugating enzyme, E2. It is
recognized that the cullin subunit (e.g., CUL4A/4B, CUL1,
CUL5) serves as a rigid scaffold in organizing the various sub-
strates for ubiquitination after complex formation. The distinct
structural motif displayed by various cullin complexes results
in a distance of over 100 Å between the RBX-E2-Ub proteins
relative to the substrate protein (45), which poses a question
as to how activated ubiquitin bridges the 100-Å gap. However,
dimerization in conjunction with domain flexibility found in
the dimeric UV-DDB complex, described here, appears to ad-
dress the multitude of proteins and chemical variability while
permitting the dynamic adjustments needed during the poly-
ubiquitination reaction.
In the context of the holo-complex with CUL4A, the dimeric
UV-DDB structure seems to be optimized to meet the spatial re-
quirements of the elongated cullin architecture. Modeling the
DDB1-CUL4ADDB2 E3 complex by superimposing CUL4A-
RBX onto the BPB-domain of DDB1 in the dimeric UV-DDB
complex shows that the 100-Å distance is readily bridged by
the activated ubiquitin-E2 moiety (E2-Ub). Particularly striking
is the overall alignment when the nucleosome is oriented onto
the dimeric architecture, using the AP24 with the dimeric UV-
DDB as the reference for placement of the nucleotide backbone
(Fig. 4). The specific BPB domain conformation of the DDB1
subunit captured in the dimeric UV-DDB would present the
activated Ub (CUL4A-RBX1-E2 –Ub complex) within 10 Å of
several lysines of DDB2 that are candidate sites for auto-ubiqui-
tination. The model also indicates that the resulting complex
would additionally position the histone proteins, which are also
ubiquitinated, to E2-Ub. Consequently, dimerization of the sub-
strate-recognition subunits, as exemplified by UV-DDB, further
supplements regulatory, fine-tuning activities so that a spectrum
of ubiquitination can be moderated, possibly permitting the
simultaneous modification of multiple substrates (e.g., XPC, his-
tones and DDB2) and/or mono- versus poly-ubiquitination of
substrates (e.g., poly-Ub of DDB2 and mono-Ub of H2A). The
structural and biochemical findings reported here provide com-
pelling evidence for the dimeric state as a critical organizational
unit of UV-DDB. The dimeric associations found in the UV-
DDB may be representative of those formed in other complexes
based on the DDB1-CUL4 ligase platform.
Functional Implications of the Dimeric State of UV-DDB. The prefer-
ence for binding to UV-damaged DNA by UV-DDB was verified
by AFM analysis, which found significantly less binding of UV-
DDB to an undamaged 517 bp PCR fragment, results consistent
with the high specificity reported for UV-DDB (10, 35, 38, 43).
The AFM analysis also shows the dimeric state of UV-DDB, brid-
ging two duplexes of UV-damaged DNA, under conditions that
reproduced UV-DDB’s specificity for damaged DNA.
The functional significance of the dimeric state can be assessed
by comparing the molecular regions identified as structurally sig-
nificant to those reported by other approaches. In the dimeric
UV-DDB complex structure, the β-wing represents the area form-
ing closest intermolecular contacts and the functional importance
of this region has strong genetic support. Four DDB2 variants,
formed by alternative splicing, were identified in Hela cells
(44). The D1 variant, with deletion of residues 153–341 that ex-
cluded part of the β-propeller domain of DDB2, but preserved
Asn360 and the β-wing, could form dimers with DDB2-WT
and itself. The variant D2, containing only the first 156 amino
acid residues, could not form the dimeric complex. Interestingly,
DDB2 splice variants are dominant negative inhibitors of NER
when expressed in HeLa cells (44). The deleterious effects of
these splice variants are difficult to reconcile from the respective
locations of the residues or segments according to the structure of
the monomeric UV-DDB complex. However, these resides map
to regions at the β-wing of DDB2 in our dimeric structure of the
UV-DDB-damaged DNA complex, residues centrally positioned
to bridge both molecules of DNA in the dimeric configuration.
Thus, residues located in the vicinity of the dimer interface
(e.g., on the β-wing region according to the UV-DDB-AP24
dimer configuration in the crystal structure) may function in
signalling the substrate complexed state of DDB2, leading to co-
operative enhancement of DNA binding affinities upon stimulat-
ing helical folding of the N-terminal domain of DDB2.
Our studies suggest that the transition between disordered to
ordered folding of the N-terminal domain of DDB2 may be in-
timately related to modulating the intermolecular associations
formed subsequent to those primary contacts formed immedi-
ately upon docking of DDB2 to DDB1 and upon the binding
of damaged DNA to DDB2 at the substrate binding site. Through
a series of fine-tuning steps, secondary intermolecular contacts
are formed between the damaged DNA substrate to DDB2
(i.e., at the β-wing and N-terminal domain of DDB2 to damaged
DNA  4 nucleotides from the lesion site) (SI Appendix,
Fig. S3C) and DDB1 to DDB2 (at the interface between the BPC
domain of DDB1 to the N-terminal domain of DDB2) (SI
Appendix, Fig. S3). These molecular interactions allow the orien-
tation of the individual subunits within the multiprotein complex
to be adjusted so that the plethora of reactions catalyzed by the
DDB1-CUL4ADDB2 multiprotein complex can be accommo-
dated for the monoubiquitination of histones, and polyubiquiti-
nation of DDB2, ultimately leading to DNA repair.
Regulation by oligomerization has been speculated for other
proteins involved in binding various states of DNA. Our extensive
studies commenced with the crystal structure elucidation, reveal-
ing the dimeric state of the UV-DDB-AP24 complex, and ex-
panded to in-depth, multi-dimensional biophysical and structural
characterization of the substrate-binding dependencies, are con-
sistent with inducing distinct dimeric states of UV-DDB. These
different lines of analysis consistently point to the roles played by
dimerization and localized conformational changes in protein
subunits which together modulate conformation of the multi-
component E3 ligase complex and influence catalytic efficiencies
of specific reactions. The iterative cycles involve discrete modi-
fication of subunit intermolecular contacts that propagates to
the overall complex and permits a spectrum of activities to be
generated, centered on dimerization that additionally reduces
spatial and molecular constraints while increasing the range of
subunits and reactions that can be accommodated.
The binding of UV-damaged DNA initiates conformational
changes at the N-terminal domain of DDB2, inducing helical
folding in the context of the bound DNA to promote dimerization
of the UV-DDB-substrate complex, to ensure that high affinity
contacts are formed only when damage is found in DNA. This
temporal and spatial interplay between domain ordering and di-
merization provides an elegant molecular rationale for DDB2’s
enhanced UV-damaged DNA selectivity (10, 38). Based on the
additional extensive contacts formed by the dimeric UV-DDB,
oligomerization can modulate substrate affinities on multiple
levels, serving to allosterically regulate the substrate-receptor
complex.
XP-E Mutations Disrupt Key Intermolecular Contacts in Dimeric UV-
DDB. The mutations found in XP-E patients have been mapped
to their locations on the human UV-DDB complex structure
(SI Appendix, Fig. S6; key amino acid mutations shown in
space-filling depictions). Genetic mutations identified in XP-E
patients (7, 9) are at residues that form either direct or key brid-
ging interactions with the oligodeoxynucleotides (K244, D307) or
DDB1 (R273, L350). Perturbation of these contacts is highly
detrimental because these mediate both direct and secondary in-
teractions with the DNA or DDB1. The effects for two of the
mutations highlight the significance of the N-terminal helical
domain and the dimer interface of DDB2. The L350P mutant
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would significantly perturb the stability of the DDB1-DDB2 com-
plex as L350 aligns the long N-terminal-α-paddle of DDB2 that
inserts into the BPA-BPC domain cleft of DDB1. The position of
L350 is central to an aliphatic cluster at the DDB1 BPC interface
with DDB2, so that mutation would cooperatively disrupt multi-
ple associations. The position of D307 is at the DDB2 dimer in-
terface, close to the β-wing loop, disturbing DNA binding as well
as dimer formation. Notably, the mutated residues identified in
XP-E patients are at sites in DDB2 that mediate multiple con-
tacts, with the detrimental consequences amplified due to disrup-
tion of correlated interactions.
Conclusions
We describe here the 2.85-Å dimeric structure of the full-length
human UV-DDB ðDDB1-DDB2Þ2 in a complex with damaged
DNA. This new structure revealed the importance of the N-term-
inal 102 residues of DDB2 in mediating interactions with DDB1
and damaged DNA. The remarkable agreement on the molecular
topology between the negative-stained EM, AFM, and crystal
structure results (Figs. 1–4), further validated by DLS and SPR
analysis, collectively supports the distinct dimeric state formed by
UV-DDB upon binding damaged DNA. Taken together these
multiple lines of evidence strongly support the existence of higher
oligomeric states of UV-DDB, in vivo. These findings have direct
regulatory and functional implications.
The dimeric UV-DDB acts as a molecular scaffold for aligning
multiple protein partners, during the complex and dynamic pro-
cess of damaged DNA detection and repair. DDB1-CUL4ADDB2
assists in transfer of ubiquitin from the E2 to the histones and
repair proteins at the site of a lesion. UV-DDB thus has a unique
role for the initiation of NER in the context of chromatin. The
structural flexibility of the N-terminal domain of DDB2 suggests
that this domain is conformationally adaptable, its precise do-
main-fold driven by substrate binding. This structural malleability
in receptors enables recognition of a wide array of diverse protein
and nucleic acid substrates. DDB2 presumably forms complexes
with multiple substrates, including histones and XPC in addition
to damaged DNA, displaying a range of binding affinities to dif-
ferent chemical lesions found in UV-irradiated DNA.We surmise
that DDB2’s selectivity—its ability to distinguish subtle discrete
differences in chemical moieties within the framework of a nu-
cleosome—is related to its domain-fold adaptability. Considered
all together, substrate-induced N-terminal-domain folding en-
dows molecular and conformational adaptability, features that
are further enhanced and optimized by dimerization.
Our findings regarding the significance of the dimeric state of
the UV-DDB-AP24 agree remarkably well with reports on other
DCAF-family proteins, providing a molecular scaffold for inte-
grating the assorted biochemical, genetic, and cellular observa-
tions into a coherent mechanism directing NER. A central
tenet evolving from these multiple lines of evidence is the pivotal
role that oligomerization plays in modulating specificities and af-
finities of associations in multi-component macromolecular com-
plexes and, consequently, controlling rates of reactions. Recently,
the concept of dimerization as a key molecular determinant in
enabling recognition and interactions between the diverse set
of proteins targeted by the family of cullin-RING E3 Ub ligases,
has gained prominence. However, experimental evidence for the
existence of dimeric substrate-receptor complexes has been lar-
gely missing. We believe that our structural and imaging studies of
UV-DDB provide such experimental support.
The E3 ligase architecture derived from our crystal structure of
the dimeric UV-DDB indicates that dimerization is a means of
modulating intermolecular association parameters in cullin-
RING E3 Ub ligase systems and is likely generalizable to other
multi-component complexes with similar modular molecular
architecture as UV-DDB. Homo-oligomerization is a fundamen-
tal step, allowing the individual components to be aligned in the
context of the holo-complex, so that a multitude of reaction para-
meters can be spatially accommodated. Thus, a wide spectrum of
functions can be regulated globally as biomolecular components
dynamically assemble and disassemble along the NER and ubi-
quitin proteasome system pathways. Our study suggests that
the rates of DNA binding and the high affinities for damaged
DNA are a consequence of optimizing molecular associations
in the holo-complex, an intrinsically basic mechanism for control-
ling substrate and protein–protein interactions, yet having pro-
found effects on the overall efficiency of DNA repair.
Materials and Methods
Protein Expression and Purification. Native and SeMet-substituted proteins
were expressed in Sf9 cells and purified as previously published (10) (SI
Appendix).
Synthetic oligodeoxynucleotides, sequences, methods of purification, and
analysis of the oligodeoxynucleotides described in this study are provided in
SI Appendix.
Electron Microscopy. Uranyl acetate stained UV-DDB samples were prepared
on grids and imaged on film in an FEI Tecnai T12 microscope operating
at 120 kV and magnification of 30;000 ×. Micrographs were digitized with
a Nikon Super CoolScan 9000 scanner and processed with the ImageJ soft-
ware (50) to remove background variations, including uneven depth of stain
and thickness of the carbon support film, and to estimate the particle size
distributions (SI Appendix).
AFM Sample Preparation and Imaging. UV-DDB was incubated with nonda-
maged or UV-irradiated 517 bp PCR fragments and diluted 1∶5- to 1∶10-fold
before deposition. All images were collected using a MultiMode V micro-
scope (Veeco Instruments). Images were captured at a scan size of
1 μm × 1 μm, a scan rate of 2–4 Hz, a target amplitude of 0.3 V and a resolu-
tion of 512 × 512 pixels (additional experimental details and statistical ana-
lysis of AFM images are provided in SI Appendix).
Crystallography. Purified native UV-DDB mixed in a 1∶3molar ratio with AP24
oligodeoxynucleotides were prepared and immediately used in crystalliza-
tion screening setups. Preliminary small crystals of the UV-DDB, with da-
maged DNA bound verified by gel electrophoresis, were obtained but
diffracted weakly to 8 Å. Further optimization using additive screening pro-
tocols (36) generated single crystals in both monoclinic and orthorhombic lat-
tices, and seeding eventually produced crystals that diffracted to 2.85–3.25 Å.
A combination of a selenomethionine anomalous phasing approach in com-
bination with partial model phasing yielded initial electron density maps
clearly defining solvent and macromolecular boundaries. Solvent flattening
and histogram matching improved the preliminary electron density maps (SI
Appendix, Fig. S7), verifying the dimeric composition of the asymmetric unit.
Iterative cycles of model building, rigid-body, molecular dynamics, simulated
annealing, and grouped-B factor refinement monitoring Rwork and Rfree va-
lues throughout, improved model accuracy and map quality, permitting the
DDB2 subunit to be traced and the AP24 oligodeoxynucleotide molecule
built into its electron densities. The asymmetric unit is comprised of the
full-length sequence of the human DDB1 (residues 1–1140), human DDB2
(residues 20–421), and 24-bp oligodeoxynucleotide duplex containing a cen-
tral abasic site, refined to Rwork∕Rfree values of 0.22∕0.24 (monoclinic) and
0.25∕0.26 (orthorhombic). Data processing and refinement statistics are
shown in (SI Appendix, Table S1), including details related to crystallization,
data processing, structure determination, and refinement for both the
monoclinic and orthorhombic forms of UV-DDB.
Dynamic Light Scattering (DLS) Analysis. A 20-μL UV-DDB sample was passed
through a 0.2-μm filtering assembly into the sample chamber of a DynaPro
(Wyatt Technology)molecular-sizing instrument equippedwithaPlateReader
(Protein Solutions).Data collectionandanalysis utilizedDynamics 6.0 software
package, asoriginallydescribed (51). Theparticle sizesofUV-DDB,measuredat
six different protein concentrations were determined in the presence and ab-
senceofdamagedoligodeoxynucleotide,AP24 (SIAppendix, Tables S2andS4).
Statistical analysis and additional details are included in SI Appendix.
Surface Plasmon Resonance (SPR). Immobilization of UV-DDB onto CM5 chip
surfaces used standard EDC/NHS-mediated amine coupling procedures (52),
using concentrations determined by the DLS results. The association and
dissociation phases for the interaction of AP24 to UV-DDB were monitored
on a BIAcore 3000 System (GE Healthcare), allowing the rates and binding
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affinities to be determined as a function of AP24 concentration. Data analysis
(BIAevaluation software version 4.1) applied a Langmuir binding model to
calculate the kinetics and affinity constants for the binding of AP24 to the
monomeric UV-DDB (SI Appendix, Table S3).
Note Added in Proof. While this paper was under review a study appeared
revealing the crystal structure of a single complex consisting of DDB1-
DDB2-CUL4A-RBX1 (CRL4ADDB2) bound to a 12 bp DNA duplex containing
a tetrahydrofuran (THF) lesion. While this structure differs significantly from
the dimeric structure of UV-DDB bound to DNA in our study, their new struc-
ture helps explain the ubiquitin ligase substrate flexibility in damage recog-
nition in chromatin (53).
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Materials and Methods 
  
Protein expression and purification: native and SeMet labeled proteins 
 
The protein components of the UV-DDB complex were co-expressed in Sf9 cells and 
purified through tandem-affinity chromatography with a His-tag on DDB1 and a FLAG-tag on 
DDB2, following the method that was developed previously (1, 2). Sf9 cells were co-infected 
with the viruses and incubated for 48 hours at 27 °C in SF900II media (Invitrogen), followed by 
centrifugation and snap freeze in liquid nitrogen. The frozen pellet was re-suspended in Sf9 lysis 
buffer 1 (500mM KCl, 50mM potassium phosphate pH 8.0, 10% glycerol, 0.5% NP-40), then 
rotated for 30 minutes at 4 °C for constant mixing. Centrifugation at 40,000 rpm in a Sorvall T- 
647.5 rotor for 45 minutes at 4 °C results in clear soluble lysate. The lysate was adjusted to 
 
10mM imidazole and incubated overnight with Ni-NTA superflow resin (Qiagen). The protein 
bound Ni-resin was washed with 20 column volumes of Sf9 lysis buffer containing 10mM 
imidazole, then eluted with Sf9 lysis buffer containing 200mM imidazole. Peak fractions were 
collected and incubated overnight with anti-FLAG M2 affinity gel (Sigma). The protein bound 
anti-FLAG gel was washed with 20 columns of Sf9 lysis buffer, then eluted with Sf9 lysis buffer 
2 (500mM KCl, 50mM potassium phosphate pH 8.0, 10% glycerol) containing 200µg/ml FLAG 
peptide (Sigma). Peak fractions were collected and concentrated in a 50KDa cut off concentrator 
(Pall Filtron) to remove the FLAG peptide. The yield of pure UV-DDB complex ranged from 1 
to 2 mg/l of Sf9 cells. An EDTA-free protease inhibitor mix (Roche Applied Science) was added 
to all buffers in the protein purification except in Sf9 lysis buffer 2. 
 
Seleno-L-methionine incorporation 
 
Expression of seleno-L-methionine labeled DDB1 and DDB2 proteins was accomplished 
by adapting a bacterial expression protocol (3). Sf9 cells were co-infected with baculovirus 
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encoding each UV-DDB subunit and incubated for 6 hours at 27 °C in SF900II media 
(Invitrogen). After centrifugation, cells were re-suspended in ESF-921 protein-free methionine- 
free cell culture medium (Expression Systems LLC) for 8 hours. 250mg/l final concentration of 
seleno-L-methionine (Acros Organics) was added to each liter of cells and further incubated for 
36-40 hours at 27 °C. The same purification procedure was carried out as above except Tris (2- 
carboxyethyl) phosphine hydrochloride (TCEP) at 1mM final concentration was added to all the 
buffers. The yield of pure seleno-L-methionine-UVDDB complex ranged from 200-250µg/l of 
Sf9 cells. 
 
DNA Oligonucleotides: synthesis, purification, and annealing 
 
Single stranded oligodeoxynucleotides were synthesized (Midland Certified Reagent 
Company Inc.; Midland, Texas) and further purified using anion-exchange chromatography 
(ProSphere P-WAX; 75x7.5 mm), eluting in a single peak during gradient purification with 25 
mM Tris pH 8.5 with 0.02% sodium azide and 0-500mM NaCl. The molecular weights of 
deoxyoligonucleotides in the purified fractions were confirmed with MALDI-TOF-MS, 
combined, and concentrated. To form the double-stranded DNA, the purified complementary 
oligodeoxynucleotides were mixed in a 1:1 molar ratio at room temperature, heated to 90°C, and 
the samples gradually cooled to room temperature overnight to anneal. After annealing, the 
oligodeoxynucleotides were further purified using anion-exchange chromatography, as described 
for the single-strand DNA purification. 
After purification, the double-strand DNA samples were buffer exchanged into 20mM Tris 
HCl, pH 7.5, 2mM MgCl2, 1mM EDTA, 2mM TECP, 5% Glycerol, and 0.02% azide by passing 
through an Ultracel concentrator three times (Amicon). While several oligodeoxynucleotides 
containing  a  tetrahydrofuran (THF)  moiety  to  mimic  abasic  lesions  were  synthesized  and 
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purified, the longest oligodeoxynucleotide duplex comprised of 24-base pairs (AP24) containing 
a central THF lesion site in complex to purified UV-DDB protein produced crystals with well- 
defined morphologies and better diffraction characteristics. Thus, the structural and functional 
results described in this study focuses on the UV-DDB-AP24 oligodeoxynucleotide complex. 
The sequences of the AP24 coding and complementary oligodeoxynucleotide strands are as 
follows: 
AP24 coding strand: 5´-GTCAGCATCG(Abasic)CATCATACAGTCA-3´ 
Complementary: 5´-TGACTGTATGATGACGATGCTGAC-3´ 
In addition, for anomalous phasing and to verify positions of DNA strands, brominated AP24 
oligodeoxynucleotide were synthesized by replacing all the deoxycytidine by 5- 
bromodeoxycytidine (BrC) in the 24-mer DNA oligodeoxynucleotide (AP24Br). The brominated 
single strand oligodeoxynucleotide were purified, annealed, and then purified again, as described 
for the unhalogenated DNA. The sequences of AP24Br oligodeoxynucleotide are as follows: 
AP24Br coding strand: 5´-GTBrCAGBrCATBrCG(_Abasic) BrCATBrCATABrCAGTBrCA-3´ 
 
Complementary: 5´-TGABrCTGTATGATGABrCGATGBrCTGABrC-3´ 
Electron Microscopy 
3µl of sample were pipetted onto a freshly glow-discharge carbon-coated grid, blotted, 
 
washed on the surface of a 100µl drop of 1% uranyl acetate stain solution, blotted again and air- 
dried. Grids were imaged in an FEI T12 microscope operating at 120kV and magnification of 
30,000x on film. Micrographs were digitized with a Nikon Super CoolScan 9000 scanner. The 
ImageJ software (4) was used for image processing of electron micrographs. Image processing to 
remove background variations, including uneven depth of stain and thickness of the carbon 
support film, allows the size distribution to be estimated (Figure S1, panels a-f). The dark areas 
are  due  to  scatter from the  uranyl acetate salt,  surrounding  white stain-excluding areas of 
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proteins. Preliminary analysis to measure representative areas shows a well-defined peak at 
 
~3500 Å2, corresponding to a spherical particle of ~70Å diameter, consistent with a monomer of 
the UV-DDB complex. A shoulder is also apparent at twice the area (~7100 Å2), corresponding 
to a dimer of the UV-DDB, representing ~5% of the particles in the absence of substrate DNA. 
However,  this peak, at ~7100  Å2, is enriched with the addition of  damaged DNA  (AP24) 
substrate and approaches 100% when an excess of damaged DNA is present (Fig S1, panels e,f). 
 
AFM sample preparation and imaging 
UV-DDB (50 nM concentration of DDB1-DDB2 heterodimer) was incubated with 25 nM 
undamaged or UV-irradiated 517 bp PCR fragments (25 nM) for 5 mins at 37 °C in a buffer 
containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl 0.2 mM MgCl2, and 0.2 mM EDTA. UV- 
irradiation was done at 20 J/m2 (254 nm wavelength) on the 517 bp PCR product at 50 µg/ml 
concentration. The protein-DNA mixtures were diluted 1:5 to 1:10 fold before deposition (25 
 
mM NaOAc, 10 mM MgOAc , 25 mM Hepes pH 7.5). All samples for AFM imaging were 
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prepared by depositing samples onto a freshly cleaved mica (SPI Supply, West Chester, PA), 
followed by washing with MilliQ water and drying under a stream of nitrogen gas. All images 
were collected using a MultiMode V microscope (Bruker, Santa Barbara, CA.) using E scanners 
in tapping mode. Pointprobe® plus noncontact/tapping mode silicon probes (PPP-NCL, Agilent) 
with spring constants of ~50 N/m and resonance frequencies of ~190 kHz were used. Images 
were captured at a scan size of 1 µm × 1 µm, a scan rate of 2-4 Hz, a target amplitude of 0.3 V 
and a resolution of 512 × 512 pixels. 
 
Volume analysis of AFM images 
 
For AFM volume analysis, dimensions of proteins were measured using Image SXM 
 
software (5, 6). AFM volume of a particle was calculated as V= S × (H - B), where V is the 
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AFM volume, S is the area generated at the base of a protein using “density slice” function of the 
SXM software (5, 7), H is the average height, and B is the background height. The standard 
equation relating the AFM volume (V) of a globular protein and its molecular weight (MW) is: V 
(nm3) = 0.3856 MW (kDa) - 1.913. This equation is based on AFM volumes of the following 
proteins and their various oligomeric states: Pot1 (65kDa), PcrA monomer (86.4 kDa), UvrA 
monomer  (105  kDa),  Taq  MutS  dimer  (181 kDa),  UvrA  dimer  (210 kDa),  and  Taq  MutS 
tetramer (362 kDa). 
 
Quantitative PCR assays 
 
In  order  to  estimate  the  number  of  photoproducts  induced  upon  UV  exposure,  we 
performed a quantitative PCR assay using untreated or treated template at a concentration of 0.1 
ng/ml in a 20 µL reaction. A 517 bp DNA fragment was amplified as described previously (8). 
Briefly, the cycling conditions are as follows: 75°C for 90 s; 94°C for 5 min; 94°C for 30 s, 57°C 
for 1 min, and 72°C for 1 min (15 or 16 cycles). 
 
Estimation of the possibility two independent monomeric binding events at vicinal lesions 
 
Calculation of lesion frequency was performed as described before (9). We found that on 
average each UV irradiated 517 bp fragment of DNA has 1.2 lesions (0.6 photoproducts per 
strand). Since UV damage is distributed according to a Poisson distribution (P(k) = λke-λ/k!), the 
percentage of molecules with 0, 1, 2, 3 and 4 or more lesions is approximately 35.37, 35.37, 
17.68, 5.89 and 5.69 %, respectively (9). 
   
For the 17.68% of molecules with 2 UV induced lesions, we can calculate the probability 
of finding 2 lesions in a 30 bp contiguous stretch (corresponding to the footprint of DDB2 on 
DNA)  of  DNA  as  P2.  UV  irradiated 517  bp  DNA  can  be  modeled  as  consisting of  517 
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nucleotides with damaged dinucleotides corresponding to the 6-4PP and CPD lesions. Thus, a 
 
DNA fragment with 2 lesions can be treated as a group of 3 objects with the first object being 
 
513 undamaged identical bases and the two lesions corresponding to the other two objects. 
Therefore, the total number of combinations of 2 lesions is given by Total outcomes = 515C2 = 
132355. The number of combinations of 2 lesions where they are within 30 nucleotides of each 
 
other (corresponding to 30 nucleotides which is roughly the footprint of DDB2 dimer on DNA) 
is calculated as Favorable outcomes = {i=1}Σ 1C1(515-i)C1  number of combinations of the two 
lesions so that the number of nucleotides between them is 0, 1, 2 and so on until 27. Thus for a 
DNA fragment containing two lesions, the probability of both of those lesions lying within the 
footprint of DDB2 dimer is P2 = favorable outcomes/total outcomes = 0.10. This corresponds to 
a total of about 1.77% of all molecules with 2 lesions within the foot print of the DDB complex. 
 
Similarly, a 517 bp fragment of DNA containing 3 lesions can be treated as 4 objects – 511 
non damaged bases, and 3 lesions. We can calculate the probability of finding at least 2 lesions 
within the footprint of DDB for DNA molecules containing 3 lesions as P3 = 1-P3, where P3 is 
the probability of the 3 lesions always being outside of the footprint of DDB2 dimer. P3 = 
favorable outcomes where the lesions do not lie within 30 bases of each other/total outcomes. 
The total number of combinations of 3 lesions is Total outcomes = 513C3  = 22369536. The 
number of favorable outcomes = {513-28} {i=1}Σ iC1(513-28-i)C1.Thus P3 = 0.85, and P3 = 0.15. Thus,  
about 0.88% of all molecules have 3 lesions within the foot print of the DDB complex. 
   
We can similarly calculate the probability of finding at least 2 lesions within the footprint 
of DDB for DNA molecules containing 4 lesions or more however, this is a sufficiently small 
fraction of molecules amounting to just 1.5% for molecules with 4 lesions (with the percentage 
of molecules with more than 4 lesions being even smaller) of molecules that we can neglect it 
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without significantly affecting our analysis. Based on these numbers, we expect approximately 
 
2.5% of all molecules to contain multiple lesions within the footprint of the DDB complex. 
   
UV-DDB/DNA crystallization 
 
For crystallization, the UV-DDB complex was mixed with the purified AP24 duplex DNA 
in a molar ratio of 1:3 (UV-DDB:DNA) in 20mM Tris pH 7.5, 2mM MgCl2, 1mM EDTA, 2mM 
TECP, 5% Glycerol, and 0.02% azide. The sample was concentrated to about 2.5 mg/ml (UV- 
DDB) using an Ultracel concentrator. Numerous crystallization screening trays were set up at 
4°C and the most promising conditions were optimized using a hanging drop diffusion method 
with a volume ratio of 1:1 (µl) of protein solution to reservoir. For data collection, crystals were 
transferred into a solution containing a cryoprotectant, typically comprised of the crystallization 
solution augmented with 22% ethylene glycol, then flash cooled in liquid nitrogen. 
 
Preliminary small crystals were grown from a stock containing native human UV-DDB 
protein that was incubated with small excess of AP24 DNA oligomer. To ascertain that AP24 
was stoichiometrically bound to UV-DDB in the crystallization condition, small crystals were 
harvested, washed, dissolved, and confirmed by gel-electrophoresis. The early crystals exhibited 
multiple  morphologies  and  diffracted  weakly  to  8Å.  Further  optimization  using  additive 
protocols (10) resulted in crystals with better defined crystal habit and morphology and were 
subsequently used for streak- and micro-seeding. After iterative cycles of optimization, single 
prismatic crystals exhibiting gradually improved X-ray diffraction characteristics were obtained. 
These crystals were used as seeds for further optimization using the matrix seeding method (11- 
13), identifying several new promising conditions. The final crystallization condition yielding 
single crystals used for data collection contained 0.25M potassium thiocyanate, 0.08M Bis-Tris 
propane  pH  6.5,  28%  w/v  PEG  3350,  and  2%  1,5-pentanediol.  The  UV-DDB  complex 
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crystallized in a monoclinic lattice, with a screw axis along the unique two-fold rotation axis 
(space  group  P21)  with  unit  cell  dimensions  of  a=76.736  Å,  b=70.877  Å,  c=191.448  Å, 
α=90.00°, β=99.68°, γ =90.00°. APS synchrotron diffraction data to 2.85 Å resolution were 
collected on the 24ID beamline. 
 
For phasing, Se-methionine substituted UV-DDB (DDB1-SeMet and DDB2-SeMet) were 
co-crystallized with AP24 (1:3 of UV-DDB to DNA) from a solution containing 0.35M di- 
ammonium tartrate and 30 %(w/v) PEG 3350, and nucleated using seeds transferred by the 
streak seeding method. The SeMet-substituted UV-DDB/AP24 complex crystallized in an 
orthorhombic lattice (spacegroup P21221), with similar unit cell parameters for two of the axis 
while the third unique axis doubled in length. The ab-inito selenomethionine SAD data was 
phased to 3.2 Å (Table 1, Table S1). with a solvent content of ~56% with one molecule in the 
asymmetric unit. The DDB1-DDB2 sequence has a total of 37 methionine residues. For 
anomalous phasing, SAD datasets were collected on selenomethionine substituted crystals and 
the datasets were merged for high redundancy. SeMet SAD data collections were done at SER- 
CAT 22ID and 22BM beamlines at APS. The SAD datasets were collected at peak energy 
wavelength, optimizing redundancy (Table S1). For all datasets, the crystals were translated 
throughout the diffraction experiments, after collection of a small wedge of data, to minimize 
effects of radiation damage. 
 
Brominated DNA (AP24Br) was also synthesized for phasing, substituting cytosine with 5- 
bromo-dC, purified, annealed, and purified as described earlier. Purified UV-DDB was co- 
crystallized with AP24Br. Similar to the crystallization of UV-DDB-AP24, UV-DDB-AP24Br 
initial crystallization hits also only grew tiny crystals with poor morphology. Further additive 
screening with a condition containing 0.2M sodium fluoride, 0.1M Bis Tris propane pH 6.5, and 
10 
33% w/v PEG 3350 produced single diffracting crystals. The best crystals were obtained with the 
additive, 0.08M GSH (L-Glutathione reduced) and GSSG (L-Glutathione oxidized). Data sets 
were collected at the Argonne Photon Source (Chicago, Illinois), on the SER-CAT and GM/CA 
beamlines and at the Stanford Synchrotron Radiation Lightsource (Palo Alto, CA), on beamlines 
BL7-1  and  BL9-1.  Due  to  the  limited  resolutions  of  diffraction  of  the  AP24Br  datasets 
(nominally 3.5-3.6 Å), the Br-datasets were used only in the early phase of model building, 
primarily to verify the placement and orientations of the AP24 DNA strands in the early models. 
 
X-ray data collection, structure determination, and model building 
Two datasets collected from crystals grown using SeMet-substituted UV-DDB protein 
were merged during processing, improving overall completeness and redundancy (Table S1). All 
datasets were processed using the HKL2000 suite (14). For the anomalous data, the intensity 
measurements for the Friedel pairs were separated at the scaling stage in HKL2000. To resolve 
the enantiomorphic ambiguity (i.e., hand of the substructure atom configuration) of the SAD 
phases, the phases were combined with those calculated from a model. Partial model phasing 
using the monoclinic P21 UV-DDB-AP24 structure was initially done in Phaser (15). Phase 
combinations of the calculated phases together with the SeMet SAD data were done in Phenix 
(16, 17), producing well-defined electron density maps. In one UV-DDB subunit, a total of 27 
 
selenium sites were found, with 21 sites having occupancy greater than 0.6. The initial FOM 
from the combined phasing was 0.76 as compared to 0.27 using the SAD data alone in Solve 
(18). Attempts to phase directly by molecular replacement using the human DDB1 and zebrafish 
DDB2 (pdb accession numbers 3EI2-3EI4) resulted in poor rotation and translation function 
values, with FOM of ~0.25 and poorly defined electron density maps with large regions of 
discontinuous  densities  and  the  AP24  oligodeoxynucleotide.  The  maps  calculated  using 
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combined phasing methods showed clear electron density for the AP24 DNA molecule, located 
close to the DDB2 domain (Figure S7). These maps were used for model rebuilding in Coot (19). 
Once the relative orientations of the DDB1, DDB2, and AP24 DNA were determined, these were 
cross-validated using the SeMet anomalous dataset. This orthorhombic crystal form (pdb ID 
code 4E5Z) independently confirmed the NT-domain fold and cross-validated the structure 
determined in the monoclinic lattice (pdb ID code 4E54) (refinement statistics for both crystal 
structures are shown in Table 1). 
 
Extensive regions of the UV-DDB were traced and built de-novo, including loop regions 
connecting the beta sheets in DDB1, the β-wings, and terminal regions of both DDB1 and 
DDB2. The NT-domain of DDB2, comprised of residues 20-100, was gradually built into 
experimental electron density maps as the earlier published structures were missing this NT 
region. The NT-region of DDB2 (residues 20-100) was iteratively extended, locally then globally 
refined, validated by iterative composite omit maps using the 2.85Å dataset. Iterative refinement 
cycles  included  residue-by-residue  fitting  followed  by  energy  minimization  and 
grouped/isotropic B-factor refinement over the entire complex. In addition to the NT-domain of 
DDB2, several regions were verified for model accuracy by generating simulated annealing omit 
maps in Phenix; these included the newly extended NT-helical α-paddle and β-wing regions, 
several loops at the DDB1-DDB2 interface, and the BPB domain of DDB1. 
 
For AP24 DNA, density was seen for all 24 bases for both strands. Also, for the damaged 
DNA strand no extra density was seen in the difference maps around the tetrahydrofuran (THF) 
legion, signifying the absence of a nucleobase. During DNA fitting, the planarities of 
complimentary bases were restrained initially, with loosening of restraints as refinement 
progressed  except for  a 2  base-pair window  around the abasic site, where the planarity is 
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disrupted. As seen in earlier structures of UV-DDB-DNA complexes, DDB2-induced DNA 
kinking is also seen in our UV-DDB-AP24 complex structures. The UV-DDB-AP24 complex 
has been refined to Rwork/Rfree values of 0.22/0.24 (monoclinic) and 0.25/0.26 (orthorhombic), 
with refinement statistics shown in Table 1 & Table S1. 
 
Dynamic Light Scattering (DLS) Analysis 
 
The DLS analysis was performed on a DynaPro (Wyatt Technology) molecular-sizing 
instrument equipped with a Plate Reader (Protein Solutions). A 20 µL UV-DDB sample was 
passed through a 0.20 µm filtering assembly into the sample chamber of the DynaPro. Data 
collection and analysis utilized Dynamics 6.0 software package, as originally described (20). For 
analyses, samples of UV-DDB were prepared using buffer (10 mM HEPES pH 7.4 and 0.15 M 
NaCl) to adjust total protein concentrations immediately before light scattering measurements. 
Data were collected under identical experimental conditions before and after the addition of 
damaged DNA substrate (AP24). The same molar ratio of 3:1 AP24:UV-DDB as that used for 
crystallization was maintained. The particle sizes and molecular weights (MW) of UV-DDB in 
the presence and absence of damaged DNA (AP24), calculated from the DLS data collected at 
six different protein concentrations, are summarized in Table S3. 
 
Surface Plasmon Resonance (SPR) analysis 
 
All SPR experiments were performed by using a BIAcore 3000 biosensor and Sensor Chip 
CM5 (GE Healthcare) at 6 ºC including maintaining the sample holders at this temperature with 
a circulating water-bath. All of the AP24 samples were diluted into running buffer (10 mM 
HEPES, pH 7.5, 0.15 M NaCl), with sample concentrations from 1.4 nM to 1.0 μM. All 
measurements were performed in series, with one channel dedicated as a control with its surface 
generated  as  similar  as  possible  to  the  sample  surface  channel  (i.e., channel 
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immobilized with UV-DDB). Immediately following injection of AP24 (i.e., damaged DNA 
substrate)  through  the  UV-DDB  immobilized  sample  channel,  AP24  was  injected  in  the 
reference channel and sample channel, at flow rates of 30 μL/min for 2.5 min. Background 
signals caused by refractive index changes and non-specific surface interactions were recorded in 
tandem. The sensorgram signals from the reference channel were subtracted from the sample 
channel (i.e., UV- DDB immobilized channel) to obtain the overall signal corresponding to the 
binding of the AP24 to UV-DDB. At the end of the association phase, the flow rate in the absence 
of the AP24 substrate was maintained to monitor dissociation for duration of 5 min. A 2M 
NaCl buffered solution regenerated the surface. 
Data analyses were performed using the BIAevaluation software to model the binding of AP24 
to UV-DDB in the monomeric and dimeric forms. Preliminary assessment evaluating the 
feasibility of the SPR approach to detecting changes in protein-substrate (AP24) binding 
parameters were conducted under steady-state conditions. Additional optimization of SPR 
experimental conditions and immobilization protocols led to two separate methods for the 
immobilization of the dimeric form of UV-DDB (further elaborated below). All measurements 
were replicated in triplicate and cross-validated when possible for comparison and cross- 
validation of several data sets. SPR datasets collected for the binding of AP24 to the monomeric 
form of UV-DDB were modeled by fitting the data to a Langmuir adsorption model. Preliminary 
SPR data at high UV-DDB concentrations suggested that the binding of AP24 to the dimeric 
form of UV-DDB exhibited interactions that are more complex. Two different protocols for the 
immobilization of the dimeric UV-DDB were used for the SPR analysis, generating two sets of 
data, each replicated in triplicate, for cross-validation. To verify that predominantly monomeric 
or dimeric forms of UV-DDB were immobilized at specific protein concentrations, DLS analyses 
were done over a range of concentrations as described in the preceding section, in the absence 
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and presence of AP24. Accordingly, at 20 µg/mL predominantly monomeric or at 800 µg/mL 
dimeric  UV-DDB  forms  were  immobilized in  separate  channels  on  research-grade 
carboxymethyl  (CM5)   chip   surfaces   via   standard   EDC/NHS-mediated   amine   coupling 
procedures (21). Briefly, the carboxymethyl dextran surface was activated using freshly a 
prepared aqueous solution containing 0.2 M EDC and 0.05 M NHS. Once the carboxymethyl 
(CM5) chip surface was activated, injection of purified UV-DDB covalently linkage formed 
between accessible nucleophilic groups (primary and secondary amines) of UV-DDB to the 
freshly formed succinamide groups on the chip surface. The same protocol was repeated by 
injecting purified and concentrated UV-DDB at 800 µg/mL, immobilizing the dimeric form in a 
separate channel. Unbound protein was removed and unreacted surface sites on the CM5 chip 
were capped by injecting 1M ethanolamine-HCl (pH 8.5). A series of AP24 association and 
dissociation experiments to monitor the interactions of AP24 to monomeric and dimeric UV- 
DDB. Contributions from non-specific interactions to the measured SPR signals were subtracted 
dynamically. Consistent experimental parameters and conditions were maintained between the 
reference and sample channels. 
 
An alternative method to generate the dimeric form in-situ on the SPR surface was used for 
determining parameters for the binding of AP24 to monomeric and dimeric forms of UV-DDB in 
series. Using this approach, data from the association phase for the binding of AP24 to the 
monomeric form of UV-DDB was measured, and complete dissociation of AP24 using 2M NaCl 
to regenerate unbound (apo) monomers of UV-DDB. To form the dimeric form of UV-DDB in- 
situ, highly concentrated UV-DDB was injected at 3mM, a concentration several times greater 
than the estimated affinity of dimerization, generating dimeric UV-DDB through innate 
oligomerization tendencies. The dimerization was allowed to proceed for 150 s and the stability 
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of the subsequent dimeric UV-DDB formed in-situ on the SPR chip surface was assessed under 
low   flow   rates  while  monitoring  the  sensorgram  for   dissociation.  The submicromolar 
dissociation constant (KD) estimated for the monomer-dimer UV-DDB association is supported 
by the stable baseline that indicated that the dimeric form of UV-DDB was stably maintained. 
The binding of AP24 to dimeric UV-DDB was measured by injecting UV-DDB-ligand at 3.0, 
1.0, 0.33, 0.11, 0.037, and 0.012 mM pre-incubated with AP24 (at the ratio of 1:3) through the 
UV-DDB affixed channel, at a flow rate of 30 µl/min. The association was allowed to proceed 
for 150 s, and dissociations of the complex monitored for 300 s and the data used to calculate the 
rates and affinities of AP24 binding (Table S3). 
 
The values obtained for the dimeric form of UV-DDB generated in-situ to those calculated 
from the sets of data collected from immobilizing the dimeric UV-DDB at a high concentration 
(800 µg/mL) are  comparable. Accounting for the heterologous population in  the  rates and 
affinity  calculations gave generally comparable values and trends. The contributions from the 
mixed monomer-dimer population were accounted for by using the state distributions obtained 
from DLS analysis.   Using BIAevaluation software (version 4.1) modeling according to 
heterogeneous ligand-parallel reaction to fit the data resulted in low residuals, indicating 
statistically valid fit. The kinetics and affinity constants estimated for AP24 in the monomeric 
and dimeric states of UV-DDB are tabulated in Table S3.   It should be noted that additional 
experimental analysis are required to fully validate these preliminary results. 
   
Expanded Discussion 
 
Dimer Interface Adjacent to Damaged DNA Binding Site in DDB2 
 
The primary DNA binding surface is  located at  the narrow end of  the β-propeller, 
opposite the DDB1 interaction region of DDB2 (Figure 2). The bound DNA molecule spans the 
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surface of DDB2, offset from the center of the 7-bladed β-propeller (Figure S2A). This offset 
can now be explained in terms of the spatial constraints arising from the dimerization interface. 
To accommodate the steric requirements allowing for dimerization of DDB2 along with binding 
of damaged DNA substrate (Figure S2B), the neighbouring intermolecular contact surfaces are 
located diametrically across a molecular face of the β-propeller domain of DDB2, leading to the 
offset (Figure S2C). The location of the dimer interface on the same molecular surface as the 
DNA binding site allows for cooperativity and coordination of oligonucleotide binding and 
dimerization. 
Using the nomenclature introduced previously (22), the damage site is denoted as “D+1” 
with the nucleotides 3’ of the damaged site denoted as D+n  and 5’ as D-n, where the number 
refers to the location of the nucleotide relative to the damage site at D+1. Overall, localized 
deformation at the abasic site forms a gap of ~15 Å and unwinds the DNA by ~18 degrees, 
radiating from the lesion (Figure S3).  This perturbs the stacking of the bases  immediately 
opposite the abasic site and the adjacent upstream nucleotide but limited in range to within two- 
nucleotides of the lesion. 
DNA damage is detected by insertion of the β-loop extending from strand-5 of the β- 
propeller domain of DDB2 into a gap in the duplex formed by CPD, 6-4PP, or abasic lesions, 
which all produce similar nucleotide deformations in the duplex (22). This insertion loop is 
comprised of three highly conserved residues -- Phe334, Gln335, and His336 – with each residue 
forming specific contacts to the bases opposite the lesion (Figure S3C). The minor groove at the 
lesion site is occupied by the abasic ribose moiety, positioned through the extra-helical flipping 
of the adjacent nucleobase (dC12), which appears to drive the distortions at the lesion as no 
significant interactions to DDB2  are  found.  The β-loop of strand  3  of  DDB2  defines  the 
perimeter of the site occupied by the nucleobase (dC12) immediately upstream of the lesion. 
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This base is an extra-helical configuration, which enlarges the gap initially produced by the 
missing nucleobase (THF11). The resulting gap is filled by the imidazolium ring of DDB2 
His336 on the 5’ side and by Gln335 on the 3’ side, limiting the lesion-induced distortion from 
being propagated. The extrahelical conformation of dC12 is maintained by a combination of H- 
bonds, hydrophobic, and π-stacking interactions between the cytosine base and DDB2 residues, 
particularly Ile200, Asn201, and Trp203 (Figure S3). The plane of the aromatic ring of Trp203 
forms the shallow base-binding plateau with Met177 and Ile200 bordering the site, which can 
accommodate both pyrimidine and purine nucleobases. Additional sequence independent 
stabilization at the flipped nucleotide next to the lesion is afforded through electrostatic contacts 
between the phosphoribose-backbone of the DNA to Arg and Lys residues of DDB2. 
Immediately 5’ of the flipped dC12, dA13 remains in the duplex, stacking over the 
carboxamide moiety of Gln335, which replaces the nucleobase of dC12. Gln335 also forms H- 
bonds to His336, stacking the imidazole ring over the purine ring of dG10, so that the canonical 
base-stacking interactions 5’ at the D+2 and 3’ at the D-1 regions are maintained in the damaged 
strand. The positively charged guanidinium groups of Arg112 bridge the two strands at D-1, D-2, 
maintaining inter-strand base-pairing contacts on the 5’ side of the lesion (Figure S3C). 
  
Dimeric UV-DDB Binds Damaged DNA with Higher Affinity than in the Monomeric State 
 
The DLS experiments clearly show that the binding of damaged DNA substrate (AP24) 
induces UV-DDB dimerization, even at the lowest protein concentration analyzed, 100 µg/mL 
concentration (which is 25X more dilute than the stock concentration used for crystallization). 
As the plots show (Figure S8), under the solution conditions for the DLS analysis (identical to 
SPR experimental conditions), in the absence of damaged DNA, a maximum of ~15% of UV- 
DDB was dimeric at the highest protein concentration studied, 1.25 mg/mL. In contrast, in the 
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presence of AP24, only dimeric UV-DDB was found at 1.25 mg/mL and less than 5% were 
monomeric even at the most dilute protein concentration analyzed, 0.1 mg/mL. Taken together 
with the kinetics and binding affinities determined by SPR, both performed under identical 
solution conditions, the binding of damaged DNA induces dimerization of UV-DDB, which 
further enhances the tightness of binding, ~doubling the rates of association and reducing the 
dissociation rates by 50%. These results are consistent with the findings from X-ray 
crystallography, EM, and  AFM,  supporting the  role  that  dimerization plays  in  modulating 
binding affinity, helping to assure fidelity of damage detection. The actual degree to which 
kinetic and affinity parameters are altered by dimerization need to be examined using UV- 
damaged DNA substrates – these analyses reflect the consistent trend found between solution 
and structural findings involving AP deoxyoligonucleotides. 
  
Functional implications of the dimeric state of UV-DDB 
   
Our analysis of dimeric UV-DDB provides conformational insights on potential 
associations between a substrate receptor and substrate, suggestive of dimerization functioning in 
regulating overall activity of the E3 ligase complex. Based on the additional extensive contacts 
formed by the dimeric UV-DDB, this new conformation can modulate substrate affinities on 
multiple levels, serving to allosterically regulate the substrate-receptor complex. Similar to the 
transcriptional factor, (Ets-1)2–S-EBS complex (Ets-1) (23), the dimeric state of UV-DDB is 
stabilized by DNA binding, inducing conformational ordering in the NT domain and further 
generating additional DNA-binding surfaces. In the Ets-1, dimerization is key to relieving auto- 
inhibition, whereby ternary complex formation of Ets-1 with itself initiates the conformational 
transition to a high-DNA-binding affinity state (23). In the UV-DDB, damaged DNA binding 
triggers the NT domain of DDB2 to adopt an α-helical paddle motif, presenting new DNA 
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binding sites. Additional DNA-contact sites are generated once the β-wing conformation is 
induced, concomitant with dimerization (Figure 2). 
 
The β-wing loop of DDB2 is located at the interface of two DNA molecules in the 
dimeric UV-DDB, so that multiple unique sites of DNA contacts are found in the dimeric UV- 
DDB, interactions that are absent in the monomeric state. These interactions are centered at the 
NT-α-helical paddle and β-wing regions of DDB2 and when analyzed together resemble a 
“winged helix” motif that has been found in numerous DNA-binding proteins (24). 
 
Winged helix proteins share a related DNA-binding motif, combining beta loops 
(‘wings’), alpha helices and beta-sheets to modulate DNA contacts. In these proteins, the helices 
form various levels of DNA contacts, from sequence-specific major groove insertions to base- 
independent electrostatically-mediated contacts to the deoxyribose-phosphate backbone of the 
DNA. Analogous to those found in other winged-helix DNA binding proteins, the β-wings in 
UV-DDB form direct contacts to the backbone atoms of the DNA (Figure 2). Additionally, the 
conformation and the apparent function of the β-wings of DDB2 in dimeric UV-DDB resemble 
those shown in the transcription factors, Ets-1, and the tripartite factor X, RFX, by linking and 
modulating nucleotide binding affinities with dimerization (23-25). In these winged-helix 
proteins, patches of hydrophobic residues are exposed causing conformational changes to present 
new protein-protein interaction surfaces and inducing dimerization as a function of nucleotide 
binding. 
 
The winged-helix DNA-binding motif in the dimeric UV-DDB is obtained by combining 
the α-paddle with the β-wing motifs in the dimeric DDB2 (23-26). The orientation of the NT-α- 
paddle domain of DDB2 relative to the DNA is similar to those formed between the helical 
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segments of Ets-1 to the DNA (PDB accession code 2nny). Both proteins contain clusters of 
acidic and basic amino acids that form charge and dipolar interactions on the helical surfaces 
facing the DNA backbone. 
 
Using our structural information to align the NT domain of DDB2 to the H-T-H winged- 
type DNA-binding motif in Ets-1 and RFX results in a high conservation of sequence homology 
(>70% identity) and in the 3D-fold. When only the primary sequence of monomeric DDB2 was 
used in various prediction programs to identify protein function, including ProFunc (26), only 
the WD40 domain was identified whereas the programs were unsuccessful in recognizing other 
functional motifs in DDB2. However, defining specific domain boundaries using the dimeric 
UV-DDB structure and combining the sequences of these as composite sites, allowed the 
successful identification of DNA binding sites in DDB2. Thus, these structural analyses support 
the findings of the crystal structure, EM, and AFM studies, verifying that non-contiguous regions 
of DDB2 can adopt DNA-binding motifs when assembled in the dimeric state. Consequently, in 
DDB2, the NT-helical and β-wing domains contain conserved DNA binding sequences that 
allow DDB2 to adopt high-affinity DNA binding motifs. Segregating these topologies so that the 
high-affinity winged-helix motif is formed only upon dimerization modulates DNA affinities, 
enabling apparently incompatible kinetic and thermodynamic oligonucleotide-binding 
characteristics to be encoded within a single protein. 
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Supplementary Tables 
    
 
Table S1: Data Statistics for SeMet UV-DDB  
 
 
 
 
 
 
 
 UV‐DDB‐AP24  
SeMet, Dimer Dataset 1 
Data collection  
X‐ray source 23ID‐B, APS 
Bravais Lattice Orthorhombic 
Cell Dimensions  
a, b, c (Å) 72.42, 76.50, 389.74 
       () 90, 90, 90 
Resolution (Å) 3.22 
# Unique reflections 30981  
Rmerge (3.2‐3.31 Å)* 0.117 (0.358) 
(3.2‐3.31 Å) 10.9 (3.1) 
Completeness (%) (3.2‐3.31 Å) 93.8 (71.3) 
Redundancy (3.2‐3.31 Å) 5.6 (3.6) 
*Values in parenthesis are for the highest resolution shell (3.2‐3.31 Å) 
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Table S2. Dynamic Light Scattering: oligomeric states of UV-DDB 
in the presence and absence of damaged DNA (AP24) 
  
 
 
 
 
 
 
 
 
 
 
 
Sample  Molecular Weight of UV‐DDB  (kDa) 
% Monomer 
200 kDa 
% Dimer 
400 kDa  Oligomeric State 
No Damaged DNA (AP24) 
UV‐DDB  
[0.1 mg/mL] 
201 
>98.5  <1.5 
Monomer Weighted <MW> kDa 
205 
No Damaged DNA (AP24) 
UV‐DDB  
[0.4 mg/mL] 
209 
~95  ~5 
Monomer‐Dimer Weighted <MW> kDa 
221.3 
No Damaged DNA (AP24) 
UV‐DDB 
[1.25 mg/mL] 
261 
~85  ~15 
Monomer‐Dimer  Weighted <MW> kDa 
245.0 
         
+ Damaged DNA (1:3 AP24*) 
UV‐DDB‐AP24  
[0.1 mg/mL] 
422 
<1  >99 
Dimer Weighted <MW> kDa 
397.5 
+ Damaged DNA (1:3 AP24*) 
UV‐DDB‐AP24  
[1.25 mg/mL] 
504 
0  100 
Dimer Weighted <MW> kDa 
400.0 
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Table S3. Surface Plasmon Resonance: relative rates and affinities of damaged DNA (AP24) 
binding for monomeric and dimeric UV-DDB 
 
* Molar ratio of UV‐DDB to AP24 is 1:3, maintaining the stoichiometric ratios used for crystallization 
and EM analysis 
 
 
 
 
Oligomeric State of UV‐DDB 
Parameters 
ka (1/Ms)  kd (1/s)  KA (1/M)  KD (M)  Chi
2 
ΔKD  
(Fold Increase )
Dimer vs Mono
   
SPR Data Set 1    
AP24 to UV‐DDB monomer  2.38×105  5.97×10‐3  3.98×107  2.5×10‐8  0.82  4X 
(3.52) AP24 to UV‐DDB dimer  4.52×105  3.21×10‐3  1.41×108  7.10×10‐9  1.01 
             
SPR Data Set 2             
AP24 to UV‐DDB monomer  2.16x105  6.24×10‐3  3.46×107  2.88×10‐8  1.19  4X  
(3.98) AP24 to UV‐DDB dimer  4.33×105  3.13×10‐3  1.38×108  7.22×10‐9  1.10 
             
Summary Monomer 
Data Sets 1&2             
AP24 to UV‐DDB monomer  2.38×105  5.97×10‐3  3.98×107  2.5×10‐8  0.82   
AP24 to UV‐DDB monomer  2.16x105  6.24×10‐3  3.46×107  2.88×10‐8  1.19   
Monomer <Average>  2.27×105  6.11×10‐3  3.72×107  2.69×10‐8  ‐‐   
             
Summary Dimer 
Data Sets 1&2             
AP24 to UV‐DDB dimer  4.52×105  3.21×10‐3  1.41×108  7.10×10‐9  1.01   
AP24 to UV‐DDB dimer  4.33×105  3.13×10‐3  1.38×108  7.22×10‐9  1.10   
Dimer <Average>  4.43×105  3.17×10‐3  1.40×108  7.16×10‐9  ‐   
             
Overall Δ in Kinetics & Affinities 
of Damaged DNA (AP24)  
 Binding Parameters in  
Dimeric Relative to Monomeric 
States of UV‐DDB  
2X 
 
½‐1X  
 
2‐4X 
 
¼‐½X 
 
‐‐ 
Association rate 
2X faster 
Dissociation rate 
2X slower Overall 
~4X Higher 
Affinity in dimeric 
state (relative to 
monomeric) 
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Table S4. Summary of UV-DDB molecular parameters 
 
[UV‐DDB] & Method  Radius (nm) 
Area 
(nm2) 
Volume 
(nm3) 
Molecular 
Weight  
(kDa) 
Oligomeric State(s) 
No DNA or Bound to Undamaged DNA 
DLS: No DNA 
UV‐DDB  
[UV‐DDB]=0.5 μM 
3.3      188  Monomer 
UV‐DDB  
[UV‐DDB]=2.2 μM  3.7      202  Monomer 
EM: No DNA 
UV‐DDB  
[UV‐DDB]=0.5 μM 
3.5  35      Monomer 
AFM: +Nondamaged DNA 
UV‐DDB  
25 nM undamaged DNA; [UV‐DDB]=50 nM 
    ~81 ± 10  184 ± 23  Monomer 
Bound to Damaged DNA 
DLS: +AP24 Abasic DNA 
UV‐DDB‐AP24  
1:3 AP24; [UV‐DDB]=0.5 μM 
6.7      403  Dimer 
UV‐DDB‐AP24  
1:3 AP24; [UV‐DDB]=2.2 μM)  7.0      433  Dimer 
EM: +AP24 Abasic DNA 
UV‐DDB‐AP24  
1:3 AP24; [UV‐DDB]=0.5 μM 
~5  71      Dimer 
AFM: +UV‐irradiated 517 bp PCR DNA 
UV‐DDB‐AP24  
1:2.5 UV‐DNA; [UV‐DDB]=50 nM 
    ~133   349.9  Dimer+ 1 Duplex DNA 
    ~139  365.4  Dimer+ 2 Duplex DNA 
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Table S5: XPE Mutations 
 
 
 
 
 
XP‐E 
Patient  Mutation 
Biochemical 
DDB2‐DDB1 
Biochemical 
DDB2‐UV‐DNA  References 
XP2RO  R273H  affected  affected  (2, 27, 28) 
XP25PV  D307Y  affected  affected  (2) 
GM01389  L350P delN349 
 
affected 
 
affected  (2) (29) 
XP82TO  K244E    affected  (2, 27, 28) 
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Supplementary Figure Legends 
  
 
Figure S1. Evidence of dimerization of UV-DDB from particle size analysis from negative 
stain electron micrographs.  
A representative area of the UV-DDB sample without DNA is shown (a) raw; (b) band-pass 
filtered to preserve features from 5-18 nm in dimension; (c) after application of a local “rolling 
ball” filter (radius 9 nm) to further remove variations in the background gradient; and (d) 
thresholded to yield countable areas (white). This procedure was applied to all micrographs and 
results were combined into a total histogram for each sample. (e) A histogram of particle areas 
estimated from a single negative stain micrograph shows a peak at ~36 nm2, corresponding to a 
circle of diameter ~7 nm that is consistent with a monomer of the UV-DDB1-DDB2 complex, 
and a shoulder at ~72 nm2  that represents a minor population of dimers. Examples of 
monomer-sized areas are indicated with arrowheads, and dimers with double-arrowheads, in (d). 
The ImageJ software (4) was used for image processing. (f) A gallery of individual particles from 
different techniques of electron microscopy, as indicated. Some negative stain images are as large 
as monomers of UV-DDB (“1") while others are twice (“2") as large. 
 
Figure S2: Electrostatic potential surfaces of dimeric UV-DDB2 in a complex with AP24 
 
DNA 
  
Electrostatic potential surfaces generated in PyMol, with positive potentials displayed in blue, 
negative in Electrostatic potential surfaces generated in PyMol, with positive potentials displayed 
in blue, negative in red, and uncharged in white. (A) The BPA domain of DDB1 displays a large 
hydrophobic region (white surfaces, outlined in a dotted yellow line) on the surfaces facing the 
β−propeller domain of DDB2. In contrast, the BPC domain of DDB1 presents strong negative 
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charge clusters (surfaces in red, outlined in a purple dotted line) facing the NT α−paddle domain 
of DDB2. (B) DDB2 displays strong positive charge clusters (in blue) facing DDB1’s BPC 
domain (outlined in a green dotted line) and at the DNA binding sites. These electrostatically 
neutralize the negative phospho-sugar backbone of the DNA, augmenting the DDB2-DNA 
binding interactions and contributing to the overall high-binding affinity for damaged DNA. (C) 
The DDB1-DDB2 molecular interface displays both aliphatic and charge characteristics, with the 
distribution of charged (in blue & red) and hydrophobic (in white) residues aligned to be 
complementary and neutralize the overall electrostatic potential upon complex formation. 
 
Figure S3: Schematic representations of the multiple sites of interactions found at the 
abasic lesion between the dimeric DDB2 and the AP24 oligodeoxynucleotide . 
 
(A) The dimeric DDB2, depicted by yellow ribbon representation, with an AP24 
oligodeoxynucleotide mer bound at each site in the monomers. The NT region of DDB2 folds 
into a helical bundle (“α-paddle”) that forms extensive interactions with a neighboring DNA 
molecule, depicted by stick-and-ball representation; the phospho-ribose backbone is colored in 
orange-red for the damaged strand and in blue for the undamaged strand. Defined sites of 
interactions between DDB2 and the damaged DNA can modulate binding affinities and optimize 
positioning of the damaged and undamaged DNA strands. Four distinct groups of interactions are 
found at the primary DNA binding site in DDB2 and mapped to the DDB2 structure, with a 
sphere representing the position of the DDB2 residue. At the lesion site on the damaged strand 
(D+1), residues at the β-loop are represented by an orange sphere; residues that stabilize the 
THF11 and dC12 (D+1) in their extrahelical configuration are denoted by yellow spheres; 
residues forming predominantly electrostatic interactions with the phosphodeoxyribose backbone 
of the DNA within a two basepair window upstream and downstream of the lesion sites are 
 denoted by violet (D-1,D-2) and green (D+3,D+4) spheres. (B) The complete 24 base pair duplex 
containing an apurinic lesion mimicked at position 11 (THF11), with the same color scheme 
representing the four groups of DDB2-DNA interactions with the damaged DNA strand. 
Additionally, DDB2 residues that form interactions with the undamaged DNA strand are 
represented by tan rectangles, with the dimer junction denoted by Asn360, colored in red. (C) 
Additional DDB2-DNA interactions are found in the dimeric DDB2; the residues from one 
monomer subunit are denoted by ovals while residues from the other subunit are denoted as 
rectangles, using the same color scheme as in Figures 2A and 2B. DDB2 interactions with the 
undamaged strand are predominantly electrostatic in nature. A large cluster of lysines and 
arginines is found opposite the lesion site and bridges between the two strands. These charge 
clusters may denote poly-ubiquitination sites, especially as DDB2-DNA contacts are likely to be 
disrupted with a cascade effect, resulting in cooperative dissociation, based on the alignment of 
these charge residues. 
Figure S4: Evidence for UV-DDB monomer to dimer transition when bound to damaged 
DNA as revealed by volume analysis using AFM.  
A. Representative surface plot of UV-DDB (50 nM) in the presence of undamaged 517 bp PCR 
fragments (25 nM) showing free UV-DDB (white arrow) and bound to the undamaged DNA 
(yellow arrow). The image is at 500 nm by 500 nm and 3 nm height scale. B. Volume analysis of 
UV-DDB bound to undamaged DNA. Inset: Gaussian fits to the data in the range 0 – 175 nm3. 
Data points outside this range were ignored to obtain the Gaussian fit. From the fit, the peak 
positions correspond to 81 and 133 nm3 with an R2= 0.9 consistent with the size of the 
heterodimer (DDB1-DDB2) and dimer of heterodimers of UV-DDB (DDB1-DDB2)2. C. 
Summary of fraction of UV-DDB bound to DNA for undamaged (gray; 37%, N=163 and UV-
 irradiated (black; 96%, N=435 DNA. Fractions were calculated a (number of UV-DDB protein-
DNA complexes)/ (number of UV-DDB protein-DNA complexes) + (number of  free  UV-DDB  
protein  molecules  on  the  mica).  D.  Overlay of percentage histograms for AFM derived 
volumes of UV-DDB molecules calculated on undamaged (dashed line) and UV-irradiated DNA 
(solid line). These data were generated by normalizing the count in each bin with respect to the 
total number of counts and converting to a percentage for each bin (undamaged DNA or UV-
irradiated DNA). E. Histogram of the differences in the percentage histograms for UV-DDB 
bound to UV-irradiated DNA with respect to the undamaged DNA calculated bin wise. 
 
Figure S5: Calibration curve for Nanoscope V.  
The AFM volume of a protein (V) is a linear function of its molecular weight (MW). Calibration 
curve for Nanoscope V was constructed by performing AFM volume analysis of the following 
proteins: Pot1 (65 kDa), PcrA (86 kDa), UvrA monomer (105 kDa), Taq MutS dimer (181 
kDa), UvrA dimer (210 kDa) and Taq MutS tetramer (362 kDa). The equation for the AFM 
volume is : V (nm3) = 0.3856 MW (kDa) – 1.913 with R2 = 0.9886. Based on this equation, the 
AFM volume of DDB1-DDB2 heterodimer (MW 
 
= 175 kDa) is 66 nm3 (dotted arrows) and that of a dimer of the DDB1-DDB2 heterodimer (MW 
 
= 350 kDa) is 133 nm3 (dashed arrows). 
   
Figure S6: XP-E mutations mapped on to the dimeric human UV-DDB structure. 
 
(A,B). Two views showing the locations of common DDB2 mutations found in XP-E patients 
(also see Table S5). These residues (represented by atomic Van der Waals surfaces) form 
multiple, bridging contacts to DDB1 (Leu350, Arg273) or DNA (Lys244, Asp307). Disruption of 
these interactions presumably lead to more global destabilization in UV-DDB, as these residues 
 appear to maintain multiple intermolecular associations in the holo-complex. (C,D). In the 
dimeric UV-DDB, the deleterious effects of two mutations in particular, Leu350 and Asn307, are 
more apparent, as these additionally modulate interactions to the NT -paddle domain of 
DDB2. Thus, Leu350 and Asp307 of DDB2 form key intermolecular associations, at the 
junctions to both DDB1 and to the damaged DNA. 
 
Figure S7: Representative electron density map of the dimeric UV-DDB-AP24 complex, 
using combined  SeMet  anomalous  phasing  approaches  combined  with  partial  model 
phasing methods. 
 
Representative electron density map, using a combined SeMet anomalous phasing approach 
along with partial model phasing methods. The initial 2Fo-Fc map, contoured at 1.8σ, clearly 
showing the AP24 oligodeoxynucleotide bound at one surface of the β−propeller of DDB2. 
 
 
Figure S8: Dynamic Light Scattering (DLS) analysis showing the particle sizes of UV-DDB 
and composition (% mass), determined at various protein complex concentrations and in the 
absence & presence of damaged DNA (AP24). 
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